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Cell-cell junctions allow cells to maintain structure, organize into complex tissues and 
organs, and communicate both physically and chemically to function in unique environments. One 
such environment is the heart where cells must maintain adhesion during coordinated and constant 
rhythmic contraction. It is estimated that cardiomyocytes experience forces in excess of 1000nN, 
more than ten times that of nonmotile epithelial cells. It is not clear how these cells maintain 
adhesion under such extreme force. One of the cellular complexes involved in cardiomyocyte 
adhesion is the fascia adherens, also known as the adherens junction. The adherens junction 
couples adjacent cardiomyocytes and integrates the contractile myofibril network between them. 
The primary link between the adherens junction and the F-actin cytoskeleton is -catenin. Two 
different -catenins are expressed in the mammalian heart and, in the work presented here, I sought 
to understand how -catenin functions in cardiomyocyte cell-cell adhesion. Specifically, my work 
addresses the properties of T(testes)-catenin, a poorly characterized isoform with expression 
limited to the testes, central nervous system, and heart. Mutations in T-catenin have been linked 
to cardiomyopathy and I sought to characterize its unique interactions with other adhesion and 
cytoskeletal proteins in the context of cardiomyocytes. I found that, in contrast to the better 
characterized E(epithelial)-catenin, T-catenin is a monomer in solution and can readily bind F-
actin in the absence of tension. I also found that both E-catenin and T-catenin bind to -catenin 
at the adherens junction with similar affinities. Finally, I showed that T-catenin binds to vinculin 
by a tension-dependent mechanism, but autoinhibition of the M-region is regulated by a distinct 
 v 
mechanism of intramolecular interaction involving the T-catenin N-terminal domain. These 
unique properties of T-catenin will help to define its function in cardiomyocytes and offer insight 
into how mutations in T-catenin contribute to cardiomyopathy. 
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The mechanisms that regulate cell-cell adhesion have been essential to the evolution of 
multicellular life and have allowed for the tissue specialization and organization observed across 
Metazoa. Cell-cell junctions allow cells to maintain structure, organize into complex tissues and 
organs, and communicate both physically and chemically to function in unique environments1. 
One such environment is the heart where cells must maintain adhesion during coordinated and 
constant rhythmic contraction2,3. It is estimated that cardiomyocytes experience forces in excess 
of 1000nN, more than ten times that of nonmotile epithelial cells4. It is not clear how these cells 
maintain adhesion under such extreme force. One of the cellular complexes involved in 
cardiomyocyte adhesion is the fascia adherens or adherens junction5. In the work presented here, 
I sought to understand how a component of the adherens junction, -catenin, functions in 
cardiomyocyte cell-cell adhesion. Specifically, my work addresses T(testes)-catenin, a poorly 
characterized isoform with expression limited to the testes, central nervous system, and heart. 
Mutations in T-catenin have been linked to cardiomyopathy and I sought to characterize its 
unique interactions with other adhesive and cytoskeletal proteins in the context of cardiomyocytes. 
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1.1 Cardiomyocytes and ICD Adhesive Complexes 
The heart pumps blood through the circulatory system to deliver oxygen and nutrients 
throughout the body. To accomplish this, the heart relies on the coordinated contractions of its 
muscle cells, called cardiomyocytes. Unlike skeletal muscle cells that organize into long, 
multinucleated syncytial fibers, cardiomyocytes function as individual cells that must physically 
couple and coordinate with one another to form the heart muscle. The syncytial cells of skeletal 
muscle allow for fast transmission of electrical signals throughout the fiber and for the contractile 
acto-myosin myofibril network to run continuously through the length of the muscle6,7. Instead of 
a true syncytium, individual cardiomyocytes create a functional syncytium through a specialized 
adhesive structure called the intercalated disc (ICD) 3,8. This difference in cellular organization is 
thought to help protect the heart against cellular death, so if one or more cells fail it does not lead 
to failure of the entire organ2.  
The ICD mechanically couples adjacent cardiomyocytes through adherens junctions, 
desmosomes, and a junction containing components of each called the hybrid junction, or area 
composita3,9-11. The ICD also electrically couples cardiomyocytes through gap junctions that 
allow ions to pass between cells and provide electrical continuity12 (Figure 1.1). Each of these 
junctional complexes are essential to proper cardiac function13. Mutations in ICD proteins have 
been linked to dilated cardiomyopathy, arrhythmogenic cardiomyopathy and hypertrophic 




Figure 1.1 Junctional complexes that make up the intercalated disc.  
Cartoon schematics of the adherens junction, area composita, desmosome and gap junction that make up the 
ICD in cardiomyocytes. 

















1.1.1 Adherens Junction 
The adherens junctions(AJ) is the most ancestral cell-cell junctional complex and is found 
in all animals from poriferans to mammals17,18. AJs connect to the actin cytoskeleton and play an 
important role in a variety of important cellular processes such as the initiation and stabilization 
of adhesion between cells, cytoskeletal and transcriptional regulation, and intracellular signaling19. 
The core of the adherens junction is made of the cadherin-catenin complex20. Classical cadherins 
are single-pass transmembrane proteins with extracellular and cytoplasmic domains. The 
extracellular domain of the cadherin forms calcium-dependent homotypic trans interactions with 
cadherins on neighboring cells20,21. Classical cadherins can also form cis interactions with adjacent 
cadherins on the same cell surface to form adhesion plaques21. Together, cis and trans interactions 
create a lattice of extracellular cadherin domains to stabilize intercellular adhesions23,24 (Figure 
1.2). The cytoplasmic tail domain is largely unstructured and recruits catenin proteins (discussed 
below) to attach the adherens junction to the F-actin cytoskeleton22,23.  
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Figure 1.2 Cis and trans interactions between classical cadherins. 
Cartoon Schematic of cis and trans interactions in an N-cadherin adhesion plaque. 
 
 N-cadherin is the only classical cadherin expressed in cardiomyocytes22. It is essential to 
heart development and loss of N-cadherin is embryonic lethal. In conditional knockouts, loss of 
N-cadherin in the developing heart prevents myocytes from forming cell-cell adhesions, causing 
cells to dissociate and disrupting heart tube formation24. N-cadherin is also required for proper 
heart function. Inducible knockout of N-cadherin in the adult mouse heart resulted in the 
disassembly of the ICD – with loss of adherens junctions, desmosomes and gap junctions – making 
it a linchpin of cardiomyocyte junctional assembly25. When N-cadherin deficient mouse hearts 
were rescued with E-cadherin, mice developed normally and survived to maturity but had 
increased rates of mortality and developed dilated cardiomyopathy. This was the result of ICD 










levels of the gap junction protein connexin-43, both of which have been associated with heart 
failure and cardiac hypertrophy26. 
The cytoplasmic tail of N-cadherin recruits two catenins in the armadillo family of proteins, 
p120-catenin and -catenin27 (Figure 1.1). Armadillo proteins get their name from the 42 amino 
acid repeat domains first discovered in the Drosophila -catenin homologue Armadillo28. p120-
catenin binds to the juxtamembrane region of the cadherin tail and plays an important role in the 
regulation of cadherin trafficking29. p120-Catenin masks an endocytic signal that is conserved 
across the classical cadherins30. Masking this signal prevents internalization to protect the cadherin 
from degradation. Along with this role, p120-catenin binds to cadherins during their biogenesis to 
aid in trafficking cadherin-catenin complexes to the membrane via kinesin transport along 
microtubules31. These mechanisms work together to regulate and maintains the population of 
cadherins at cell-cell junctions32. p120-Catenin is also involved in a variety of signaling pathways 
that regulate cytoskeletal organization, most notably the Rho-GTPases 33,34. Its action on these 
pathways makes it a candidate for relaying outside-in signaling to regulate cellular processes like 
growth, polarization, migration and differentiation in response to external environmental cues32,34. 
-Catenin, the other armadillo family catenin protein, is recruited to the distal portion of 
the cadherin tail. -catenin in turn, recruits -catenin to the adherens junction27. This function can 
also be performed by the desmosomal protein plakoglobin, a closely related protein that can also 
bind to the cadherin tail. Consistent with overlapping functions at the AJ, plakoglobin can 
compensate for the loss of -catenin in in adult mouse heart. However, -catenin cannot bind to 
desmosomal cadherins35,36 and cannot compensate for loss of plakoglobin in mouse hearts37. 
Complete loss of -catenin is embryonic lethal in mice and embryos are unable to complete 
gastrulation38. This is partially due to its vital signaling role during development in the Wnt 
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signaling pathway. In the canonical Wnt pathway, Wnt binding to the Frizzled/LRP5/LRP6 
receptors causes -catenin to accumulate in the cytoplasm, promoting translocation to the nucleus 
where it functions as a transcriptional activator to regulate  cell fate determination, migration, cell 
polarity and organogenesis39. Mis-regulation of the Wnt pathway and overexpression of -catenin 
in cardiomyocytes and cardiac fibroblasts has also been linked to cardiac injury, fibrosis and 
hypertrophy40. It is not clear if plakoglobin plays a role in the regulation of Wnt signaling. 
-Catenin is recruited by -catenin to the cadherin tail and it serves as the primary link 
between the adherens junction and F-actin41-43. It is responsible for connecting to the cortical actin 
cytoskeleton as well as integrating myofibrils across cell-cell contacts in cardiomyocytes44,45. 
Three different -catenin isoforms are expressed in mammals: E(epithelial)-catenin, 
N(neuronal)-catenin and T(testes)-catenin46-48. E-catenin is ubiquitously expressed and 
critical for development49. Knockout of E-catenin in mice is embryonic lethal, blocking 
gastrulation50. N-catenin is expressed in neuronal cells and is important for neural development 
and axon migration. Mice lacking N-catenin develop hypomorphic brains and die around 
birth51,52. T-catenin is expressed in the testes, heart and central nervous system. However, it is 
developmentally dispensable, and knockout mice develop fully and are fertile49,53. E-catenin and 
T-catenin are expressed in the mammalian heart and both are required for proper heart 
function48,54. In cardiac-specific E-catenin knockout mice, the cardiomyocyte adherens junction 
is disrupted leading to dilated cardiomyopathy and increased incidence of rupture caused by 
thinning of the heart wall11. T-catenin knockout mice also develop dilated cardiomyopathy at 3-
6 months of age53. Two mutations in T-catenin have been linked to arrhythmogenic 
cardiomyopathy(ACM) in humans16,55, a disease that is associated with arrhythmias and electrical 
abnormalities of the heart56. The link between ACM and T-catenin is not well understood. 
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1.1.2 Desmosome 
Desmosomes are a mechanical junction found in tissues under high stress such as the heart 
and skin57. They are adapted to these high stress conditions through their attachment to the 
intermediate filament cytoskeleton. The name intermediate filament was coined from their average 
10nm diameter that falls between 6nm actin filaments and 25nm microtubules. A variety of 
intermediate filaments are expressed in different cell types, including keratin in skin, neuronal 
filaments in neurons and desmin in myocytes58. Intermediate filaments can be stretched to several 
times their length and stiffen under strain to increase mechanical stability in tissues58. A variety of 
intermediate filaments are expressed to support different tissues, with cardiomyocytes and other 
muscle cells expressing desmin59. Desmosomes have been closely tied to the assembly and 
maintenance of other junctional complexes at the ICD and mutations in many desmosomal proteins 
have been linked to arrhythmogenic cardiomyopathy15,56,60. 
Desmosomes are thought to have evolved in the vertebrate lineage from several duplication 
events of adherens junction genes, so unsurprisingly they share similar structural components1. 
The desmosomal cadherins desmoglein and desmocolin are transmembrane proteins that make 
homotypic or heterotypic trans interactions with desmosomal cadherins on opposing cells61. 
Unlike classical cadherins, these trans interactions adopt a hyperadhesive state that does not 
require calcium ions under normal tissue conditions. Hyperadhesion is essential for maintaining 
stable contacts in response to mechanical stress, but these interactions can also revert to a weaker 
calcium dependent state during tissue remodeling and wound healing57. 
The tail of desmosomal cadherins recruits two armadillo proteins, plakoglobin and 
plakophilin. Plakoglobin and plakophilin are paralogues of -catenin and p120-catenin, 
respectively1. In contrast to plakoglobin, plakophilin cannot bind to classical cadherins and only 
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binds to the tail of desmosomal cadherins. These proteins then recruit the plakin family protein 
desmoplakin to the desmosome to link the complex to the intermediate filament cytoskeleton60.  
Plakophilins are p120-catenin family proteins composed of an N-terminal head and 9 
armadillo repeats with flexible linker regions between repeats 5 and 662. Most proteins known to 
interact with plakophilin bind to the head domain, including the desmosomal cadherin tail and 
desmoplakin, but the associations of the armadillo repeats of plakophilins are not well 
understood62,63. Three different plakophilins are expressed in mammals with different expression 
profiles. Plakophilin-1 is expressed in the upper layers of stratified epithelia, like the epidermis63,64. 
Plakophilin-2 is expressed in simple epithelia and the lower layers of stratified epithelia. It is also 
expressed in non-epithelial tissues and is the primary form expressed in cardiomyocytes65.62 
Plakophilin-3 is expressed in both simple and stratified epithelia, but is equally expressed 
throughout the different layers63,64. In addition to their structural role in adhesion, plakophilins can 
also shuttle into the nucleus where they are thought to play a role in cell signaling by regulating 
the cell cycle through the Wnt and Ras signaling pathways65,66. 
Desmoplakin is an obligate desmosomal protein that is organized into three major domains. 
The N-terminus contains a globular head domain that binds to plakoglobin and plakophilin. The 
C-terminal tail contains three plakin repeats and a GSR domain that binds intermediate filaments. 
These two domains are connected by a middle alpha helical rod domain63. Desmoplakin is 
expressed as two different splice variants: DP1 is 332kDa and DP2 is 260kDa. These two isoforms 
are identical, apart from a truncated rod domain in DP2. These two variants are coexpressed in 
most tissues with the exception of the heart that only expresses significant amounts of DP166. 
Mutations in desmosomes are the primary cause of arrhythmogenic 
cardiomyopathy(ACM) 62. ACM is estimated to affect as many as 1 in 1000-5000 people and is 
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the leading cause of sudden cardiac death in young individuals67,68. As this disease progresses, 
cardiomyocytes are replaced by fibrofatty tissue in the ventricle of the heart. Fibrotic tissue is 
unable to properly conduct electrical signals to coordinate contractions and results in arrhythmias, 
tachycardia, and electrical and physical abnormalities in the myocardium56. Oftentimes these 
symptoms are not recognized or displayed during disease progression and the first symptom is 
sudden cardiac death, so efforts are being made to determine viable biomarkers for diagnosis56,69. 
Mutations in a desmosome component account for as many as 50 percent of cases, and mutations 
in plakophilin-2 account for as many as 70% of familial cases56,70. It was initially thought that 
mutations in desmosomal components caused defects in cell-cell adhesion leading to ACM, but 
recent findings into the role(s) of the desmosome in cell signaling and crosstalk with other 
junctions have made this conclusion less clear. Desmoplakin is important for the trafficking of the 
gap junction protein connexin-43 to the membrane and to prevent its degradation by the lysosome 
once it has been delivered71,72. Plakophilin-2 is also linked to the proper function of Nav 1.5, a 
voltage gated sodium channel important for depolarization of cardiomyocytes73. These results 
point to ACM mutations in desmosomal proteins causing defects in electrical conduction, possibly 
in addition to a defect in adhesion. Notably, desmosomal proteins can also associate closely with 
adherens junction proteins to form a hybrid junction called the area composita10,68. Defects in the 
area composita have also been linked to ACM in humans, so it is also possible that the disease 
results from a failure to form proper cell-cell adhesions15,16. 
1.1.3 Area Composita 
In epithelial cells, adherens junctions and desmosomes form two distinct junctions whose 
localization is largely distinct along cell borders. In cardiomyocytes, it has been found that 
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components of each of these junctions are in close proximity74 and T-catenin can directly bind 
to the desmosome protein plakophilin-275 (Figure 1.1). Adherens junctions containing T-catenin 
can directly bind to F-actin and recruit Plakophilin-2 and Desmoplakin to bind intermediate 
filaments to make a unique junction that integrates these two cytoskeletal networks. This hybrid 
junction is thought to be important in reinforcing and strengthening the cell-cell adhesions in the 
high stress environment of cardiomyocytes75,76. 
The formation of the area composita takes place late in development. Mouse hearts have 
distinct junctional plaques of desmosomes and adherens junctions during embryonic development. 
Postnatally, these junctions begin to colocalize along the ICD77. T-catenin expression also turns 
on perinatally suggesting the increased expression may be connected to the intermixing of these 
junctions and the formation of the area composita76. 
1.1.4 Gap Junction 
Gap Junctions allow for the movement of ions and other small molecules to permit 
intercellular communication throughout the body78. In the heart, gap junctions carry the electrical 
signals necessary for proper rhythm and coordination of cardiomyocyte contraction79. Gap 
junctions are made up of integral membrane proteins called connexins that organize into hexamers 
called connexons. Connexons on one cell bind connexons on an opposing cell to create a pore 
known as the gap junction80(Figure 1.1). Gap junctions are non-selective and allow diffusion of 
molecules under about 1000 Daltons. They further assemble into plaques varying is size from tens 
to thousands of gap junctions along lateral portions of the ICD81,82. 
Three different connexins are predominantly expressed in the mammalian heart with 
different expression levels depending on location: connexin-45, connexin-40 and connexin-4379. 
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Connexin-45 is the predominant subunit in the pacemaker cells of the sinoatrial node and the 
atrioventricular node. These cells are weakly coupled to allow for proper pacemaker function83. 
Connexin-40 is highly expressed in Purkinje Fibers. These cells have rapid conductance and carry 
the electrical signal to the distal tip of the ventricle84. Ventricular cardiomyocytes express almost 
exclusively connexin-43 with only trace amounts of other connexins to propagate the contractile 
signal to the rest of the heart79,83.  
Connexin-43 is essential for proper development and heart function. Mice lacking 
Connexin-43 survive to term but die at birth as a result of swelling and blockage of right ventricular 
outflow, inhibiting gas exchange85. Heart specific knockout of connexin-43 results in hearts that 
appear physically normal and contractile, but mice die from sudden cardiac death as a result of 
ventricular arrhythmias by two months of age86. Defects in gap junction function and localization 
have also been associated with heart disease. Analysis of the ICD in Carvajal Syndrome patients, 
a disease that includes ACM, showed decreased expression of connexin-4382. This syndrome has 
been linked to mutations in desmoplakin, and desmoplakin is required for the proper delivery and 
maintenance of connexin-43 at the ICD71,72. Naxos Disease, another form of ACM caused by 
mutations in plakoglobin also fails to make normal gap junctions at the ICD resulting in 
arrhythmias87. These results, along with the observation that gap junctions fail to form when N-
cadherin is lost at the ICD, highlight how interactions between mechanical junctions and gap 
junctions are crucial for proper heart function5,82. 
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1.2 The -Catenin Family of Proteins 
 
Figure 1.3 -Catenin domain organization. 
-catenins are organized into three major domains. The N-terminus binds -catenin and homodimerizes in 
some -catenins. The M-region binds ligands like vinculin. The C-terminus binds to F-actin. 
 
-Catenins are found throughout the animal kingdom, from the simplest metazoan sponges all the 
way to humans17,88. -Catenin homologues even predate metazoans and are present in the slime 
mold Dictyostelium discoidium that lacks classical cadherins18. Despite the evolutionary 
divergence of these species, -catenins have maintained a core structural organization17(Figure 
1.3). The N-terminal domain is made up of two four-helix bundles that share a common -helix 
between them89. The N-domain binds to -catenin and mediates homodimerization in some -
catenins43,90,91. The middle M-region is a series of three four-helix bundles that serves as a scaffold 
for other adherens junction ligands92-95. Many of these ligands bind to the actin cytoskeleton and 
help stabilize the adherens junction in response to tension45,96. The C-terminal domain is a five-
helix bundle and binds directly to F-actin97-100.  
The first structural studies of -catenin focused on the N-terminus of mouse E-catenin. 
The structure of the N-terminal homodimerization domain, aa 82-279, was crystalized as well as 
a chimera of the E-catenin N-terminus (aa 57-264) flexibly linked to -catenin -catenin binding 
site (aa118-151) 89. This structure established that the N-terminus of E-catenin is composed of 
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antiparallel four-helix bundles and that the homodimerization domain and -catenin binding 
regions overlap89. The crystal structure of the mouse N-catenin N-terminus (aa1-261) was 
resolved more than a decade later. Whereas the E-catenin N-terminus crystalized as a 
homodimer89 the N-catenin N-terminus crystalized as a monomer but was organized as two four-
helix bundles, similar to E-catenin 101. Further structural studies crystalized the M-fragment of 
E-catenin, corresponding to the M2-M3 regions. These studies established that the M-fragment 
is also composed of antiparallel four-helix bundles92,93. The work from Pokutta and colleagues 
also revealed, for the first time, that the binding site for afadin in E-catenin M-region is likely 
cryptic (masked) in full length E-catenin93. 
A decade later, the binding site of another important -catenin M-region ligand – vinculin 
- was mapped to the M1 region of E-catenin and a complex was crystalized showing that M1 
binds to vinculin by a helix addition mechanism95. This work also helped to establish that E-
catenin binding to vinculin is autoinhibited through intramolecular interactions95. Based in part on 
these findings, it was subsequently proposed that the mechanism of autoinhibition was through a 
network of salt bridge residues spanning the M-region, and activation (vinculin binding) required 
tension to break these interactions102-104. Six salt bridges are predicted to form between residue 
pairs within 4 angstroms of each other in mouse E-catenin: Glu 277-Arg 451, Arg 326-Glu 521, 
Asp 392-Arg 548, Arg 383-Asp 510 and Asp 503-Arg 551103. In the absence of these 
intramolecular interactions the vinculin binding site is largely unstructured94. Similarly, the M-
region of N-catenin was crystalized and shares a similar domain organization and intramolecular 
interactions to that of E-catenin94. 
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Nearly full length structures of mouse E-catenin97,105 and human E-catenin106 have been 
solved. These studies showed that intramolecular interactions govern the recruitment of vinculin97 
and allosteric changes occur throughout the protein upon homodimerization106 or binding to the 
cadherin/catenin complex105. These allosteric changes have implications for differences in F-actin 
binding depending on the dimerization state of E-catenin. Crystal structures of the F-actin 
binding region of E- and N-catenin have also been solved97,99,100. These studies illuminated the 
structural basis of E-catenin catch-bond behavior and how tension applied to F-actin strengthens 
the interaction99,100.  
Three -catenins are expressed in mammals: E-catenin, N-catenin and T-catenin. E-
catenin was first described in epithelia but is ubiquitously expressed throughout the body. It is the 
best characterized and most widely studied of the family. Canonically, it functions to link the 
adherens junction to the F-actin cytoskeleton, but it also plays a role in other cellular processes. 
E-catenin also regulates a variety of cell signaling pathways important for development and 
cancer, and regulates the cytoskeleton during cell migration and morphogenesis. N-catenin was 
first characterized in the nervous system and is highly expressed in the brain. It plays an important 
role in axon guidance, regulation of synapse formation and the proper development of the brain. 
T-catenin was first discovered in the peritubular myoid cells in the testes. These are contractile 
cells that provide support and structure to the seminiferous tubules107, but T-catenin is also highly 
expressed in the central nervous system and heart, and is best known for its role at the ICD48,49. 
Little is known about the molecular or cellular functions of T-catenin or how it is linked to disease 
in these diverse tissue types (discussed more below), but it has been shown to be an important 
factor required for proper heart function53. 
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1.2.1 -Catenin in disease 
-Catenins play a vital role in development and are also associated with a variety of 
diseases. Mouse embryos lacking E-catenin are not viable and development is arrested prior to 
implantation due to defects in cell-cell adhesion50. It plays a critical role maintaining flexible yet 
strong adhesions to maintain structure during the complex cellular movements of 
morphogenesis108. When it is lost in other tissues, E-catenin can have adverse signaling effects 
in addition to loss of adhesion. When E-catenin is conditionally knocked out in the skin and 
brain, cell hyperproliferation was observed along with defects in cell polarity109,110. E-catenin 
has also been linked to cancer through a myriad of signaling pathway, such as Wnt/-catenin, NF-
κB, Hippo/Yap and Hedgehog signaling99,100. It is a negative regulator of proliferation, and even 
though it has not been studied as extensively as -catenin or E-cadherin in this role, E-catenin 
has emerged as an important tumor suppressor.  
The expression of N-catenin is much more restricted than that of E-catenin and is largely 
limited to the brain and the cervical spinal cord49. Mice lacking N-catenin develop hypomorphic 
brains, particularly affecting the hippocampus and cerebellum, and die perinatally51. N-catenin 
plays a role in developing these portions of the brain by supporting axon migration52. Similar to 
E-catenin, N-catenin has also been shown to play a role as a tumor suppressor. In the neural 
crest derived cancer neuroblastoma, decreased N-catenin levels are correlated with poorer 
prognosis. Forcing its expression decreased growth of cancer cells in culture and also limited signs 
of cancer progression such as migration, angiogenesis, and invasion by inhibiting NF-κB 
signaling111. 
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T-catenin is most highly expressed in the central nervous system and the heart, but is also 
present in the peripheral nervous system, testes, skeletal muscle, and trace amounts in other tissue 
types49. Unlike the other two members of the mammalian -catenin family it is dispensable for 
development, with knockout mice developing normally and surviving through sexual maturity. 
However, by 6 months of age, T-catenin knockout mice develop dilated cardiomyopathy and 
ventricular arrhythmias after ischemia. This is presumably the result of reduced junctional integrity 
and connectivity between cardiomyocytes as plakophilin-2 and connexin-43 levels are reduced at 
the ICD53. Mutations in T-catenin have also been linked to cardiomyopathy in humans. The N-
terminal V94D mutation and the deletion of Leucine 765 in the actin binding domain both 
independently result in ACM16. ACM is typically associated with the desmosome, and mutations 
in T-catenin linked to the same disorder suggest an important functional connection between the 
two112.  
T-catenin has also been associated with a variety of other diseases outside of the heart. 
Similar to the other -catenin family members, T-catenin may function as a tumor suppressor. 
SNPs and deletions in T-catenin have been linked to laryngeal carcinoma and hybrid 
neurofibroma/schwannoma113,114. Mono-allelic or reduced expression has also been associated 
with a variety of other cancer types, including in tissues with normally low expression, suggesting 
protein expression likely does not directly correlate with transcript number49. 
Consistent with its high expression levels in the central nervous system, T-catenin has 
also been associated with neurological diseases49. The CTNNA3 gene that encodes T-catenin is 
one of the largest genes in the human genome and is located near a common chromosomal fragile 
site linked to late onset Alzheimer’s Disease115,116. It has also been linked in a number of cases to 
autism, with deletions in T-catenin found in patients with sporadic autism117-119. Some progress 
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has been made in understanding the connection of T-catenin to autism, since knockout mice show 
changes in signaling pathways associated with the disorder such as GABA-A receptor 
activation119. It was also found that T-catenin may not be expressed in neurons at all, and is 
instead highly expressed in neurological support cells such as ependymal calls that line the 
ventricles of the brain and central canal of the spinal cord, and oligodendrocytes that surround 
neurons with myelin in the central nervous system119,120. It is not known whether mis-regulation 
of T-catenin function is causal in these disorders, exacerbates another underlying cause or is 
simply associated by chance121.  
1.2.2 -Catenin ligands 
-Catenin acts as a scaffold to recruit a wide range of proteins to the adherens junction. 
Many of these proteins are thought to be necessary for proper cell-cell junction formation and 
function. However, the composition of these protein complexes, how their recruitment is regulated 
and how their function may differ between -catenin family members are all poorly understood. 
Most studies of -catenin ligand interactions have focused on E-catenin, whereas ligand 
interactions with other members of the mammalian -catenin family have not been tested. In the 
studies presented, here we examine the interactions between the -catenin ligands -catenin, F-
actin and vinculin. 
1.2.2.1 -catenin 
-Catenin is recruited to the cadherin tail through its interaction with -catenin or 
plakoglobin122. The binding site for -catenin/plakoglobin overlaps the homodimerization domain 
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of E-catenin in the N-terminus, so the /-catenin heterodimer and E-catenin homodimer are 
mutually exclusive89. The cadherin tail increases the affinity of the interaction between -catenin 
and E-catenin tenfold over that of -catenin alone to the low nanomolar range (25nM for -cat 
alone vs 1nM for -cat/E-cad tail) 43. A similar effect is observed with N-catenin and T-catenin, 
with both binding to -catenin in complex with the cadherin tail with an affinity in the low 
nanomolar range43,123.These results show that each member of the -catenin family can associate 
with the adherens junction through -catenin with similar affinities but it is not clear whether this 
is also the case with plakoglobin. 
Note that E-catenin binding to -catenin independent of the adherens junction impacts 
cell functions by inhibiting the Wnt signaling pathway124. E-catenin is able to bind -catenin and 
inhibit its translocation to the nucleus to prevent Wnt-related transcription. Wnt signaling promotes 
cell growth and is an important in many cancers. Inhibition of this pathway is one mechanism in 
which E-catenin may act as an important tumor suppressor125. 
1.2.2.2 Actin 
The F-actin cytoskeleton provides necessary support and structure to the cell and anchors 
to  cell-cell junctions126. Actin filaments along with myosin are the main components of myofibrils 
in striated muscle, and in cardiomyocytes -catenin is required to integrate the myofibrils across 
the ICD45. -Catenin serves as the primary link between the adherens junction and F-actin23. 
However, the strength and regulation of this linkage varies across the mammalian -catenins.  
When E-catenin is bound to -catenin at the adherens junction it has a very weak affinity 
for F-actin in the absence of tension. However, when E-catenin is bound to itself (homodimer 
state) it can readily bind to F-actin with an affinity in the low micromolar range127. This difference 
 20 
in affinity is because E-catenin, when bound to the cadherin/- catenin complex, forms a catch 
bond with F-actin and cannot fully engage with the actin filament unless under force20,42,99. The 
catch bond behavior of E-catenin is the result of a small alpha-helix termed H0 at the N-terminus 
of the actin binding domain, and also gives a preferred directionality to actin binding at the 
junction98,100. 
The E-catenin dimer acts away from the adherens junction to remodel the F-actin 
cytoskeleton. This cytoplasmic pool of E-catenin inhibits actin nucleation by the Arp2/3 
complex. When this pool is sequestered, lamellipodia and membrane dynamics are increased 
resulting in increased cell migration128.  
1.2.2.3 Vinculin 
One of the best characterized ligands of -catenin is vinculin. Vinculin is known to be 
recruited to focal adhesions in a tension dependent manner through an interaction with the protein 
talin129. Vinculin serves to stabilize the connection to actin filaments and aid in focal adhesion 
maturation130. Vinculin and -catenin are homologous proteins and vinculin plays a very similar 
role in adherens junctions as it does in focal adhesions46. Vinculin is recruited to the adherens 
junction by binding to the M1 region of E-catenin131,132. It is believed that vinculin adds another 
actin binding interface to help stabilize and reinforce the adherens junction in response to 
actomyosin contractile force96.  
Mice lacking vinculin are not viable and develop heart and brain defects during 
development133. Vinculin is essential for heart development and junctional organization, and when 
it is lost in cardiomyocytes, mice develop dilated cardiomyopathy and suffer from sudden cardiac 
death134,135. It is responsible for the integration and proper organization of myofibrils across the 
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ICD in cardiomyocytes and these structures are lost when vinculin cannot be recruited to the cell-
cell junctions45,136. Vinculin plays an important role in maintaining cardiomyocyte junctions in 
humans and it has been found that a missense mutation in vinculin increases susceptibility to 
hypertrophic cardiomyopathy and disrupted ICD organization inducing interstitial fibrosis137.  
The mechanism of vinculin recruitment to E-catenin is through a mechanosensitive 
conformational change of the E-catenin M-region95(Figure 1.4). When not under tension the M-
region adopts a closed autoinhibited conformation97. The M-region is maintained in the 
autoinhibited conformation by a network of salt bridge residues that span between the M1, M2 and 
M3 regions103. Tension breaks these salt bridges and M1 is able to unfurl away from the rest of the 
M-region102. The vinculin head domain is then able to bind to the free M1 region where the E-
catenin -helix is inserted into the 4-helix bundle of vinculin138. Once vinculin is bound, the 
conformation of E-catenin is “locked” in the open conformation and even if tension is on the 
complex is lost, vinculin remains bound102. 
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Figure 1.4 E-catenin undergoes a conformational change in response to force to recruit vinculin. 
 
Vinculin is also regulated by its own mechanism of autoinhibition which limits ligand 
binding139. The N-terminal head of vinculin is able to bind the C-terminal tail domain and hold it 
in the closed conformation140. This mechanism is regulated by actomyosin contractile tension and 
also requires multiple ligand associations to relieve autoinhibition141. This mechanism ensures the 
proper recruitment of vinculin to junctions under stress and is only activated when its necessary 
ligands are present140. 
It is unclear if a similar mechanism of autoinhibition of vinculin binding is present in other 
members of the -catenin family. Here we show that the T-catenin M-region is not autoinhibited 
in the same way that E-catenin is despite 5 of the 6 salt bridge pairs being conserved. Instead 
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vinculin binding to T-catenin is regulated by a previously undescribed intramolecular interaction 
between the N-Terminus and the M-region123. This unique mechanism of M-region autoinhibition 
may play an important role in how ligands are recruited to individual adherens junctions when a 
different -catenin is present. 
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2.0 T-catenin is a constitutive actin-binding -catenin that directly couples the cadherin-
catenin complex to actin 
This text was published in the Journal of Biological Chemistry in 2016: 
Wickline ED, Dale IW, Merkel CD, Heier JA, Stolz DB, Kwiatkowski AV. αT-Catenin Is a 
Constitutive Actin-binding α-Catenin That Directly Couples the Cadherin·Catenin Complex to 
Actin Filaments. J Biol Chem. 2016;291(30):15687-15699. doi:10.1074/jbc.M116.735423. 
 
Contributions: I assisted in purifying recombinant proteins used for experiments 
throughout the paper. I repeated and verified T-catenin WT, V94D and E-catenin trypsin 
limited proteolysis experiments (Fig. 2.1D and Fig. 2.4I). I also performed and analyzed all sucrose 
gradient experiments (Fig. 2.2E-G and Fig. 2.4F-G). I performed the F-actin co-sedimentation 
experiments for T-catenin/-catenin and verified the results of T-catenin WT and V94D (Fig. 
2.3A-B and Fig. 2.5A-B). Finally, I helped write and edit the manuscript and responded to reviewer 
comments. 
2.1 Overview 
-Catenin is the primary link between the cadherin/catenin complex and the actin 
cytoskeleton. Mammalian E-catenin is allosterically regulated: the monomer binds the -
catenin/cadherin complex, whereas the homodimer does not bind -catenin but interacts with F-
actin. As part of the cadherin/catenin complex, E-catenin requires force to bind F-actin strongly. 
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It is not known if these properties are conserved across the mammalian -catenin family. Here we 
show that T(Testes)-catenin, a protein unique to amniotes that is expressed predominantly in the 
heart, is a constitutive actin-binding -catenin. We demonstrate that T-catenin is primarily a 
monomer in solution and that T-catenin monomer binds F-actin in co-sedimentation assays as 
strong as E-catenin homodimer. The -catenin/T-catenin heterocomplex also binds F-actin with 
high affinity, unlike the -catenin/E-catenin complex, indicating that T-catenin can directly link 
the cadherin/catenin complex to the actin cytoskeleton. Finally, we show that a mutation in T-
catenin linked to arrhythmogenic right ventricular cardiomyopathy (ARVC) – V94D –promotes 
homodimerization, blocks -catenin binding and, in cardiomyocytes, disrupts localization at cell-
cell contacts. Together, our data demonstrate that T-catenin is a constitutively active actin-
binding protein that can physically couple the cadherin-catenin complex to F-actin in the absence 
of tension. We speculate that these properties are optimized to meet the demands of cardiomyocyte 
adhesion. 
2.2 Introduction 
The adherens junction (AJ) mechanically couples the actin cytoskeletons of adjacent cells 
to establish and maintain intercellular adhesion142-144. The core of the AJ is the cadherin-catenin 
complex145. Classical cadherins are single-pass transmembrane proteins with an extracellular 
domain that mediates calcium-dependent homotypic interactions146. The adhesive properties of 
classical cadherins are driven by the recruitment of cytosolic catenin proteins to the cadherin tail: 
p120-catenin binds to the juxta-membrane domain and -catenin binds to the distal part of the 
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tail147. -Catenin, in turn, recruits -catenin to the cadherin-catenin complex43,89. -Catenin is a 
filamentous actin (F-actin) binding protein and the primary link between the AJ and the actin 
cytoskeleton41,42,127,148. 
In mammals, E (Epithelial)-catenin is allosterically regulated: the monomer binds the -
catenin/cadherin complex, whereas the homodimer does not bind -catenin but interacts with F-
actin127,148. -Catenin binding to E-catenin sterically hinders F-actin binding43,106, explaining 
how E-catenin as part of the cadherin/catenin complex has a weak affinity for F-actin. More 
recently, it was shown that the cadherin-catenin complex binds strongly to F-actin under force, 
indicating that the E-catenin-actin interface is dynamically regulated by tension42. In addition, 
evidence suggests that tension can regulate E-catenin conformation: actomyosin-generated force 
stretches the middle (M)-domain to reveal binding sites for cytoskeletal proteins such as 
vinculin95,96,103,149,150. Thus, E-catenin is a dynamic and multifunctional protein regulated by 
tension. 
-Catenin functions in adhesion and mechanical signaling must be integrated in all tissues. 
In cardiomyocytes, the AJ functions with the desmosome to physically link opposing cells in a 
specialized adhesive structure called the intercalated disc (ICD) 5. Contractile forces place physical 
demands on heart junctional complexes: not only must they withstand repeated cycles of force, 
tension-sensing proteins within these complexes must be “tuned” to regulate signaling and 
maintain homeostasis151. Two -catenin proteins are expressed in the mammalian heart – E-
catenin and T (Testes)-catenin48,75,152. In contrast to the widely studied and well-defined 
mammalian E-catenin, little is known about T-catenin, a protein unique to amniotes that is 
expressed predominantly in the heart and testes48,153. T-catenin is expressed in cardiomyocytes 
where it localizes to the ICD, and genetic ablation of T-catenin in mice causes dilated 
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cardiomyopathy (DCM) 48,53,75. Notably, two mutations in T-catenin have been linked to 
arrhythmogenic right ventricular cardiomyopathy (ARVC): an amino acid (aa) change in the N-
terminus (valine to aspartic acid, V94D) and deletion of one aa in the C-terminal ABD (loss of a 
leucine, L765del) 16. However, the molecular properties of T-catenin are undefined and how 
these mutations affect T-catenin function in cardiomyocytes remains unclear. 
Here we show that T-catenin is a constitutive actin-binding -catenin that can directly 
couple the AJ to the actin cytoskeleton. Our data also reveal that the V94D mutation linked to 
ARVC alters T-catenin dimerization potential to disrupt -catenin binding and cellular 
localization. We postulate that T-catenin protein conformation and ligand binding properties are 
tuned to meet the specific demands of cardiomyocyte adhesion. 
2.3 Results 
2.3.1 T-catenin domain stability differs from E-catenin. 
Structural studies of E-catenin have revealed that the protein is a series of helical 
bundles43,89,93,97,106. The N-terminal (N) domain consists of two four-helix bundles (Fig. 2.1A, N1 
and N2) and binds -catenin and mediates homodimerization89. The middle (M) region is 
composed of three four-helix bundles (Fig. 2.1A, M1-M3) and binds vinculin in response to 
mechanical force95,102,103,149,150,154. A small linker region connects the C-terminal five-helix actin-
binding domain (ABD) to the M region (Fig. 2.1A). We compared the amino acid sequence of M. 
musculus T-catenin to M. musculus E-catenin and M. musculus N-catenin. αT-catenin is 58% 
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identical and 77% similar to αE-catenin; likewise, it is 59% identical and 77% similar to αN-
catenin (Fig. 2.1B). αE-catenin and αN-catenin are 81% identical and 91% similar, making T-
catenin the most divergent of the mammalian family. We then analyzed sequence homology across 
domains between T-catenin and E-catenin (Fig. 2.1C). The region with the lowest degree of 
homology was N2 (39% identical and 61% similar) whereas the region with the highest was M2 
(62% identical and 92% similar). 
We then questioned if sequence differences affected domain organization in T-catenin. 
We purified recombinant M. musculus T-catenin and M. musculus E-catenin from E. coli and 
used limited trypsin proteolysis to examine domain organization. As shown previously155,156, 
tryptic digest of E-catenin monomer revealed two stable fragments: the modulation domain (aa 
385–651) and the -catenin binding/homodimerization domain (aa 82-287) (Fig. 2.1D). Tryptic 
digest of T-catenin revealed three stable fragments at 30, 25 and 18 kDa (Fig. 2.1D). N-terminal 
sequencing revealed that the 30 kDa fragment started at aa 379 and contained bundles M2 and M3 
(Fig. 2.1D). The entire M2-M3 region forms a protease resistant fragment in mouse E-catenin 
(Fig. 2.1D) 92,127,155 and fish E-catenin156. Notably, the 18 kDa fragment started at aa 485, near 
the end of domain M2, and contained the entire M3 domain.  This suggests that, unlike E-catenin, 
the T-catenin M2-M3 region exists in a more open, protease-sensitive state. Finally, the 25 kDa 
fragment started at aa 108, similar to the dimerization/-catenin-binding domain in E-catenin (aa 
82–287), though this fragment – similar to M2-M3 – was markedly less protease-resistant than in 
E-catenin. We conclude that the conformation of T-catenin is similar to E-catenin, though 
with differences in the stability of both N-terminal and middle domains that could impact function. 
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Figure 2.1 T-catenin domain organization. 
A. E-catenin is composed of 5 four-helix bundles, a linker region and a five-helix bundle tail. Domain amino 
acid boundaries are marked. The 2 N-terminal four-helix bundles (N1 and N2) bind -catenin and mediate 
homodimerization (protease-resistant region underlined). The middle region contains 3 four-helix bundles 
(M1-M3; protease-resistant M-fragment underlined). The C-terminal domain binds F-actin (actin binding 
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domain, ABD). T-catenin possesses a similar domain organization based on sequence homology. Trypsin-
resistant fragments (from D) are shown as color-coded lines below T-catenin. B. Percent identity (blue) and 
percent similarity (orange) between M. musculus E-catenin, N-catenin, T-catenin and vinculin. C. 
Percent identity (blue) and percent similarity (orange) between M. musculus E-catenin and T-catenin 
domains. D. Limited proteolysis of recombinant T-catenin (left) and E-catenin monomer (right). 
Coomassie-stained SDS-PAGE gel of proteins incubated for 0, 2.5, 5, 15, 30, 60 and 120 minutes at room 
temperature in 0.05 mg/ml of trypsin. M-fragment (M, aa 385-651) and -catenin/dimerization (/D, aa 82-
287) fragments in E-catenin marked with black arrows. Stable T-catenin fragments of 30 (yellow), 25 
(blue) and 18 kDa (orange) noted with colored arrows. E. Edman sequencing results of limited proteolysis 
fragments. Projected fragments mapped on full-length sequence (A) as color-coded lines. 
2.3.2 T-catenin is a monomer in solution 
We assessed the oligomerization state of T-catenin by chromatography. Recombinant 
T-catenin protein prepared from E. coli was first purified by MonoQ ion exchange 
chromatography (IEC, Fig. 2.2A). Two peaks were routinely observed during elution off a MonoQ 
column (Fig. 2.2A, top chromatogram), and SDS-PAGE analysis of peak fractions revealed they 
both contained full-length T-catenin (Fig. 2.2A, bottom gel). A similar IEC profile is observed 
with M. musculus E-catenin (data not shown), and the two peaks correspond to the monomer 
(peak 1) and homodimer (peak 2) species. Both T-catenin peak fractions were subsequently 
purified over a Superdex 200 (S200) size exclusion chromatography (SEC) column. The MonoQ 
peak 1 fraction eluted in a single, discrete peak (Fig. 2.2B, purple line), consistent with it being a 
single, likely monomeric, species. The S200 elution profile of MonoQ peak 2 was similar to peak 
1, though a second, small peak was sometimes observed where a dimer species would be expected 
to elute (Fig. 2.2B, red line). 
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We then compared the primary S200 peak (elution volume 60-70 mls, concentrated to 25-
50 µM) of T-catenin to E-catenin monomer and homodimer by analytical SEC. At all 
concentrations tested (25-50 µM), T-catenin eluted in a single peak after both E-catenin 
homodimer and monomer, suggesting that T-catenin is a monomer (Fig. 2.2C). We then used 
SEC and sucrose density gradient centrifugation to determine the molecular mass of T-catenin, 
E-catenin monomer and E-catenin homodimer157. The SEC elution profiles (Fig. 2.2C) were 
compared to known standard proteins to calculate the Stokes radius (Fig. 2.2D). The calculated 
Stokes radius of E-catenin homodimer was similar to past observations (6.5 versus 7.4 nm; (35)) 
and the Stokes radii of both E-catenin monomer and homodimer species were comparable to our 
previously measured radii of gyration from small angle X-ray scattering (4.5 and 6.0 nm, 
respectively156). The Stokes radius of T-catenin was calculated to be 4.7 nm, slightly smaller than 
E-catenin monomer (Fig. 2.2D). 
We then used sucrose density gradient centrifugation to determine the sedimentation 
coefficients of T-catenin, E-catenin monomer and E-catenin homodimer. Proteins were 
separated on 5-20% sucrose gradients, the average fraction peak determined and compared to a 
standard curve to calculate the sedimentation coefficient (Fig. 2.2E, F). The Svedberg coefficients 
were determined to be 7.0 S for E-catenin homodimer (identical to past calculation90), 5.2 S for 
E-catenin monomer and 5.7 S for T-catenin. Molecular weights were then estimated based on 
the measured Stokes radii and sedimentation coefficients (Fig. 2.2G). The molecular weight of 
T-catenin was calculated to be 109 kDa, similar to E-catenin monomer (106 kDa). Finally, T-
catenin migrated as a single band by native-PAGE, faster than either E-catenin monomer or 
dimer, consistent with the SEC analysis (Fig. 2.2H). We conclude that T-catenin is primarily a 
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monomer in solution. It is important to note that these recombinant proteins are purified from E. 
coli and lack post translational modifications. A phosphorylation site at Y177 is present in the N-
terminus of E-catenin but is not within the homodimerization domain43,158. Phosphorylation of 
this residue disrupts E-catenin binding to APC but does affect binding to -catenin but blocking 
binding to APC increases the transcription of Wnt target genes158. There has not yet been any 
evidence showing post translational modifications influencing dimerization in -catenin. 
Dimerization kinetics differ significantly between mouse E-catenin and N-catenin at 
physiological temperatures43. E-catenin homodimerization is significantly weaker than N-
catenin, but a kinetic block limits disassociation once an E-catenin dimer is formed. The presence 
of two peaks in the MonoQ elution profile (Fig. 2.2A) and the minor peak in the peak 2 SEC 
elution (Fig. 2.2B) suggest that the T-catenin might exist as a homodimer. However, if the 
MonoQ peak 2 elution represented a homodimer species of T-catenin, the majority of these 
dimers dissociated during SEC (Fig. 2.2B). We were never able to purify a sufficient quantity of 
the potential dimer species for analysis by SEC or native-PAGE. Also, attempts to promote 
dimerization by incubation of the monomer at physiological (37 °C) temperatures caused the 
protein to aggregate and fall out of solution. Though we were unable to analyze the dimerization 
kinetics of wild-type (wt) T-catenin, our analysis of the V94D mutant revealed that T-catenin, 
similar to E-catenin and N-catenin, has dimerization potential (described below). Nonetheless, 
we took advantage of the lack of apparent dimerization in solution to study the behavior of T-
catenin monomer binding to F-actin. 
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Figure 2.2 αT-catenin is a compact monomer.  
A. MonoQ anion exchange chromatography of recombinant T-catenin (top) and Coomassie-stained SDS-
PAGE of fractions (bottom). B. Superdex 200 (S200) size exclusion chromatography (SEC) of αT-catenin 
MonoQ peak fractions. C. Analytical S200 SEC of recombinant αE-catenin homodimer, αE-catenin monomer 
and αT-catenin. Elution profiles used to calculate Kav. D. Stokes radii of αE-catenin homodimer, αE-catenin 
 34 
monomer and αT-catenin. Kav was calculated for standard proteins carbonic anhydrase (CA, Rs = 2.4 nm), 
bovine serum albumin (BSA, Rs = 3.5 nm), alcohol dehydrogenase (AD, Rs = 4.6 nm), -amylase (BA, Rs = 5.4 
nm), apoferritin (A, Rs = 6.7 nm) and thyroglobulin (T, Rs = 8.5 nm). Standard curve was created by plotting 
(-logKav)
1/2 versus Rs. αE-catenin homodimer, αE-catenin monomer and αT-catenin Rs determined from 
standard curve. E. Sucrose gradient sedimentation of αE-catenin monomer (αE-M), E-catenin dimer (E-D) 
and αT-catenin (T). Fractions were collected from 5-20% sucrose gradients and analyzed by Coomassie-
stained SDS-PAGE (top). The percentage of protein in each fraction was measured, plotted and the data fit to 
a Gaussian curve. F. Sedimentation coefficient of αE-catenin dimer, αE-catenin monomer and αT-catenin. 
Standard curve was created by plotting the sedimentation coefficient (S) versus the average sucrose gradient 
fraction of protein standards (similar standards as D; CA = 2.8 S, BSA = 4.3 S, AD = 7.4 S, BA = 8.9 S, A = 
16.6 S). αE-catenin dimer, αE-catenin monomer and αT-catenin S determined from standard curve. G. 
Calculated molecular weights of αE-catenin dimer, αE-catenin monomer and αT-catenin. H. Native PAGE 
analysis of recombinant αE-catenin dimer (Ecat D), αE-catenin monomer (Ecat M) and αT-catenin 
(Tcat). IEC, ion exchange chromatography; SEC, size exclusion chromatography. 
2.3.3 T-catenin monomer binds and bundles F-actin. 
Mammalian E-catenin binds and bundles F-actin41,42,127,148,159, though in the absence of 
force, homodimerization is required to potentiate F-actin binding. We tested if T-catenin 
monomer binds F-actin using an F-actin cosedimentation assay. Increasing concentrations of T-
catenin were incubated in the presence or absence of 2 µM F-actin, the samples centrifuged and 
resulting pellets analyzed. T-catenin cosedimented with F-actin above background (Fig. 2.3A), 
and the bound protein was quantified and plotted over free protein to calculate the affinity of the 
interaction (Fig. 2.3B). BSA and E-catenin were run as negative and positive controls, 
respectively (Fig. 2.3A, right panels). Plotted data was fit a hyperbolic function (Fig. 2.3B). T-
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catenin bound to F-actin with Kd of 0.4 ± 0.2 µM, similar to E-catenin dimer (1.0 μM159). Thus, 
T-catenin monomer is a constitutive actin-binding protein and, unlike E-catenin, 
homodimerization is not required for strong F-actin binding in the absence of force42,127,148. 
To investigate if T-catenin monomer bundles F-actin, we used transmission electron 
microscopy (TEM) to visualize T-catenin incubated with actin filaments. Weak bundling of 2 
µM F-actin was observed with 4 µM T-catenin (Fig. 2.3C, quantification in 2.5D). In contrast, 
robust bundling of 2 µM F-actin was observed with 4 µM E-catenin homodimer (Fig. 2.3C, 
2.5D). The weak bundling observed with T-catenin could result from either the dimer species 
being stabilized on the actin filament or activation of a cryptic dimerization domain, as observed 
in vinculin tail160. We conclude that T-catenin is a poor bundler of F-actin. 
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Figure 2.3 αT-catenin binds F-actin. 
A. High-speed cosedimentation assay of αT-catenin with F-actin. Left panels. Increasing concentrations (0.1 – 
3.0 µM) of αT-catenin were incubated with or without 2 µM F-actin, incubated for 30 minutes at RT and 
centrifuged. Starting (6.25% of total) and pelleted material (25% of total) were separated by SDS-PAGE and 
stained with Coomassie dye. Right panels. 4 µM of E-catenin dimer and 4 µM BSA were routinely run as 
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positive and negative controls, respectively. B. Bound αT-catenin (µM/µM actin) from A was plotted against 
free αT-catenin (µM) and data fit to a hyperbolic function (black line). The average Kd and Bmax plus or 
minus standard deviation from four independent experiments are shown. Results from these experiments 
were: experiment 1, Kd = 0.3 µM, Bmax = 0.6; experiment 2, Kd = 0.8 µM, Bmax = 0.7; experiment 3, Kd = 0.3 
µM, Bmax = 0.5; experiment 4 (binding results shown in A and plotted in B), Kd = 0.3 µM, Bmax = 0.3. C. 
Negative-stain transmission electron micrographs of 2 µM F-actin in the absence or presence of 4 µM T-
catenin or 4 µM E-catenin homodimer. Scales bars are 2 microns. D. Increasing concentrations (0.25 – 8.0 
µM) of αT-catenin/β-catenin complex were incubated with or without 2 µM F-actin, incubated for 30 minutes 
at RT and centrifuged. Starting (6.25% of total) and pelleted material (25% of total) was separated by SDS-
PAGE and stained with Coomassie dye. E. Bound αT-catenin/β-catenin (µM/µM actin) from D was plotted 
against free T-catenin/β-catenin (µM) and data fit to a hyperbolic function (black line). The average Kd and 
Bmax plus or minus standard deviation from three independent experiments are shown. Results from these 
experiments were: experiment 1 (binding results shown in D and plotted in E), Kd = 1.0 µM, Bmax = 0.2; 
experiment 2, Kd = 1.4 µM, Bmax = 0.2; experiment 3, Kd = 1.1 µM, Bmax = 0.2. 
2.3.4 T-catenin couples -catenin to F-actin. 
Binding to -catenin weakens the affinity of E-catenin for F-actin127,148. To test if T-
catenin can bind F-actin as part of the cadherin/catenin complex, we purified mouse -catenin and 
mixed it with T-catenin. As expected, T-catenin bound to -catenin with a 1:1 stoichiometry 
(data not shown) and we isolated the -catenin/T-catenin complex by SEC. Increasing 
concentrations of the -catenin/T-catenin complex were incubated in the presence or absence of 
F-actin, centrifuged and the pelleted material analyzed as above. Though the -catenin/T-catenin 
complex pelleted in the absence of F-actin (Fig. 2.3D, No F-actin panel), we were able to calculate 
the affinity of the complex for F-actin. The -catenin/T-catenin complex bound to F-actin with 
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a Kd of 1.1 ± 0.2 µM (Fig. 2.3E). Though -catenin lowers the affinity of T-catenin for F-actin 
slightly, the interaction strength is considerably stronger than that of the D. rerio -catenin/E-
catenin complex (>10 µM) and similar to the strength of E-catenin homodimer association with 
F-actin156,159. Thus, T-catenin can bind both -catenin and F-actin simultaneously to directly link 
the cadherin-catenin complex to the actin cytoskeleton. This is distinct from E-catenin, in which 
force is needed to strengthen the association between the cadherin-catenin complex and F-actin42. 
Though tension may strengthen the interaction between T-catenin and F-actin, we speculate that 
basal binding permits coupling between the cadherin-catenin complex and actin through T-
catenin over a range of forces. 
2.3.5 T-catenin V94D mutation creates an obligate homodimer. 
Two mutations in T-catenin have been linked to ARVC: replacement of a valine for an 
aspartic acid at aa 94 (V94D) in the N1 domain and deletion of a leucine at aa 765 (L765del) in 
the ABD16. Yeast two-hybrid and overexpression studies suggest the V94D mutant interferes with 
-catenin binding and the L765del mutation promotes oligomerization16. However, it is not clear 
how these mutations affect the biochemical properties of T-catenin or impact cellular function in 
cardiomyocytes. We used site-directed mutagenesis to make the V94D and L765del mutations in 
T-catenin and attempted to purify the mutant proteins. We were unable to purify L765del – the 
mutation rendered the expressed protein insoluble (data not shown). However, we were successful 
in expressing and purifying the V94D mutant. Surprisingly, V94D eluted as a single peak off the 
MonoQ column rather than two as observed with wt T-catenin (Fig. 2.4A). We then ran the V94D 
peak over an S200 SEC column where it eluted as a single peak before wt T-catenin and similar 
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to the possible homodimer peak (Fig. 2.4B). We then compared the concentrated V94D protein 
(25-30 µM; concentrations greater than this precipitated out of solution) to wt T-catenin by 
analytical SEC. The V94D mutant eluted as a single species before wt T-catenin with a larger 
Stokes radius (Fig. 2.2C, G; 5.8 nm versus 4.7 nm). The V94D mutant also displayed a higher 
sedimentation coefficient than wt T-catenin (Fig. 2.4D, G; 7.7 S versus 5.7 S). The Stokes radius 
and sedimentation coefficient produced a molecular weight of 183 kDa (Fig. 2.4G), roughly 
double that of wt T-catenin. We conclude that the V94D mutation creates a stable T-catenin 
homodimer. 
Since full-length T-catenin V94D is difficult to purify, we deleted the ABD (aa 660-895) 
in both wt and V94D T-catenin to improve protein yield. We analyzed the SEC and sedimentation 
properties of the ΔABD constructs (Fig. 2.4E-G). Similar to the full-length construct, the V94D 
mutation altered the elution and sedimentation profiles of the ΔABD construct (Fig. 2.4E, F). The 
calculated molecular weight of T-catenin V94D ΔABD was 146 kDa, compared to 90 kDa of 
T-catenin ΔABD, consistent with it forming a homodimer. 
We analyzed the oligomeric state of the T-catenin ΔABD proteins by crosslinking. 
Increasing concentrations of T-catenin ΔABD and T-catenin V94D ΔABD were incubated with 
or without the crosslinker BS3 and the resulting products analyzed by SDS-PAGE. As expected, 
T-catenin ΔABD and T-catenin V94D ΔABD ran as 75 kDa proteins in the absence of 
crosslinker (Fig. 2.4H). In the presence of BS3, however, V94D migrated as a 150 kDa protein at 
all concentrations tested, indicating a crosslinked dimer. Incubation with BS3 did not affect T-
catenin ΔABD migration at low concentrations, though at higher concentrations (2 µM and 4 µM) 
a 150 kDa species was detected. We speculate that this could reflect a transient homodimer species. 
We conclude that the V94D mutation promotes dimerization of T-catenin. 
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We used limited proteolysis to determine if the V94D mutation affected domain 
organization. Like wt T-catenin, three fragments were resistant to trypsin cleavage in V94D (Fig. 
2.4I). However, the -catenin/homodimerization domain (aa 108 start, confirmed by Edman 
degradation sequencing) was protected relative to wt (blue arrowhead in Fig. 2.4I, compare to blue 
arrowhead in Fig. 2.1D), consistent with this domain being stabilized in the homodimer state. 
We then questioned if the V94D homodimer could interact with -catenin. We mixed 
increasing concentrations of wt or V94D T-catenin with GST-tagged -catenin, pulled down the 
-catenin and assessed binding. Wild-type T-catenin bound GST--catenin at stoichiometric 
levels; however, little to no V94D bound (Fig. 2.4J). Thus, the V94D mutation creates an obligate 




Figure 2.4 . αT-catenin V94D mutation promotes homodimerization. 
A. MonoQ anion exchange chromatography of T-catenin V94D mutant (solid red line) and wt T-catenin 
(dashed orange line shown as reference; chromatogram same as in Fig. 2A). B. S200 SEC of αT-catenin V94D 
MonoQ peak fraction and T-catenin wt peak 2 fraction. C. Analytical S200 SEC of T-catenin V94D and 
T-catenin wt. Elution profile used to calculate Rs in G. D. Sucrose gradient sedimentation of T-catenin 
V94D. Fractions were collected from 5-20% sucrose gradients and analyzed by Coomassie-stained SDS-
PAGE. The percentage of V94D in each fraction was measured, plotted and the data fit to a Gaussian curve 
(red line). T-catenin sedimentation profile from Fig. 2E (dashed orange line) shown for comparison. 
Average peak used to calculate sedimentation coefficient in G. E. Analytical S200 SEC of T-catenin ΔABD 
and T-catenin V94D ΔABD. Elution profiles used to calculate Rs in G. F. Sucrose gradient sedimentation of 
T-catenin ΔABD and T-catenin V94D ΔABD. Average peaks used to calculate sedimentation coefficients in 
G. G. Calculated molecular weights of T-catenin V94D, T-catenin ΔABD and T-catenin V94D ΔABD. H. 
Cross-linking experiments with T-catenin ΔABD and T-catenin V94D ΔABD. Decreasing concentrations of 
protein (4 µM – 0.5 µM) were incubated with or without 1 mM BS3 for 30 minutes at RT, separated by SDS-
PAGE and stained with Coomassie dye. I. Limited proteolysis of T-catenin V94D. Color-coded arrows mark 
stable fragments mapped in Fig. 1A. J. Increasing concentrations of purified T-catenin wt or T-catenin 
V94D protein were incubated with GST-tagged full-length β-catenin for 1 hour at RT, washed, and then 
analyzed by SDS-PAGE. IEC, ion exchange chromatography; SEC, size exclusion chromatography. 
2.3.6 T-catenin V94D binds and bundles F-actin. 
Dimerization promotes E-catenin binding to F-actin127,148. We questioned if the V94D 
potentiates T-catenin binding to F-actin. The V94D mutant cosedimented with F-actin (Fig. 
2.5A) with a similar affinity to wt T-catenin (0.4 µM ± 0.1 µM, Fig. 2.4B), suggesting that 
homodimerization does not increase the affinity of T-catenin for F-actin. 
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We then tested if the V94D homodimer could bundle F-actin. We consistently observed 
increased bundling of 2 µM F-actin with 4 µM T-catenin V94D relative to 4 µM wt T-catenin 
(Fig. 2.5C-D). Though increased, the level of bundling was still less than that observed with 4 µM 
E-catenin homodimer (Fig. 2.3C, 2.5D). We conclude that the V94D mutation promotes T-
catenin-mediated F-actin bundling. 
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Figure 2.5 T-catenin V94D binds F-actin and promotes bundling. 
A. High-speed cosedimentation assay of αT-catenin V94D with F-actin. Increasing concentrations (0.125 – 6.0 
µM) of αT-catenin V94D were incubated with or without 2 µM F-actin, incubated for 30 minutes at RT and 
centrifuged. Starting (6.25% of total) and pelleted material (25% of total) were separated by SDS-PAGE and 
stained with Coomassie dye. B. Bound αT-catenin V94D (µM/µM actin) from A was plotted against free αT-
catenin V94D (µM) and data fit to a hyperbolic function (black line). The average Kd and Bmax plus or minus 
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standard deviation from three independent experiments are shown. Results from these experiments were: 
experiment 1, Kd = 0.4 µM, Bmax = 0.4; experiment 2 (binding results shown in A and plotted in B), Kd = 0.2 
µM, Bmax = 0.3; experiment 3, Kd = 0.4 µM, Bmax = 0.2. C. Negative-stain transmission electron 
micrographs of 2 µM F-actin in the presence of 4 µM T-catenin or 4 µM T-catenin V94D. Scales bars are 2 
microns. D. F-actin bundle width was measured in E-catenin homodimer (Ecat-D; Fig. 3C), wt T-catenin 
(Tcat) and V94D T-catenin (V94D) samples. Scatter plot of all measurements (Ecat-D, n = 291; Tcat, n 
= 337; V94D, n = 449) from at least three images shown. The orange vertical line marks the median and the 
bars define the interquartile range. Mean and standard deviation: Ecat-D = 0.34 ± 0.17; Tcat = 0.13 ± 0.06; 
V94D = 0.21 ± 0.12). ***p < 0.001, One-way ANOVA with Dunn’s multiple comparison test. 
2.3.7 T-catenin V94D disrupts localization in cardiomyocytes. 
T-catenin localizes to the adherens junction at the ICD in cardiomyocytes48. To determine 
if the V94D mutation disrupted T-catenin cellular localization, we transiently expressed EGFP-
tagged wt or V94D T-catenin in neonatal mouse cardiomyocytes. EGFP-T-catenin localized 
specifically to cell-cell contacts in cardiomyocytes where it colocalized with both E-catenin and 
N-cadherin (Fig. 2.6A, C; zoom in 2.6E). In contrast, V94D was largely peripheral to cell-cell 
contacts (Fig. 2.6B, D; zoom in 2.6E) and localized to actin fibers (orange arrowheads in 2.6B 
and 2.6D). This was confirmed by directly measuring colocalization between N-cadherin and 
EGFP-T-catenin or EGFP-T-catenin V94D signals at AJ clusters in transfected cells using 
Pearson’s r (Fig. 2.6F). This analysis revealed a significant reduction in colocalization between 
N-cadherin and EGFP-T-catenin V94D at AJs (Fig. 2.6F). Thus, the V94D mutation disrupts 
T-catenin subcellular localization in cardiomyocytes. 
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Figure 2.6 T-catenin V94D mutation disrupts localization in cardiomyocytes. 
A-E. Mouse neonatal cardiomyocytes transfected with EGFP-tagged T-catenin or T-catenin V94D. Cells 
were fixed 48 hours post-transfection and stained with Alexa-labeled phalloidin and antibodies against E-
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catenin (A–B) or N-cadherin (C–E). EGFP-T-catenin colocalized with N-cadherin at cell-cell contacts (C; 
magnification of boxed contacts in E, left panels) whereas EGFP-T-catenin V94D localization was largely 
adjacent to N-cadherin-rich contacts (D; magnification of boxed contacts in E, right panels). EGFP-T-
catenin V94D was also observed on actin fibers (orange arrows in B and D). Scale bars are 10 microns. F. 
Pearson’s r was calculated between N-cadherin and EGFP-T-catenin or EGFP-T-catenin V94D signals at 
individual AJ clusters in transfected cells (EGFP-Tcat/Ncad, n = 61 AJ clusters; EGFP-V94D/Ncad, n = 74 
AJ clusters). Scatter plot with all data points shown. The orange horizontal line marks the median and the 
bars define the interquartile range. Mean and standard deviation: EGFP-Tcat/Ncad = 0.64 ± 0.14; EGFP-
V94D/Ncad = 0.44 ± 0.18. ***p < 0.0001, unpaired t test. 
2.4 Discussion 
2.4.1 T-catenin binds F-actin strongly as a monomer. 
Our in vitro results show that, in solution, T-catenin binds F-actin as a monomer and in 
complex with -catenin, properties that separate it from mammalian E-catenin. T-catenin 
monomer binds F-actin with a slightly higher affinity than E-catenin homodimer (0.4 µM versus 
1.0 µM) 159. While -catenin binding reduces the affinity of T-catenin for F-actin, the reduction 
is relatively small (from 0.4 µM to 1.1 µM). We conclude that T-catenin binding to F-actin, 
unlike mammalian E-catenin, is not allosterically regulated. This would permit T-catenin to 
directly couple the cadherin-catenin complex to the actin cytoskeleton in the absence of tension, 
though mechanical force could strengthen the T-catenin-actin interface. 
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2.4.2 T-catenin has dimerization potential. 
Both M. musculus E-catenin and N-catenin homodimerize in solution, though the 
kinetics of dimerization differ significantly between the two mammalian -catenins43. At 
physiological temperature, the homodimerization affinity of N-catenin is more than 10x greater 
than the homodimerization affinity of E-catenin (2 µM versus 25 µM). However, the kinetics of 
dissociation differ markedly: N-catenin equilibrates quickly whereas a kinetic block limits E-
catenin dissociation43. The E-catenin dimer is thus stabilized and can persist at concentrations 
well below the Kd of association. Our in vitro results suggest that T-catenin has the ability to 
homodimerize. We observed a monomer and putative dimer species by IEC, though the dimer 
quickly dissociated upon dilution during SEC. Stronger evidence comes from our analysis of the 
V94D mutation, where a single amino acid change shifted the protein to the homodimer state. 
Crosslinking studies with the T-catenin ΔABD constructs also provide evidence for dimerization 
potential in the wt protein. Unfortunately, our inability to maintain soluble T-catenin at or near 
physiological temperature (37 °C) precluded a detailed analysis of dimerization kinetics. 
Nonetheless, our results lead us to postulate that T-catenin has dimerization potential and that 
the homodimer species, similar to N-catenin, dissociates quickly (i.e., no kinetic block). 
Evidence suggests a potential role for the -catenin homodimer in migration and cell-cell 
adhesion128,159,161. However, a physiological role for the -catenin homodimer in cardiomyocytes 
and whether putative E-catenin and T-catenin homodimers function similarly in vivo is unclear. 
The V94D mutation, which drives T-catenin into the dimer state in vitro, shifted localization 
from cell-cell contacts and promoted recruitment to F-actin bundles when expressed in 
cardiomyocytes. Actin filament crosslinking is essential for cardiomyocyte cytoskeletal 
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organization and function. The barbed ends of actin filaments from adjoining sarcomeres 
interdigitate at the Z-disc, where they are crosslinked primarily by -actinin to form a structural 
lattice162. -Actinin is an established -catenin ligand91,163 and we have detected T-catenin in 
complex with -actinin in cardiomyocyte lysates1. Thus, the T-catenin homodimer could have a 
role in cytoskeleton organization in cardiomyocytes. Alternatively, homodimerization may serve 
to regulate interactions with -catenin and/or plakoglobin along the ICD. Additional work is 
needed to elucidate the putative role of the T-catenin homodimer in cardiomyocyte biology. 
2.4.3 V94D mutation linked to ARVC promotes homodimerization. 
The V94D mutation in T-catenin is linked to ARVC, though the heterozygous mutation 
has only been documented in one individual16. It was previously shown that the mutation reduced 
both -catenin binding and homodimerization potential in a yeast two-hybrid assay16. In contrast, 
we found that V94D promotes T-catenin homodimerization, in effect creating an obligate 
homodimer species that cannot bind -catenin. Not surprisingly, the V94D mutant disrupted cell-
cell contact localization when expressed in cardiomyocytes. In the heterozygous state, it is unclear 
if 1) V94D interacts with wt T-catenin to disrupt localization to cell junctions and T-catenin-
mediated adhesion, and/or 2) if the mis-localized mutant protein disrupts cytoskeletal organization. 
Nonetheless, to the best of our knowledge this is one of the first demonstrations of how a disease-
linked mutation in -catenin disrupts a fundamental molecular property. 
 
1 Wickline and Kwiatkowski, unpublished observation 
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2.4.4 T-catenin domain stability. 
Our limited proteolysis experiments revealed that both the -catenin/homodimerization 
domain and middle domain were more protease-sensitive in T-catenin than in E-catenin. 
Notably, the N2 bundle within the -catenin/homodimerization domain of T-catenin is the region 
with the least conservation compared to E-catenin. T-catenin binds -catenin (Fig. 4D) and 
plakoglobin (Kwiatkowski, unpublished observation), though the strengths of these interactions 
are untested. Differences in N2 could impact T-catenin ligand binding, including self-association, 
to regulate molecular complex formation at cell-cell contacts. 
The core M region (M1-M3) of E-catenin is required for its function as a mechanosensor 
in which tension alters -catenin conformation to promote ligand binding95,102,149,164. Recent 
structural and single molecule studies coupled with molecular dynamic simulations support a 
model in which mechanical force reorients M2 and M3 to release M1, which contains the vinculin 
binding domain95,102,103. A salt-bridge network between M domains is postulated to maintain E-
catenin in the autoinhibited conformation in the absence of tension103. Based on sequence 
homology, a similar salt-bridge network could exist in T-catenin, though our limited proteolysis 
results showed that the T-catenin M-fragment (M2-M3) was less stable than in E-catenin. We 
speculate that increased flexibility within the T-catenin M2 and M3 domains could reduce the 
force required for activation, permitting M1 release and ligand recruitment at lower tension states. 
Increased flexibility between the M2 and M3 domains could also promote ligand binding 
within this region. Notably, T-catenin – but not E-catenin – was shown to bind plakophilin-2 
(PKP2), a desmosomal protein that links to intermediate filaments (IFs), and the binding interface 
was mapped to M375. T-catenin, through association with PKP2, may function as molecular link 
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to integrate the actin and IF cytoskeletons at the ICD. It is possible that structural differences within 
core M region between -catenins could regulate both mechanosensing and ligand binding 
properties. 
2.4.5 T-catenin function in cardiomyocytes 
-Catenin functions in adhesion and mechanical signaling must be integrated in all tissues. 
Contractile forces place physical demands on heart junctional complexes: not only must they 
withstand repeated cycles of force, tension-sensing proteins within these complexes must be 
“tuned” to regulate signaling and maintain homeostasis. Our in vitro studies showed that T-
catenin could directly couple the actin cytoskeleton to the cadherin/catenin in the absence of 
tension. We speculate that this property of T-catenin might permit the cadherin-catenin complex 
to maintain a static linkage to the actomyosin network over a range of forces, such as those 
produced by repeated cycles of contraction and relaxation in cardiomyocytes. Our biochemical 
analyses also suggest that T-catenin dimerization properties and M region stability differ from 
E-catenin. How these differences impact in vivo function is unclear, but we speculate that they 
could impact molecular interactions and tension sensing. In the mammalian heart, T-catenin may 
have evolved to complement E-catenin functions in adhesion and signaling. 
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2.5 Experimental Procedures 
2.5.1 Plasmids 
DNA encoding full-length M. musculus T-catenin was cloned into pGEX-TEV159 to 
create a fusion between GST and T-catenin. Site-directed mutagenesis was used to create the 
valine to aspartic acid mutation at amino acid 94 (V94D) in T-catenin. The N-terminal head 
region (aa 1-659) of T-catenin or T-catenin V94D was cloned into pGEX-TEV to create the 
ΔABD constructs. Wild type (wt) and V94D T-catenin were cloned into pEGFP-C1 for 
expression in mammalian cells. 
2.5.2 Recombinant Protein Expression and Purification 
GST-tagged T-catenin, E-catenin and -catenin were expressed in BL21 (DE3) E. coli 
cells and purified as described155,159 (see appendix B for detailed protocol). GST-tagged proteins 
bound to glutathione-agarose were equilibrated in cleavage/elution buffer (20 mM Tris pH 8.0, 
150 mM NaCl, 2 mM EDTA, 1 mM DTT and 10% glycerol) and then incubated with tobacco etch 
virus (TEV) protease overnight at 4 °C to cleave protein from the GST tag. All proteins were 
purified by MonoQ anion exchange chromatography followed by Superdex 200 (S200) gel 
filtration chromatography in 20 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol and 1 mM DTT. 
Eluted protein was concentrated to 20–50 μM working concentrations using a Millipore column 
concentrator, flash frozen in liquid nitrogen and stored at -80 °C. 
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2.5.3 Size Exclusion Chromatography 
Analytical size exclusion chromatography (SEC) was performed at 4°C on a Superdex 200 
column in 20 mM Tris pH 8.0, 150 mM NaCl and 1 mM DTT. Protein was injected at 25-30 μM. 
2.5.4 Native PAGE 
FPLC-purified αE-catenin and T-catenin were diluted in cold native gel sample buffer 
(20 mM Tris pH 6.8, 150 mM NaCl, 300 mM sucrose, 100 mM DTT and 0.02% bromophenol 
blue) and loaded onto a 5% native gel (running gel: 0.4 M Tris pH 8.8, 5% acrylamide; stacking 
gel: 0.1 M Tris pH 6.8, 5% acrylamide). Gels were run at 80 V for 5 hours at 4 °C, stained with 
Coomassie blue, and imaged on a LI-COR scanner. 
2.5.5 Limited proteolysis and Edman degradation sequencing  
For detailed protocol see appendix C. 12 μM αT-catenin and was incubated at room 
temperature in 0.05 mg/mL sequence-grade trypsin (Roche) in 20 mM Tris pH 8.0, 150 mM NaCl 
and 1 mM DTT. Reactions were stopped with 2X Laemmli buffer at the indicated times and 
samples analyzed by SDS-PAGE. For N-terminal sequencing, digested peptides were blotted onto 
PVDF membrane, stained with 0.1% Coomassie R-250/40% methanol/1% acetic acid, destained 
and dried. Individual bands were excised and sequenced by Edman degradation (Iowa State 
University Protein Facility). 
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2.5.6 Stokes radius measurements 
The Stokes radius (Rs) was determined by analytical size exclusion chromatography using 
a Superdex 200 column equilibrated with 20 mM Tris pH 8.0, 150 mM NaCl and 1 mM DTT. 
Standard proteins were bovine carbonic anhydrase (Rs = 2.4 nm), bovine serum albumin (Rs = 3.5 
nm), yeast alcohol dehydrogenase (Rs = 4.6 nm), sweet potato -amylase (Rs = 5.4 nm), horse 
spleen apoferritin (Rs = 6.7 nm) and bovine thyroglobulin (Rs = 8.5 nm). The partition coefficient, 
Kav, was calculated for all standards and -catenin proteins used in this study. The Stokes radius 
was calculated from a standard curve of (-logKav)1/2 versus Rs. 
2.5.7 Sucrose density gradient centrifugation 
Gradients of sucrose were made by layering sucrose dissolved in 20 mM Tris pH 8.0, 150 
mM NaCl from 20% to 5% in 2.5% increments in 13 x 63 mm ultracentrifuge tubes as described165. 
Each layer was frozen in a dry ice/ethanol bath before the addition of the next layer. Tubes were 
stored at - 80 °C until use. Tubes were thawed overnight at 4 °C to establish a gradient. 100 µl of 
sample was layered on top and centrifuged in a Thermo Scientific Sorvall S100-AT rotor at 70,000 
rpm (200,000 g) for 4 hours at 4 °C. All -catenin proteins were loaded at concentrations ≥ 20 
µM. After centrifugation, 200 µl fractions were collected and analyzed by SDS-PAGE. Gels were 
imaged on a LI-COR scanner and the percentage of protein in each fraction was measured in 
ImageJ. Plotted data was fit to a Gaussian curve to determine the average fraction in Prism 
software. Standard proteins were bovine carbonic anhydrase (2.8 S), bovine serum albumin (4.3 
S), yeast alcohol dehydrogenase (7.4 S), sweet potato -amylase (8.9 S) and horse spleen 
 55 
apoferritin (16.6 S). The sedimentation coefficient of -catenin proteins was determined from a 
standard curve of sedimentation coefficient (Svederg units, S) versus fraction. 
2.5.8 Molecular weight calculations 
The molecular mass of -catenin proteins used in this study was calculated from the 
measured Stokes radius and sedimentation coefficient as described157,166. 
2.5.9 Actin co-sedimentation assays 
For a detailed protocol see appendix A. Chicken muscle G-actin (Cytoskeleton, Inc.) was 
incubated in 1X actin polymerization buffer (20 mM HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2, 
0.5 mM ATP, 1 mM EGTA) for 1 hour at room temperature to polymerize filaments. Gel-filtered 
αT-catenin or αT-catenin/β-catenin heterocomplex was diluted to indicated concentrations in 1X 
reaction buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.5 mM ATP, 1 mM EGTA, 
1 mM DTT and 0.02% Thesit) with and without 2 µM F-actin and incubated for 30 minutes at 
room temperature. Samples were centrifuged at 50,000 rpm (>100,000 g) for 20 minutes at 4°C in 
an S100-AT3 rotor. Pellets were resuspended in Laemmli sample buffer, separated by SDS-PAGE 
and stained with Coomassie blue. Gels were imaged on a LI-COR scanner, and measured and 
quantified in ImageJ. To determine the amount of bound protein, background sedimentation (no 
F-actin pellet) was first subtracted from cosedimentation (F-actin pellet). Bound protein across 
samples was then normalized to the F-actin pellet. The amount of bound protein was calculated 
from a standard curve created from the starting material. All binding data was processed with 
Prism software. 
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2.5.10 F-actin bundling 
Protein samples were prepared as for the actin cosedimentation assays and deposited on 
carbon grids. Samples were fixed in 2.5% glutaraldehyde, stained with 1% uranyl acetate for 1-3 
minutes and examined in a JEOL JEM-1011 transmission electron microscope (TEM). To quantify 
bundling, a 20 micron by 20 micron grid was overlaid on images and the width of all bundles in 
four random squares on the grid measured using ImageJ. The data was plotted and analyzed with 
Prism software. 
2.5.11 Crosslinking experiments 
Purified T-catenin ΔABD and T-catenin V94D ΔABD were incubated with or without 
1 mM BS3 (bis(sulfosuccinimidyl)suberate, Thermo Scientific) in 20 mM HEPES pH 7.4, 150 
mM DTT and 1 mM DTT for 30 minutes at RT, separated by SDS-PAGE, stained with Coomassie 
dye and imaged on a LI-COR scanner. 
2.5.12 GST pulldown experiments 
Increasing amounts of T-catenin or T-catenin V94D (1-15 µg) were added to 15 µg of 
GST--catenin bound to glutathione agarose in 20 mM Tris pH 8, 150 mM NaCl and 5 mM DTT. 
Samples were incubated with gentle mixing for >2 hours at 4 °C and then washed 5 times in PBS 
+ 0.05% Tween 20 and 5 mM DTT before elution in Laemmli sample buffer. Samples were 
separated by SDS-PAGE, stained with Coomassie dye and imaged on a LI-COR scanner. 
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2.5.13 Cardiomyocyte isolation and culture 
All animal work was approved by the University of Pittsburgh Division of Laboratory 
Animal Resources. Cardiomyocytes were isolated from mouse neonates (P1-P3) as described167. 
Cardiomyocytes were plated onto collagen-coated coverslips and maintained in 78% DMEM, 17% 
M-199, 4% horse serum, 1% penicillin/streptomycin, 1 µM AraC and 1 µM isoproterenol. 
Transfections were performed 24 hours post-plating using Lipofectamine 2000 (Life 
Technologies). 
2.5.14 Immunostaining and confocal microscopy 
For a detailed protocol see appendix D. Cells were fixed in 4% paraformaldehyde (PFA) 
in PHEM buffer (60 mM 1,4-piperazinediethanesulfonic acid, pH 7.0, 25 mM HEPES, pH 7.0, 10 
mM EGTA, pH 8.0, 2 mM MgCl2, 0.12 M sucrose), washed with PBS, blocked for 1 hour at RT 
in PBS + 10% BSA, washed three times in PBS, incubated with primary in PBS + 1% BSA for 1 
hour at RT, washed three times in PBS, incubated with secondary in PBS + 1% BSA for 1 hour at 
RT, washed three times in PBS, and mounted in Fluoromount G (Electron Microscopy Sciences). 
F-actin was stained using Alexa Fluor phalloidin (Invitrogen) and antibodies against E-catenin 
(Enzo Life Sciences) or N-cadherin (Invitrogen). Cells were imaged on a Nikon Eclipse Ti inverted 
microscope outfitted with a Prairie swept field confocal scanner, Agilent monolithic laser launch 
and Andor iXon3 camera using NIS-Elements imaging software. Maximum projections of 4 
micron image stacks were created for image analysis and presentation. For Pearson’s r 
calculations, signal colocalization was measured between user-defined N-cadherin-positive AJ 
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clusters and EGFP signals using ImageJ. Colocalization data was plotted and analyzed with Prism 
software. 
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3.0 Distinct intramolecular interactions regulate autoinhibition of vinculin binding in T-
catenin and E-catenin 
This text was published in the Journal of Biological Chemistry in 2021: 
Heier JA, Pokutta S, Dale IW, et al. Distinct intramolecular interactions regulate autoinhibition of 
vinculin binding in 𝛂T-catenin and 𝛂E-catenin. J Biol Chem. 2021;296:100582. 
doi:10.1016/j.jbc.2021.100582. 
 
Contributions: I purified all proteins used in the experiments. I performed all published 
ITC experiments with the exception of those involving vinculin binding T-catenin 1-659. I also 
performed all crosslinking and limited proteolysis experiments, in addition to the quantification of 
vinculin recruitment in R2/7 cells. Finally, I wrote and edited the original and revised manuscripts. 
3.1 Overview 
-Catenin binds directly to -catenin and connects the cadherin-catenin complex to the 
actin cytoskeleton. Tension regulates -catenin conformation: actomyosin-generated force 
stretches the middle(M)-region to relieve autoinhibition and reveal a binding site for the actin-
binding protein vinculin. Here we describe the biochemical properties of T(testes)-catenin, an -
catenin isoform critical for cardiac function, and how intramolecular interactions regulate vinculin 
binding autoinhibition. Isothermal titration calorimetry (ITC) showed that T-catenin binds the -
catenin/N-cadherin complex with a similar low nanomolar affinity to that of E-catenin. Limited 
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proteolysis revealed that the T-catenin M-region adopts a more open conformation than E-
catenin. The T-catenin M-region binds the vinculin N-terminus with low nanomolar affinity, 
indicating that the isolated T-catenin M-region is not autoinhibited and thereby distinct from E-
catenin. However, the T-catenin head (N- and M-regions) binds vinculin 1000-fold more weakly 
(low micromolar affinity), indicating that the N-terminus regulates M-region binding to vinculin. 
In cells, T-catenin recruitment of vinculin to cell-cell contacts requires the actin-binding domain 
and actomyosin-generated tension, indicating that force regulates vinculin binding. Together, our 
results show that the T-catenin N-terminus is required to maintain M-region autoinhibition and 
modulate vinculin binding. We postulate that the unique molecular properties of T-catenin allow 
it to function as a scaffold for building specific adhesion complexes. 
3.2 Introduction 
The cadherin-catenin-complex that forms the core of the adherens junction (AJ) is required 
for intercellular adhesion and tissue integrity20,145,168. Classical cadherins are single-pass 
transmembrane proteins with an extracellular domain that forms trans interactions with cadherins 
on adjacent cells147,169,170. The adhesive properties of classical cadherins are driven by the 
recruitment of cytosolic catenin proteins to the cadherin tail: p120-catenin binds to the juxta-
membrane domain and -catenin binds to the distal part of the tail. -Catenin recruits -catenin, a 
mechanoresponsive actin-binding protein41-43,98,108,127,148,170. The AJ mechanically couples and 
integrates the actin cytoskeletons between cells to allow dynamic adhesion and tissue 
morphogenesis20. 
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The best characterized member of the -catenin family of proteins is mammalian 
E(epithelial)-catenin. Structurally, it is composed of 5 four-helix bundles connected to a C-
terminal five-helix bundle by a flexible linker97,105,106. The two N-terminal four-helix bundles form 
the N-domain that binds -catenin and mediates homodimerization43,89-91. The middle three four-
helix bundles form the middle (M)-region that functions as a mechanosensor92,93,95,103,149,171. The 
C-terminal five-helix bundle forms the F-actin binding domain (ABD) 42,98-100. F-actin binding is 
allosterically regulated: E-catenin can bind F-actin readily as a homodimer, but when in complex 
with -catenin, mechanical force is required for strong F-actin binding42,100,127,148. In addition, 
when tension is applied to E-catenin, salt bridge interactions within the M-region are broken, 
allowing the domain to unfurl and reveal cryptic binding sites for other cytoskeletal binding 
proteins such as vinculin95,102-105,149,164,172,173. The recruitment of these proteins is thought to help 
stabilize the AJ in response to increased tension and further integrate the actin cytoskeleton across 
cell-cell contacts45,96,149,164,172,174.  
Three -catenin family proteins are expressed in mammals: the ubiquitous E-catenin, N 
(Neuronal)-catenin and T (Testes)-catenin17,175. E-catenin and N-catenin are 81% identical 
and 91% similar in amino acid sequence. T-catenin is 58-59% identical and 77% similar to E-
catenin and N-catenin, making it the most divergent of the family13,17,175. T-catenin is 
predominantly expressed in the heart, testes, brain and spinal cord48,49. In the heart, it localizes to 
the intercalated disc (ICD), a specialized adhesive structure that maintains mechanical coupling 
and chemical communication between cardiomyocytes5,75. In mice, loss of T-catenin from the 
heart causes dilated cardiomyopathy and mutations in T-catenin are linked to arrhythmogenic 
ventricular cardiomyopathy in humans16,53. In addition to cardiomyopathy, T-catenin is linked to 
multiple human diseases, including asthma, neurological disease and cancer49,119,153. 
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Despite a growing awareness of its importance in human disease, the molecular properties 
and ligand interactions of T-catenin remain poorly understood. Our previous work revealed that 
T-catenin, unlike mammalian E-catenin, is a monomer in solution that can bind to F-actin with 
low micromolar affinity in the absence of tension. F-actin binding is also not allosterically 
regulated, as the -catenin/T-catenin complex binds to F-actin with the same affinity as T-
catenin monomer13. Single molecule pulling experiments have shown the T-catenin M-region to 
be mechanoresponsive as it unfurls in a force range similar to E-catenin176. 
Here we show that T-catenin associates with the components of the cadherin/catenin 
complex with an affinity similar to E-catenin in vitro, revealing that they may compete with one 
another for binding -catenin at the plasma membrane. We also show that the M-region of T-
catenin is not autoinhibited and can bind the vinculin N-terminus in the absence of tension with 
strong affinity. Unlike aE-catenin, however, when the N-terminus of T-catenin is attached to the 
M-region, the affinity for vinculin drops significantly. This indicates that interdomain interactions 
between the N-terminus and the M-region of T-catenin regulate its interaction with vinculin. We 
measured the recruitment of vinculin to cell-cell contacts and found that, despite the distinct 
mechanism of regulation, recruitment of vinculin is still tension dependent. Our findings indicate 
that the way in which tension regulates vinculin binding differs between E-catenin and T-
catenin. We postulate that this mechanism is important for the ability of T-catenin to build 
specific and distinct molecular complexes at AJs. 
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3.3 Results 
3.3.1 T-catenin binds tightly to the -catenin/N-cadherin core complex 
We characterized the interaction between T-catenin and -catenin by isothermal titration 
calorimetry (ITC) using purified recombinant proteins. We used the head region (comprising the 
N- and M-domains) of T-catenin (aa1-659, Fig. 3.1A) for these experiments since it is more 
stable than full-length T-catenin and yields sufficiently high protein concentrations for ITC. Past 
studies revealed that E-catenin head region (aa1-651) binds -catenin and the -catenin•E-
cadherin tail complex with a similar affinity to full-length E-catenin43. We observed that the T-
catenin head binds -catenin with a dissociation constant ~250 nM (Fig. 3.1B, Table 3.1). The 
affinity of T-catenin for -catenin is an order of magnitude weaker than the association of E-
catenin or N-catenin for -catenin (15-20 nM) 43. 
Cadherin tail binding to -catenin strengthens the affinity between -catenin and -
catenin43. N-cadherin is the primary classical cadherin expressed in cardiomyocytes25. We tested 
if the N-cadherin tail (Ncadcyto) influences the T-catenin/-catenin interaction by titrating -
catenin•Ncadcyto complex into T-catenin head (Fig. 1C). The affinity of this interaction was 5-6 
nM (Table 3.1), indicating that T-catenin binds to the cadherin•-catenin complex an order of 
magnitude more strongly than to -catenin alone. This affinity is similar to the 1-2 nM affinity 
observed between the cadherin tail•-catenin complex and E-catenin or N-catenin43 and 
suggests that T-catenin can effectively compete with E-catenin for binding to the membrane-
associated cadherin•-catenin complex. 
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Figure 3.1 T-catenin binds the N-cadherin•-catenin complex with nanomolar affinity. 
A. Domain organization of T-catenin. Amino acid domain boundaries marked. B-C. T-catenin head region 
(aa1-659, Tcat head) binding to -catenin (B) or the -catenin•N-cadherin cytoplasmic tail (-cat•Ncadcyto) 
complex (C) was measured by ITC. The ratio of heat released (kcal) per mole of -catenin or -cat•Ncadcyto 
injected into T-catenin head was plotted against the molar ratio of T-catenin head and -catenin or T-
catenin head and -cat•Ncadcyto. Thermodynamic properties derived from these traces are shown in Table 1. 
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Table 3.1 ITC measurements of T-catenin fragments binding to -catenin or -catenin•N-cadherin 










T-catenin head (1-659) + -catenin 264.1  109.1 -14.6  2.1 -5.6 -9.0 
T-catenin head (1-659) + -catenin•Ncadcyto 5.6  0.6 -27.0  0.2 -15.8 -11.3 
T-catenin N1-N2 (1-259) + -catenin•Ncadcyto 6.9  12.0 -18.9  1.0 -7.8 -11.1 
 
3.3.2 T-catenin N-terminus is monomeric 
Full-length T-catenin is primarily a monomer in solution, though it does have 
homodimerization potential in vitro13. The best evidence for dimerization potential comes from a 
point mutation linked to arrhythmogenic ventricular cardiomyopathy in humans, V94D, that 
renders T-catenin an obligate homodimer13,16. We analyzed the oligomerization properties of the 
T-catenin N1-N2 (aa1-259, Fig. 3.1A) and compared them to the V94D mutant. Analytical size 
exclusion chromatography (SEC) of T-catenin wild type (wt) N1-N2 and V94D N1-N2 revealed 
that wt N1-N2 eluted as a single monomer species (Fig. 2A, blue line) whereas the V94D mutant 
eluted as a dimer species (Fig 3.2A, red line). 
We then analyzed the oligomeric state of the T-catenin N-terminus by cross-linking. 
Increasing concentrations of T-catenin N1-N2 were incubated with or without the cross-linker 
bis(sulfosuccinimidyl)suberate (BS3) at 4 °C or 37 °C and the resulting products analyzed by SDS-
PAGE. As expected, the T-catenin N1-N2 migrated as a 25 kDa protein in the absence of cross-
linker (Fig. 3.2B). Incubation with BS3 did not affect migration at low concentrations, although at 
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higher concentrations (4 and 8 µM), larger species were detected at both temperatures. In contrast, 
T-catenin V94D N1-N2 ran as 50 kDa protein in the presence of BS3 at all concentrations tested 
(Fig. 3.2C), indicating a cross-linked dimer. We conclude that the T-catenin N-terminus, similar 
to full-length protein, is primarily a monomer in solution. 
We then tested the ability of the T-catenin N1-N2 to bind to the -catenin•Ncadcyto 
complex by ITC. The affinity of this interaction was 7 nM (Fig. 3.2D, Table 3.1), similar to the 




Figure 3.2 T-catenin N1-N2 is a monomer in solution. 
A. Analytical SEC of 30 µM T-catenin N1-N2 (aa1-259, blue line) and 30 µM T-catenin V94D N1-N2 (red 
line). B. Crosslinking experiments with T-catenin N1-N2. Increasing concentrations of T-catenin a were 
incubated with or without 1 mM BST at 4 C (left panel) or 37 C (right panel) for 30 minutes, separated by 
SDS-PAGE and stained with Coomassie dye. C. Crosslinking experiments with T-catenin V94D N1-N2. 
Increasing concentrations of T-catenin V94D N1-N2 were incubated with or without 1 mM BST at 4 C for 
30 minutes, separated by SDS-PAGE and stained with Coomassie dye. D. T-catenin N1-N2  binding to -
catenin•N-cadherin cytoplasmic tail (-cat•Ncadcyto) was measured by ITC. Thermodynamic properties 
derived from this trace are shown in Table 1. 
 68 
3.3.3 T-catenin M-region binds vinculin 
The E-catenin M-region is autoinhibited with respect to vinculin binding: mechanical 
force is required to break an internal salt bridge network within M1-M3 to reveal the vinculin 
binding site in M1103,104. The T-catenin M-region also recruits vinculin and force is required to 
unfurl M1 to promote high affinity binding176. However, our previous proteolysis experiments of 
full-length T-catenin revealed that the M2-M3 region existed in a more open, protease-sensitive 
state13. Notably, the amino acids that form the salt bridges required for autoinhibition in the E-
catenin M-region are conserved in T-catenin, with the exception of E277 in M1 that pairs with 
R451 in M2. In T-catenin, the arginine is conserved at the corresponding residue (aa446), but the 
glutamic acid is replaced by a threonine at aa272103, preventing these residues from interacting. 
We questioned if T-catenin M1-M3 adopted an autoinhibited conformation. 
We examined the organization and vinculin binding properties of the complete T-catenin 
M-region (M1-M3, aa260-626). T-catenin M1-M3 eluted as a single, discrete peak by SEC, 
identical to E-catenin M1-M3 (aa273-651; Fig. 3.3A). We then probed the M-region flexibility 
by limited trypsin proteolysis. Tryptic digestion of E-catenin M1-M3 revealed that it was largely 
protease-resistant: nearly 50% of the fragment was still intact after 120 minutes of digestion, 
consistent with it forming a closed, autoinhibited domain (Fig. 3.3B). In contrast, T-catenin M1-
M3 was completely digested after 60 minutes into three stable fragments at 23, 16 and 12 kDa 
(Fig. 3.3B). Note that both M-regions contain a similar number of lysine and arginine residues (47 
in E-catenin and 39 in T-catenin), the majority of which are conserved. N-terminal sequencing 
revealed that the 23 kDa and 16 kDa fragments both started at aa379 and represented the M2-M3 
and M2 bundles, respectively. The 12 kDa fragment started at aa485 and corresponded to the M3 
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bundle (Fig. 3.3C). Similar protease resistant fragments were observed from digest of full-length 
protein13 and are consistent with the T-catenin M-region adopting a more open, protease-
sensitive state relative to E-catenin, despite five of the six salt bridge residue pairs being 
conserved. Likewise, the isolated T-catenin M1-M3 fragment does not appear to adopt a stable, 
autoinhibited conformation. 
We then measured the affinity of T-catenin M1-M3 for vinculin. We used the vinculin 
D1fragment (aa1-259) which contains the first two four-helix bundles and binds to E-catenin 
with a similar affinity to the vinculin head domain, D1-D495. As previously observed95, the 
autoinhibited E-catenin M1-M3 fragment bound weakly to vinculin D1 (Fig. 3.3D, Table 2). 
When M3 was deleted from this fragment, auto-inhibition was relieved and E-catenin M1-M2 
bound to vinculin with low nanomolar affinity, as observed previously (Fig. 3.3E, Table 2) 95. In 
contrast, the T-catenin M1-M3 fragment showed strong, nanomolar binding to vinculin D1 
similar to E-catenin M1-M2 (Fig. 3.3F, Table 3.2), indicating that T-catenin M1-M3 binding 
to vinculin was not autoinhibited. Whereas binding to E-catenin M1-M2 or M1-M3 is 
endothermic (entropy driven), consistent with unfolding of the M1 bundle needed for this 
interaction95, binding to T-catenin M1-M3 was exothermic, suggesting that T-catenin M1 is 




Figure 3.3 T-catenin M1-M3 binds vinculin D1 with high affinity. 
A. Analytical SEC of recombinant T-catenin M1-M3 (aa260-626) and E-catenin M1-M3 (aa273-651). B. 
Limited proteolysis of T-catenin and E-catenin M1-M3 fragments. Proteins incubated for 0, 2.5, 5, 15, 30, 
60, and 120 min at room temperature in 0.05 mg/ml trypsin, resolved by SDS-PAGE and stained with 
Coomassie dye. Stable fragments of 23 (yellow-orange), 16 (yellow) and 12 kDa (orange) are marked with 
colored arrows. C. Edman sequencing results of limited proteolysis fragments. Protein fragments are mapped 
on the M1-M3 sequence as color-coded lines. D-F. Representative ITC traces of E-catenin M1-M3 (D), E-
catenin M1-M2 (aa273-510, E) and T-catenin M1-M3 (F) binding to vinculin D1 (aa1-259). Thermodynamic 
properties derived from these traces are shown in Table 2. 
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E-catenin M1-M3 (273-651) + Vinculin D1 10420  4588.4 12.8  5.2 19.6 -6.8 
E-catenin M1-M2 (273-510) + Vinculin D1 31.9  9.1 8.7  0.2 18.9 -10.3 
T-catenin M1-M3 (260-626) + Vinculin D1 60.5  19.2 -2.2  1.0 13.8 -9.8 
T-catenin head (1-659) + Vinculin D1 4690  2740 2.3  1.3 9.6 -7.3 
T-catenin head (1-659)•-catenin + Vinculin D1 2770  875 4.4  0.6 11.9 -7.5 
T-catenin N2-M3 (147-626) + Vinculin D1 50.2  40.4 4.0  0.1 14.1 -10.1 
I27-T-catenin M1-M3 (260-626) + Vinculin D1 245.3  39.7 4.8  0.3 13.8 -9.0 
T-catenin N1-N2 (1-259)/M1-M3 (260-626) + Vinculin 
D1 
50.1  17.5 -3.1  0.1 6.9 -10.0 
 
3.3.4 T-catenin N-terminus regulates vinculin binding 
Recent in vitro single molecule stretching experiments revealed that force is required to 
expose the vinculin binding site in T-catenin M1-M3176. However, our ITC results with the T-
catenin M1-M3 fragment indicated that tension was not required to release M1. In the stretching 
experiments, the T-catenin M1-M3 fragment was flanked by a pair of titin I27 immunoglobulin-
like domains and the N-terminus of the fusion protein was tethered to a substrate176. We questioned 
if N-terminal associations with M1-M3 stabilize M1 and regulate vinculin binding.  
We first characterized the interaction between T-catenin head domain and vinculin D1 
by ITC. The binding shifted from exothermic to endothermic and the affinity was ~5 µM, two 
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orders of magnitude weaker than observed with M1-M3 (Fig. 3.4A, Table 3.2). This suggested 
that the addition of N1-N2 stabilized M1 and inhibited vinculin binding.  
Recent work revealed allosteric coupling between the N-terminal domains and M-region 
of E-catenin105. Specifically, the presence of -catenin caused changes in the accessibility of 
cysteine residues in the N2-M2 interface and in M3. Since -catenin binding alters the relative 
positions of the E-catenin N1 and N2 domains43, we tested if -catenin binding to the T-catenin 
N-region affected vinculin binding to the M-region. Vinculin D1 was titrated into a solution of 
purified T-catenin head•-catenin complex. The presence of -catenin had little impact on the 
affinity (~3 µM, Fig. 3.4B, Table 3.2), indicating that N-terminal-mediated autoinhibition was 
maintained. This result is consistent with past work showing that the -catenin•cadherin complex 
had no effect on E-catenin binding to vinculin95.  
We then asked if the entire N-terminus is required to regulate M1 binding. The addition of 
N2 to T-catenin M1-M3 (aa147-626) did not weaken vinculin D1 binding relative to M1-M3 (Kd 
= 50 nM, Fig. 3.4C, Table 3.2). The reaction switched from exothermic to endothermic, 
suggesting partial compensation of M1 stability in this fragment. Thus, all or part of N1 is required 
to regulate M1 interactions with vinculin. This is consistent with the observation that removing 
the first 56 residues of  N1 from full-length E-catenin reduces the inhibition of vinculin binding 
by about 50 fold95. 
We next questioned if the titin repeats attached to M1-M3 in the construct used by Pang, 
Le and colleagues176 stabilized M1. We titrated vinculin D1 into a solution of the 2I27-T-catenin 
M1-M3(aa259-667)-2I27 construct. Notably, the binding was endothermic and the affinity was 
~250 nM, markedly weaker than observed with T-catenin M1-M3 alone (Fig. 3.4D, Table 3.2). 
We speculate that the well-structured titin repeats promote M1 stability and may sterically occlude 
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vinculin D1 binding, thus reducing the affinity. The M1 stability and steric hindrance provided by 
the I27 repeats partially mimic the complete N-terminus and likely explain why tension is needed 
to promote vinculin binding in the single molecule stretching experiments whereas T-catenin 
M1-M3 in solution binds vinculin readily. 
Given that the entire N-terminus is required to regulate vinculin binding in T-catenin, we 
asked if N1-N2 could regulate M1-M3 in trans. We titrated vinculin D1 into an equimolar mixture 
of T-catenin N1-N2 and M1-M3. The binding reaction was similar to M1-M3 alone: exothermic 
with a Kd of 50 nM (Fig. 3.4E, Table 3.2). This result indicates that the M-region must be 
physically coupled to the N-terminus to stabilize M1 and regulate ligand accessibility. 
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Figure 3.4 T-catenin N-terminus regulates vinculin binding to M1-M3. 
A-D. Representative ITC traces of vinculin D1 binding to T-catenin head (A), T-catenin head/-catenin 
complex, T-catenin N2-M3 (aa147-626), 2I27-T-catenin M1-M3(aa259-667)-2I27 (D), and T-catenin N1-
N2/M1-M3 complex (E). Thermodynamic properties derived from these traces are shown in Table 2. 
3.3.5 Tension recruits vinculin to T-catenin 
We tested the ability of T-catenin to restore cell-cell adhesion and recruit vinculin in -
catenin-deficient R2/7 carcinoma cells131. We transiently expressed EGFP-E-catenin or EGFP-
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T-catenin in R2/7 cells and analyzed cell-cell contact formation and endogenous vinculin 
recruitment by immunostaining. Both EGFP-E-catenin and EGFP-T-catenin restored cell-cell 
adhesion, organized F-actin along cell-cell contacts and recruited vinculin to junctions (Fig. 3.5). 
To determine if vinculin recruitment was tension dependent, we treated cells with DMSO or 50 
µM blebbistatin to suppress myosin activity for 30 minutes and stained for vinculin (Fig. 3.5, A-
D). E-catenin and T-catenin recruited similar levels of vinculin in DMSO controls (Fig. 3.5, A, 
B and E). Importantly, blebbistatin treatment significantly reduced vinculin recruitment to both 
E-catenin and T-catenin containing AJs (Fig. 3.5, C, D and E). Thus, myosin-based tension is 
required to recruit vinculin to T-catenin, similar to E-catenin. 
We then examined the correlation between EGFP fusion expression and vinculin 
recruitment. As expected, EGFP-E-catenin expression levels did not correlate with vinculin 
levels since vinculin was only recruited when E-catenin was activated by sufficient tension149,172. 
However, we observed a strong positive correlation between EGFP-T-catenin expression and 
vinculin recruitment. We observed a similar positive correlation with constitutively-open E-
catenin constructs in cardiomyocytes45. Together, these results suggest that while vinculin 
recruitment to T-catenin is tension dependent, the force threshold for binding may be low, 
permitting all/most AJ-incorporated T-catenin molecules to recruit vinculin. 
Finally, we tested if actin binding was required to relieve T-catenin autoinhibition and if 
removal of M3 opened the M-region to permit vinculin recruitment. We expressed EGFP-tagged 
truncations of E-catenin and T-catenin: the head domain lacking the ABD (N1-M3) or the head 
domain minus M3 and ABD (N1-M2). All EGFP-tagged E-catenin and T-catenin fragments 
expressed as soluble proteins of the predicted size (Fig. 3.5N). E-catenin and T-catenin N1-M3 
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(aa1-670 and aa1- 659. respectively) were both cytosolic and, as expected, unable to form cell-cell 
contacts and recruit vinculin (Fig. 3.5, J and K). Deletion of M3 in E-catenin relieves 
autoinhibition, and E-catenin N1-M2 (aa1-510) was able to recruit vinculin and restore cell-cell 
adhesion, as shown previously131. Here vinculin provides the necessary actin-binding activity to 
link the cadherin-catenin complex to F-actin through E-catenin. In contrast, T-catenin N1-M2 
(aa1-502) was cytosolic and failed to recruit vinculin to cell-cell contacts. This suggests that, in 
T-catenin, loss of M3 does not release M1 for ligand binding and underscores the importance of 
the N-terminus in regulating M1 binding to vinculin. 
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Figure 3.5 . T-catenin recruitment of vinculin to cell-cell contacts is tension-dependent 
A-D. R2/7 cells were transfected with EGFP-E-catenin full length (Ecat FL; A and C) or EGFP-T-catenin 
full length (Tcat FL; B and D) and treated for 30 mins with DMSO (A and B) or 50 µM blebbistatin (C and 
D) before fixation. Cells were stained for F-actin and vinculin. Individual and merged vinculin (magenta) and 
GFP (green) channels shown. E. Quantification of vinculin intensity at cell-cell contacts. Signal intensity at 
contacts was divided by the average cytoplasmic intensity and a scatter plot of all data points is shown. The 
black horizontal line is the median and the error bars define the interquartile range. One-way ANOVA with 
Tukey’s comparisons; n.s. = not significant. n  24 images from two independent experiments. F-I. Vinculin 
contact/cytoplasmic ratio (C/C) was plotted against the average GFP intensity of each fusion construct from 
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the masked cell contact region. Linear regression analysis was performed to calculate the slope (red line), 
95% confidence intervals (black lines surrounding slope) and R2 value. The slope deviation from zero was 
analyzed for significance (p value). n  24 images from two independent experiments. J-M. R2/7 cells were 
transfected with EGFP-tagged E-catenin head (aa1-670, J), T-catenin head (aa1-659, K), E-catenin N1-
M2 (aa1-510, L) and T-catenin N1-M2 (aa1-502, M), fixed and stained for vinculin. Individual GFP (top 
panel) and vinculin (bottom panel) channels shown. Scale bar is 10 µm in all images. N. R2/7 cells transfected 
with EGFP-tagged E-catenin or T-catenin full-length (FL), head, or N1-M2 constructs. Cell lysates 
separated by SDS-PAGE and blotted for GFP (top) or GAPDH (bottom). 
3.4 Discussion 
3.4.1 T-catenin forms a strong AJ core with cadherin•-catenin 
Our ITC results show that the -catenin•N-cadherin tail complex binds with high, ~5 nM 
affinity to T-catenin similar to 1-2 nM affinity previously reported between the -
catenin•cadherin tail complex and E-catenin43. Thus T-catenin forms a strong cadherin-catenin 
core complex like E-catenin to link actin to the AJ. T-catenin is co-expressed with E-catenin 
in multiple mammalian tissues and, in the heart, it is enriched along the ICD with E-
catenin48,119,153,177. It is unknown if E-catenin and T-catenin bind stochastically to the 
cadherin•-catenin complex in cardiomyocytes or if binding is regulated to favor one -catenin or 
the other. Notably, loss of either E-catenin or T-catenin from the mouse heart causes dilated 
cardiomyopathy11,53, suggesting that each -catenin has a unique, critical role in ICD function and 
heart physiology. In addition, E-catenin and T-catenin (Heier and Kwiatkowski, unpublished 
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data) also bind plakoglobin, the desmosome-associated -catenin homolog that is enriched at the 
ICD35,64. Plakoglobin binds the cadherin tail with an affinity similar to -catenin and both 
plakoglobin and -catenin are enriched at cardiomyocyte AJs177. The downstream consequences 
of -catenin binding to plakoglobin or -catenin are not clear, but recent evidence that the N-
terminus and M-region of E-catenin are allosterically coupled105 raises the possibility that 
differential binding could affect downstream ligand recruitment. Future work is expected to reveal 
how specific cadherin•-catenin/plakoglobin•-catenin complexes are formed and function to 
regulate adhesion and signaling. 
In the absence of the cadherin tail, -catenin alone binds T-catenin an order of magnitude 
weaker than E-catenin (~250 nM versus ~20 nM). This suggest that T-catenin does not compete 
with E-catenin for binding cytosolic -catenin. Though there is evidence of a cytosolic E-
catenin•-catenin complex in epithelial cells128, the physiological relevance of this interaction is 
not clear and a similar -catenin•-catenin complex in cardiomyocytes has not been reported. 
E-catenin can homodimerize and the cadherin-free, cytosolic homodimer pool regulates 
actin dynamics and cell motility43,127,128,148,178. In contrast, full-length T-catenin is a monomer in 
solution and has limited dimerization potential with no evidence of homodimerization in vivo13. 
Our results here show that the isolated T-catenin N-terminus is also monomeric. We speculate 
that limited dimerization potential and weaker affinity for -catenin favor a cadherin-free, 
cytosolic pool of T-catenin monomer. The role of such a monomer pool is unclear. 
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3.4.2 The T-catenin M-region does not adopt an autoinhibited conformation in isolation 
Structural, biochemical and biophysical data indicate that the E-catenin M-region adopts 
an autoinhibited conformation95,102-105,149,164,172,173. The vinculin binding site is buried in the folded 
M1 domain and interactions between M1, M2 and M3 maintain the autoinhibited form. Tension 
breaks these interactions to release M1, allowing it to unfold and bind strongly to vinculin. More 
recent biophysical data suggest that the T-catenin M-region adopts a similar conformation with 
force being required to free M1 for high affinity binding to vinculin176. 
Our limited proteolysis experiments with the isolated T-catenin M-region indicate that it 
exists in a more open, protease-sensitive conformation. Consistent with this, ITC results revealed 
that the T-catenin M-region binds vinculin with low nanomolar affinity and is not autoinhibited. 
T-catenin possesses 5 of the 6 residue pairs that form the salt bridge network that mediates E-
catenin autoinhibition103. The E277-R451 bridge between M1 and M2 in E-catenin is not 
conserved in T-catenin, with the glutamic acid replaced by a threonine at aa272. The threonine 
at aa272 is conserved across the T-catenin family. Assuming no major structural differences 
between the E-catenin and T-catenin M-regions, the T272 and R446 residues would not be able 
to interact. In simulations, the E-catenin E277-R451 salt bridge is predicted to rupture quickly 
under external force103,105. Unfortunately, we lack a structure of the T-catenin M-region to 
determine if a similar network regulates domain organization. However, our data demonstrate that 
such inter-bundle interactions within the T-catenin M-region are insufficient for autoinhibition. 
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3.4.3 The N-terminus is required for T-catenin M-region autoinhibition 
The T-catenin head fragment (N1-M3) showed weak, micromolar binding to vinculin, 
indicating that the N-terminus regulates M-region autoinhibition. The entire N-terminus (N1-N2) 
is required for autoinhibition since deleting N1 restored strong vinculin binding. Notably, 
replacing the N-terminus with another well-structured protein moiety, the titin I27 repeats, reduced 
vinculin binding and caused the binding reaction to switch from exothermic to endothermic, 
suggesting the M1 was stabilized. This observation explains the force-dependent vinculin binding 
to the T-catenin M-region observed in recent biophysical experiments176. The ability of the titin 
I27 repeats to partially restore autoinhibition also suggests that steric, nonspecific interactions 
rather than specific interdomain associations (e.g., salt bridges) between the T-catenin N-
terminus and M-region promote M1 folding and M-region autoinhibition. Interestingly, the first 
56 residues of E-catenin contribute to the inhibition of vinculin binding in addition to the M3 
domain95. 
3.4.4 T-catenin recruits vinculin 
Expression of EGFP-T-catenin was sufficient to restore cell-cell contacts and recruit 
vinculin in -catenin deficient R2/7 cells. Vinculin binding to T-catenin requires actin binding 
by the latter and is tension-dependent, similar to E-catenin. This is consistent with the vinculin 
binding site in the T-catenin M1 domain being occluded in the absence of force. Notably, deletion 
of M3 in T-catenin did not relieve autoinhibition, offering additional evidence that the 
intramolecular interactions required for autoinhibition in T-catenin differ from E-catenin.  
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Vinculin is recruited to E-catenin to bolster the AJ connection to actin under mechanical 
load45,149,174,179. Neither the physiological context nor the functional role of vinculin recruitment to 
T-catenin have been established in vivo. Loss of E-catenin from the mouse heart disrupts AJ 
formation and causes a marked decrease in vinculin expression and recruitment, despite the 
presence of T-catenin, resulting in cardiomyopathy11. The inability of T-catenin to compensate 
for E-catenin in the heart underscores how the two -catenins, despite sharing core properties, 
are likely regulated by distinct mechanisms and play unique roles in junction organization and 
signaling. 
Together, our data support a model in which the T-catenin N-terminus functions to 
regulate M-region stability and autoinhibition. Our in situ data indicate that force is required to 
reveal the vinculin binding site. We speculate that it may do so by separating the M-region from 
the N-terminus to remove steric hinderance rather than breaking a network of internal M-region 
salt bridges. This could provide cadherin/-catenin/T-catenin complexes in cardiomyocytes with 
distinct mechanical properties, allowing ligand binding and allosteric signaling over a unique force 
scale relative to E-catenin-containing complexes. While we have focused on vinculin binding to 
M1, intrinsic differences in T-catenin M-region organization could also affect other M1 as well 
as M2 and M3 ligand interactions, possibly independent of force. Intramolecular and allosteric 
interactions are emerging as an important factor in the regulation of -catenin conformation and 
molecular complex formation at the AJ. Further work is needed to define how molecular 
differences between the -catenin protein family regulate mechanical adhesion and signaling. 
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3.5 Experimental Procedures 
3.5.1 Plasmids 
Full-length M. musculus -catenin, T-catenin and E-catenin as well as T-catenin head 
region (aa1-659) in pGEX-TEV were described previously13,43,148. The vinculin D1 construct (aa1-
259) in pGEX-TEV was described in95. M. musculus T-catenin N1-N2 (aa1-259) N1-M3 (aa 1-
659), M1-M3 (aa 260-626) N2-M3 (aa 147-626) and E-catenin M1-M3 (aa273-651), M1-M2 
(aa273-510) were cloned into pGEX-TEV. The constructs encoding T-catenin M1-M3 flanked 
by I27 handles in pET151/D-TOPO was kindly provided to us by Dr. Jie Yan176. 
For mammalian cell expression, full-length M. musculus E-catenin and T-catenin in 
pEGFP-C1 were described previously13,148. M. musculus E-catenin fragments aa1-670 and aa1-
510 and T-catenin fragments aa1-659 and aa1-502 were cloned into pEGFP-C1.  
3.5.2 Recombinant Protein Expression and Purification 
For a detailed protocol see appendix B. GST-tagged and His-tagged fusion proteins were 
expressed in BL21-Gsold E. coli cells and purified as described in13,159. GST-tagged proteins were 
bound to glutathione-agarose conjugated beads while His-tagged proteins were bound to Ni-NTA 
beads. Bound beads were then equilibrated in cleavage buffer (20 mM Tris pH 8.0, 150 mM NaCl, 
2 mM EDTA, 10% glycerol and 1 mM DTT or BME) and incubated with tobacco etch virus 
protease overnight at 4C to cleave proteins from the respective tag. Proteins were then purified 
by MonoQ or MonoS ion exchange chromatography at 4C, followed by S200 gel filtration 
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chromatography at 4C. Purified proteins were eluted in 20 mM Tris pH 8.0, 150 mM NaCl, 10% 
glycerol, and 1 mM DTT, concentrated to working concentrations using a Millipore column 
concentrator and flash frozen in liquid nitrogen. 
3.5.3 Limited Proteolysis and Edman Degradation Sequencing 
For a detailed protocol see appendix C. Proteins were diluted to 12 M in 20 mM Tris pH 
8.0, 150 mM NaCl and 1 mM DTT and incubated at RT in 0.05 mg/mL sequencing grade trypsin 
(Roche Applied Science). Digestions were stopped with 2X Laemmli sample buffer and placed on 
ice until analysis. Samples were boiled and run by SDS-PAGE, then stained with 0.1% Coomassie 
Blue R-250, 40% ethanol, and 10% acetic acid. Gels were scanned on a LI-COR scanner. For N-
terminal sequencing, digested peptides were blotted onto PVDF membrane, stained (0.1% 
Coomassie Blue R-250, 40% methanol, and 1% acetic acid), destained and dried. Individual bands 
were excised from the membrane and sequenced by Edman degradation (Iowa State University 
Protein Facility). 
3.5.4 Crosslinking Experiments 
T-catenin protein fragments were incubated with or without 1 mM BS3 (Thermo 
Scientific) in 20 mM HEPES, pH 7.4, 150 mM NaCl, and 1 mM DTT for 30 min at 4C or 37C, 
separated by SDS-PAGE, stained with Coomassie dye and imaged on a LI-COR scanner. 
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3.5.5 Isothermal Titration Calorimetry 
Proteins used for ITC were purified as described except the S200 buffer was replaced with 
ITC Buffer (20mM HEPES pH 8.0, 150mM NaCl, 1mM TCEP). Identical buffer was used to 
purify both cell and titrant samples to ensure buffer match. Only fresh, unfrozen proteins were 
used for ITC. Measurements were performed on a Malvern MicroCal PEAQ-ITC or MicroCal VP-
ITC calorimeter (Malvern Panalytical). For experiments on the MicroCal PEAQ-ITC, titration 
occurred by an initial 0.5 L injection followed by 18 x 2 L injections of 110-150 M -catenin, 
103-158 µM -catenin/N-cadherin tail complex or 396-600 M vinculin aa1-259 (D1) into the cell 
containing 9-55 M of T-catenin or E-catenin. For experiments on the MircoCal VP-ITC, 
ligand was added with an initial 2 µL injection followed by 32 x 9 µL injections. The concentration 
of T-catenin head or T-catenin head•-catenin complex in the cell varied between 22 and 56 
µM. Vinculin D1 concentrations in the syringe varied between 240 and 546 µM. All calorimetry 
experiments were performed at 25C. All data analysis was performed using Malvern MicroCal 
ITC analysis software. For baseline correction, a mean baseline value, calculated by averaging the 
data points at saturation, was subtracted from each data point. 
3.5.6 Cell Culture 
 R2/7 carcinoma cells were cultured in DMEM (4.5 g/L glucose), 10% fetal bovine serum, 
1mM sodium pyruvate and penicillin/streptomycin. Lipofectamine 2000 was used for all transient 
transfections. 
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3.5.7 Western Blot 
R2/7 cells were lysed 48-72 hrs post-transfection in RIPA buffer (10mM Tris pH 7.5, 5mM 
EDTA, 0.1% Triton-X 100, 0.1% SDS, 0.1% deoxycholate, 150mM NaCl) plus protease inhibitors 
(Millipore). Lysate protein concentration was measured by BCA and 15 µg of each sample was 
separated by SDS-PAGE and transferred onto a PVDF membrane (Bio-Rad). The membrane was 
blocked in TBST + 5% BSA, washed in TBST and incubated with anti-GFP (1:1000, Invitrogen 
A11122) and anti-GAPDH (1:500, Millipore MAB374) antibodies for 1 hr at RT. The membrane 
was washed twice in TBST and then incubated with anti-rabbit IRDye 680 and anti-mouse IRDye 
800 for 1 hr at RT, washed twice with TBST and washed once with PBS. Membranes were scanned 
on a Bio-Rad ChemiDoc MP imaging system. 
3.5.8 Immunostaining and Confocal Microscopy 
For a detailed protocol see appendix D. Cells were fixed in 4% paraformaldehyde in PHEM 
buffer (60 mM 1,4-piperazin- ediethanesulfonic acid pH 7.0, 25 mM HEPES pH 7.0, 10 mM 
EGTA pH 8.0, 2 mM MgCl and 0.12 M sucrose), washed with PBS, permeabilized with 0.2% 
Triton X-100 in PBS for 2 minutes and then blocked for 1 hr at RT in PBS + 10% BSA. Samples 
were washed three times in PBS, incubated with primary in PBS + 1% BSA for 1 hr at RT, washed 
three times in PBS, incubated with secondary in PBS + 1% BSA for 1 hr at RT, washed three times 
in PBS, and mounted in ProLong Diamond mounting medium. Cells were imaged on a Nikon 
Eclipse Ti inverted microscope outfitted with a Prairie swept field confocal scanner, Agilent 
monolithic laser launch, and Andor iXon3 camera using NIS-Elements imaging software. 
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3.5.9 Image Analysis 
To quantify vinculin recruitment to EGFP-tagged E-catenin and T-catenin, a maximum 
projection was created from 4 planes of the z-stack (600 nm total distance) where cell-cell contacts 
were best in focus. IsoJ Dark thresholding was used to create a mask of the GFP channel to define 
the region of analysis in ImageJ. Vinculin signal intensity was then measured within the masked 
region. Next, three random intensity measurements of vinculin staining were taken in the cell 
cytoplasm and these values averaged. Finally, the vinculin intensity within the mask was divided 
by the cytoplasmic signal to normalize between samples and calculate the contact/cytoplasmic 
ratio. Colocalization data were plotted with Prism software (GraphPad). A one-way ANOVA with 
Tukey’s comparisons was performed to determine significance; p < 0.05. 
To examine the relationship between EGPF-αE-catenin or EGFP-T-catenin levels and 
vinculin recruitment, the vinculin contact/cytoplasmic ratio was plotted against the average GFP 
intensity of each fusion construct within the masked cell contact region (described above). Linear 
regression analysis was performed to calculate the slope, 95% confidence intervals, R square value 
and p value using Prism software (GraphPad). 
 
 88 
4.0 Discussion and Perspectives 
4.1 Study Synopses 
In these studies, I sought to characterize the molecular properties and ligand interactions 
of T-catenin. Understanding these interactions will help to define the role T-catenin plays in 
cardiomyocyte adhesion, identify how mutations in T-catenin may contribute to cardiomyopathy 
and determine how T-catenin functions with E-catenin to regulate adhesion in the mammalian 
heart. I discovered that while T-catenin and E-catenin are structurally and biochemically 
similar, potential differences in intramolecular interactions contribute to important variations in 
ligand binding and ligand binding regulation. These results reveal that E-catenin should not 
necessarily be used as a default for -catenin behavior and that there may be greater diversity 
within the -catenin family than previously realized. 
We found that recombinant T-catenin is primarily a monomer in solution with only 
limited potential to dimerize in vitro. In contrast, E-catenin can readily dimerize in solution. In 
addition, T-catenin monomer can bind to F-actin in the absence of tension with the same affinity 
as E-catenin dimer, and binding to -catenin does not affect this interaction. This property of T-
catenin likely means it does not interact with the F-actin cytoskeleton in the same manner as E-
catenin at adherens junctions. Note that the V94D mutation in T-catenin associated with ACM 
causes it to constitutively dimerize. This mutation does not affect F-actin binding affinity but 
increases its ability to bundle actin fibers. Dimerization does however block T-catenin 
interactions with -catenin, causing it to mis-localize to the actin cytoskeleton near the cell 
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membrane and to stress fibers. This result shows that T-catenin localization to adherens junctions 
is necessary for proper heart function. It also shows that if T-catenin can dimerize in vitro, the 
process must be regulated to ensure proper localization when necessary. 
T-catenin binds to -catenin with a 10-fold weaker affinity than that of E-catenin 
(264nM vs 23nM43). However, when -catenin is in complex with the N-cadherin tail this affinity 
strengthens to a low nanomolar affinity equal to E-catenin (6nM vs 1nM43). This result shows 
that T-catenin and E-catenin associate with the adherens junction with very similar affinity and 
likely compete for binding to -catenin. 
Limited proteolysis revealed that the T-catenin M-region appeared to be much more 
sensitive to digestion than the E-catenin M-region and therefore the domain was more dynamic. 
Based on this result, we hypothesized that vinculin would bind with high affinity to the T-catenin 
M-region. Indeed, the T-catenin M-region in isolation is not autoinhibited and binds vinculin 
with high affinity(60nM). However, when the N-terminus of T-catenin is connected to the M-
region the high affinity interaction is lost(4.7M) and the reaction becomes endothermic, 
indicating that unfolding is necessary for binging to occur. This result shows that the N-terminus 
is responsible for autoinhibition of vinculin binding in T-catenin, a mechanism distinct from E-
catenin. We also showed that the salt bridge network responsible for E-catenin M-region 
autoinhibition of vinculin binding103 does not play a role in this interaction in T-catenin. When 
the T-catenin N1-M2 construct was transfected into cells, it remained autoinhibited and was 
unable to recruit vinculin despite all potential salt bridges being disrupted. In contrast, the same 
construct in E-catenin could effectively recruit vinculin and restore cell-cell contacts. We also 
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show that both of T-catenin and E-catenin are regulated by tension, but it is still unclear whether 
the amount of force required to relieve autoinhibition varies. 
Together, these results reveal differences in the internal mechanisms of autoinhibition and 
dimerization in T-catenin compared to E-catenin. We also identified differences in ligand 
interactions that likely influence the interactions between T-catenin and the F-actin cytoskeleton. 
These results provide clues into how unique adherens junctions are built around T-catenin and 
the role those junctions may play in cell-cell adhesion in cardiomyocytes. 
4.2 Perspectives 
4.2.1 T-catenin M-region regulation and complex formation. 
The mechanosensitivity of the E-catenin M-region has been well characterized92,95,97,103 
but it is unknown whether this mechanism is conserved across the -catenin family. We showed 
that the mechanism of regulation for the T-catenin M-region still requires tension to relieve 
autoinhibition but is distinct from E-catenin. M-region activation plays an important role in what 
ligands are recruited to the adherens junction and when they are recruited, and the ligands recruited 
have implications for proper adherens junction function177,180.  
Our results show a positive correlation between T-catenin and vinculin at cell-cell 
contacts (Fig 3.5G) suggesting that T-catenin at adherens junctions is in a more open 
conformation. Based on this result, T-catenin may require less force to relieve autoinhibition of 
vinculin binding. Along with the fact that T-catenin can readily bind to F-actin while bound to 
 91 
-catenin, these factors suggest that T-catenin is active in different conditions than E-catenin. 
Since E-catenin cannot compensate for T-catenin in the heart, their roles are distinct and likely 
involve recruitment of distinct ligands. One example of the specialized roles of -catenin is 
myofibril integration across the ICD. Vinculin recruitment to E-catenin is required for proper 
myofibril formation and T-catenin cannot compensate despite also being able to bind vinculin45. 
Another example is plakophilin-2 recruitment to T-catenin, which can only be recruited to T-
catenin and creates the hybrid junction integrating both the F-actin and intermediate filament 
cytoskeletons75. Both vinculin and plakophilin-2 are recruited to the M-region of -catenin along 
with other proteins such as -actinin91 and afadin93,181. It is likely that these ligands are 
preferentially recruited to a particular -catenin to make distinct adherens junction complexes.  
To begin testing this hypothesis, we investigated the interaction between T-catenin and 
afadin using recombinant proteins (see appendix B). We purified the coiled-coil region of rat 
afadin spanning amino acids 1417-1564. We also purified the T-catenin M-region (aa260-626), 
T-head region (aa1-659), and T M1-ABD (aa260-895) to test 1) if afadin can bind to T-
catenin, and 2) if binding is regulated by similar intramolecular interactions as vinculin. We first 
used analytical size exclusion chromatography to determine if the T-catenin M-region can bind 
afadin in solution. We incubated 20µM T-catenin M1-M3 with 20µM rat afadin aa1417-1564 for 
one hour at room temperature and ran the protein mixture over a Superdex200 10/300 column 
(GE). We observed a robust complex (Fig. 4.1A). Interestingly, we also found that the T-catenin 
M1-M3 fragment could bind both vinculin and afadin at the same time, which has not previously 
been shown. We then tested the ability of vinculin and afadin to bind T-catenin M1-ABD. We 
found that vinculin bound readily to T-catenin M1-ABD, consistent with our previous 
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observation that the N-terminus is required for autoinhibition (Fig. 4.1B). However, afadin was 
not readily recruited to this fragment, indicating an intramolecular interaction between the M-
region and the ABD may regulate afadin binding. However, vinculin binding to M1-ABD 
increased afadin recruitment (Fig. 4.1B). Vinculin may increase the affinity of T-catenin M1-
ABD for afadin, but SEC is unable to measure affinity with accuracy so further experiments are 
necessary to determine if this is the case. 
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Figure 4.1 T-catenin binds to afadin and the interaction is regulated by intramolecular interactions 
A. T-catenin, vinculin and afadin analytical size exclusion chromatograms (left) and fraction run by SDS-
PAGE (right). B. T-catenin 260-895, vinculin and afadin analytical size exclusion chromatograms (left) and 
fraction run by SDS-PAGE (right). 
 
To determine the affinity of the interaction between the T-catenin M-region and the afadin 
coiled coil domain we turned again to ITC. Purified afadin coiled coil domain was titrated into 
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T-catenin M-region (Fig. 4.2). Consistent with the SEC results, afadin readily bound the T-
catenin M-region with an affinity around 100nM in an exothermic reaction. This result indicates 
that, similar to vinculin, T-catenin M-region binding to afadin is not autoinhibited. Going 
forward, ITC can be used with other T-catenin fragments to better understand the intramolecular 
interaction that regulate this interaction. Other proteins such as vinculin can be bound to T-
catenin in the cell of the ITC to determine if they change the affinity for afadin or vice versa. These 
measurements will help to better understand the order of ligand recrutment to the maturing 
adherens junction as well as the allosteric changes that occur during ligand binding. 
 
 
Figure 4.2 Afadin binds to T-catenin M-region by ITC. 
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It is not well understood how adherens junctions are assembled, particularly at the ICD. It 
is possible that the non-overlapping functions of these two -catenins is the result of the unique 
suite of ligands recruited to each. Understanding the difference in M-region regulation between  
T-catenin and E-catenin will help to determine how ligands are recruited to assemble adherens 
junctions that are properly suited to maintain adhesion in a particular environment. 
4.2.2 The role of the extrajunctional pool of T-catenin. 
E-catenin is mostly known as a junctional protein, but roughly one third of total cellular 
protein is cytoplasmic in epithelial cells128. E-catenin has known functions outside of the 
adherens junction, particularly in regulating cytoskeletal organization and cell signaling. E-
catenin dimer effectively binds and bundles F-actin(Fig. 2.3C) and inhibits the Arp2/3 complex to 
promote a less branched F-actin network127,159. E-catenin dimer can also be recruited to the 
plasma membrane independent of the cadherin through an interaction with phosphatidylinositol-
3,4,5-trisphosphate. This recruitment promotes epithelial cell migration and enhanced cell-cell 
adhesion178. E-catenin also recruits other factors to organize the F-actin cytoskeleton like 
mENA/VASP, zyxin, TES, EPLIN and formins182-184 although it is not known if these proteins can 
be recruited to the E-catenin dimer or if association with the cadherin complex is required. 
T-catenin shows very limited dimerization potential and is primarily a monomer in in 
vitro conditions (Fig. 2.2). The monomeric state of T-catenin cannot bundle F-actin as effectively 
as E-catenin dimer and in cells extrajunctional T-catenin is unlikely to organize actin into 
bundles. It is also unknown whether T-catenin can inhibit the Arp2/3 complex and alter actin 
filament architecture similar to E-catenin 159. In addition, the more open M-region of T-catenin 
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may be able to readily recruit organizers of the F-actin landscape that are normally only bound to 
E-catenin when it is under tension. This has the potential to make T-catenin a cytoplasmic F-
actin organizing center unique from E-catenin. However, it is unknown if T-catenin is recruited 
or able to associate with phosphatidylinositol as a monomer. These differences and how E-
catenin and T-catenin work in tandem warrants more study to determine how they influence the 
F-actin cytoskeletal landscape away from the adherens junction. 
E-catenin can also regulate a variety of signaling pathways, most notably the Wnt/-
catenin pathway125. E-catenin inhibits Wnt/-catenin signaling by binding to -catenin and 
preventing its translocation to the nucleus124,185. The E-catenin dimerization domain overlaps 
with the -catenin binding domain so these two complexes are mutually exclusive89. Thus, 
cytoplasmic -catenin cannot bind to E-catenin dimer to regulate Wnt signaling. T-catenin is a 
monomer in solution so -catenin would not have to compete with another T-catenin for binding 
in the cytoplasm. However, this may be offset by the fact that the affinity of T-catenin for -
catenin is 10-fold weaker than that of E-catenin (Table 3.1) 43. Note however that these 
measurements were calculated from proteins purified from E. coli and lack post translational 
modifications like phosphorylation that could change these interactions in mammalian cells. How 
the different members of the -catenin family regulate Wnt signaling is complex and will require 
more study. 
Another aspect of extrajunctional T-catenin biology that has not been explored is its 
impact on plakophilin-2 signaling. Plakophilin-2 is a transcriptional regulator of the Wnt and Ras 
signaling pathway influencing the cell cycle186 but has also been connected to the transcriptional 
control of calcium channels in the heart187. The transcriptional regulation of these channels may 
be a cause of ACM in patients with mutations in plakophilin-2. Since T-catenin specifically binds 
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plakophilin-2, it may play are role in the regulation of these signaling pathways through a similar 
mechanism as E-catenin and Wnt/-catenin signaling. We have recently discovered that T-
catenin is a small percentage of the total -catenin expressed in cultured neonatal mouse 
cardiomyocytes and may be as little as 2% (Kwiatkowski lab unpublished data). This makes it 
difficult to imagine that such as small percentage of protein when mutated can have a large impact 
on adhesion alone and result in a disease state. T-catenin playing a role in signaling provides a 
mechanism by which the effect of a mutation in the protein can be amplified to result in a more 
severe condition like ACM. 
4.2.3 T-catenin beyond the heart. 
T-catenin being the linchpin of the area composita gives it a distinct functional role in 
cardiomyocytes. However, other cell types with T-catenin do not contain hybrid junctions and 
many do not even express desmosomal proteins49. What is the function of T-catenin in these 
diverse tissues? This has been a difficult question to address as many of the tissues where T-
catenin is expressed show no obvious phenotype when T-catenin expression is lost53. 
T-catenin is expressed primarily in the heart as well as the testes, skeletal muscle, and 
central and peripheral nervous system49. In the testes, T-catenin is expressed in the peritubular 
myoid cells48. These are smooth muscle-like cells that help to transport immotile sperm by 
contracting to move them through the tubule107. In the nervous system, T-catenin does not seem 
to be present in neurons but is instead expressed in support cells like the ependymal cells that line 
the ventricles and central canal of the spinal cord and oligodendrocytes that produce myelin in the 
central nervous system119,120. 
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Notably, many of these cell types are contractile with the exception of the cells in the 
nervous system. T-catenin could be contributing to organizing contractile F-actin network in 
these cells. T-catenin could act as a scaffold for Z-disc formation in sarcomeres and in dense 
bodies, as -catenin is known to bind to the Z-disc protein -actinin91. Alternatively, T-could be 
responsible for maintaining adhesion in high tension environments such as the heart, but neural 
cells are not normally under high tension and skeletal muscle does not have cell-cell junctions and 
instead forms long syncytial fibers. 
It is also possible that T-catenin plays a specialized role in cell signaling. T-catenin has 
been shown to suppress airway hypersensitivity associated with asthma and allergic reactions, but 
it is unclear what cells are responsible for this reaction153. Knockout of T-catenin also alters 
transcription of pathways associated with Alzheimers and Autism in the mouse cerebellum119. 
Decreases in T-catenin expression have also been associated with a variety of cancers, but it is 
not clear whether this is the result of transcriptional changes or from the loss of cell adhesion49. 
Overall, it is not clear if there is a common niche being filled by T-catenin across these different 
cell types. T-catenin likely fills a variety of roles from adhesion to signaling to help maintain 
proper cell function, much like E-catenin. Additional studies will be necessary to fully 
understand the role of T-catenin throughout the body. 
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Appendix A Measuring protein binding to F-actin by co-sedimentation 
This text was published in the Journal of Visual Experiments in 2017. 
Heier JA, Dickinson DJ, Kwiatkowski AV. Measuring Protein Binding to F-actin by Co-
sedimentation. JoVE. 2017;(123):1-8. doi:10.3791/55613. 
Appendix A.1 Overview 
Filamentous actin (F-actin) organization within cells is regulated by a large number of 
actin-binding proteins that control actin nucleation, growth, cross-linking and/or disassembly. This 
protocol describes a technique – the actin co-sedimentation or pelleting assay – to determine if a 
protein or protein domain binds F-actin and to measure the affinity of the interaction (dissociation 
equilibrium constant). In this technique, a protein of interest is first incubated with F-actin in 
solution. Then, differential centrifugation is used to sediment the actin filaments and the pelleted 
material is analyzed by SDS-PAGE. If the protein of interest binds F-actin, it will co-sediment 
with the actin filaments. The products of the binding reaction (F-actin and the protein of interest) 
can be quantified to determine the affinity of the interaction. The actin pelleting assay is a 
straightforward technique for determining if a protein of interest binds F-actin and assessing how 
changes to that protein, such as ligand binding, affect its interaction with F-actin. 
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Appendix A.2 Introduction 
Actin is an essential cytoskeletal protein that plays a critical role in multiple cellular 
processes, including motility, contraction, adhesion and morphology188. Actin exists in two forms: 
monomeric globular actin (G-actin) and polymerized filamentous actin (F-actin). Within cells, F-
actin organization is controlled by a large collection of proteins that regulate the nucleation, 
growth, cross-linking and disassembly of actin filaments189-191. However, how multiple actin-
binding proteins function in concert to regulate actin network organization is still largely unclear. 
 Measurement of protein-protein interactions is an important approach for understanding 
at the biochemical level how proteins exert their effects on cell behavior. Many different assays 
can be used to detect interactions between purified proteins. Common approaches for soluble 
proteins include pull-downs, fluorescence polarization, isothermal titration calorimetry and 
surface plasmon resonance. Importantly, all of these assays require proteins to be soluble, and are 
thus difficult to adapt to a polymeric, filamentous protein such as F-actin. Here, we describe a 
technique – the actin co-sedimentation or pelleting assay – to determine if a protein or protein 
domain binds F-actin and to measure the affinity of the interaction. 
The actin pelleting assay is a relatively straightforward technique that does not require 
specialized equipment, aside from an ultracentrifuge. All reagents can be made, assuming 
knowledge of basic biochemistry, or purchased. Once binding to F-actin is established, the assay 
can be used to measure the apparent affinity (dissociation equilibrium constant) 156. Also, once an 
affinity is established, the pelleting assay is a useful tool to measure how changes to the protein of 
interest (i.e., post-translational modifications, mutations, ligand binding) affect its interaction with 
F-actin13. The technique does have limitations (see Discussion) that the researcher should be aware 
of before attempting the assay. 
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Appendix A.3 Protocol 
Appendix A.3.1 Prepare Materials 
1.1) Purify the protein of interest (see section 2). 
 
1.2) Prepare or purchase G-actin.  
Note: G-actin can be isolated from multiple sources188; alternatively, it can be purchased. 
Reconstituted G-actin (in 5 mM Tris pH 8.0, 0.2 mM CaCl2, 0.2 mM ATP (Adenosine 
triphosphate) and 0.5 mM dithiothreitol (DTT)) should be flash frozen, stored at –80 °C at >10 
mg/mL in small (10-20 µL) aliquots and thawed just before use. G-actin aliquots should not be 
refrozen. 
 
1.3) Prepare or purchase control protein, such as BSA (see step 4.4). 
 
1.4) Prepare 10X Polymerization Buffer (200 mM Imidazole pH 7.0, 1 M KCl, 20 mM MgCl2, 5 
mM ATP, 10 mM EGTA (Ethylene glycol-bis(-aminoethyl ether)-N,N,N',N'-tetraacetic acid). 
Make 10X stock, and adjust pH after addition of ATP if necessary, aliquot (25 µL is a useful 
volume) and store at -80°C. 
 
1.5) Prepare 10X Reaction Buffer (200 mM Imidazole pH 7.0, 1.5 M NaCl, 20 mM MgCl2, 5 mM 
ATP, 10 mM EGTA). Make 10X stock, adjust pH after addition of ATP if necessary, aliquot (50-
100 µL is a useful volume) and store at -80°C. 
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Note: The composition of the Reaction Buffer is flexible and may need to be adjusted to reduce 
background sedimentation, limit non-specific binding and/or improve binding (steps 1.5.1 – 1.5.3).  
 
1.5.1) Adjust the pH of the Reaction Buffer between 6 and 8 to optimize protein stability. At lower 
or higher pH, substitute an appropriate buffer for imidazole.  
Note: Use pH 7.0 as a starting point unless a protein requires a lower or higher pH for stability. 
Do not use a buffer with pH below 6.0 or higher than 8.0 as this may disrupt actin. Recommended 
buffers (final concentration and optimal pH listed) include: 20 mM MOPS (3-(N-
morpholino)propanesulfonic acid), pH = 6.5; 20 mM Imidazole, pH = 7.0; 10 mM HEPES (4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid), pH = 7.5; 20 mM Tris, pH = 8.0.  
 
1.5.2) Vary the salt concentration of the Reaction Buffer depending on the needs of the assay.  
Note: Actin is an acidic protein and almost all actin-binding proteins rely to some extent on 
electrostatic interactions to associate with actin. Therefore, increasing salt concentration decreases 
actin binding in most cases. The Reaction Buffer uses a physiological level of salt (150 mM NaCl, 
working concentration) and this is the recommended starting point. If necessary, the salt 
concentration can be lowered (e.g., to 100 mM) to promote binding, or increased to limit binding.  
 
1.5.3) Do not change the concentrations of MgCl2, ATP or EGTA in the Reaction Buffer unless 
there is a specific reason to do so. 
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Appendix A.3.2 Prepare test protein for the assay 
2.1) Prepare high purity protein using liquid chromatography for best results192. 
Note: If using recombinant protein, large protein tags such as GST (Glutathione-S-transferase) 
should be removed by protease cleavage from the target protein as they can interfere with binding. 
GST also causes homodimerization of fusion proteins, which can artificially increase the affinity 
of actin binding. 
 
2.2) Determine protein concentration by measuring the absorbance at 280 nm. Then divide by the 
extinction coefficient. The extinction coefficient can be calculated from the protein sequence using 
sequence analysis or online tools. Alternatively, determine protein concentration using Bradford 
or BCA (bicinchoninic acid) methods. 
Note: For initial experiments, 50-100 µL of protein at 20-40 µM is usually sufficient. This will 
permit analysis of binding in the low micromolar range, a useful starting point for most actin-
binding proteins. A larger quantity, and often times higher concentration, of protein is needed for 
generating a binding curve to calculate affinity (see section 5). 
 
2.3) Hard spin protein (50,000-100,000 x g for 10 min at 4 °C) to remove aggregates of insoluble 
protein just before use. If solubility is a concern, re-measure protein concentration (step 2.2) after 
centrifugation.  
Appendix A.3.3 Prepare F-actin 
3.1) Remove an aliquot of G-actin from the -80 °C freezer and thaw it quickly. 
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3.2) Add the 10X polymerization buffer to G-actin to a final concentration of 1X. Ensure that the 
G-actin concentration in 1X polymerization buffer is at least 10-20 µM, well above the critical 
concentration. Incubate for 1 h at RT (room temperature) to allow actin to polymerize. 
 
3.3) After polymerization, store the F-actin in solution at 4 °C where it is stable for a few weeks. 
Before using the F-actin again after storage, gently invert or flick the tube several times to ensure 
that all actin is dissolved and uniformly distributed in solution. 
Note: (Optional) Add phalloidin to achieve a 1:1 molar ratio of G-actin:phalloidin. Incubate 30 
min at RT to allow phalloidin to bind the F-actin. Phalloidin stabilizes F-actin and accomplishes 
two things: (i) it reduces the amount of actin that does not sediment during centrifugation; and (ii) 
it allows F-actin to be diluted below the critical concentration (~0.5 µM), which is often necessary 
if varying the amount of F-actin to generate a binding curve (see section 5 on measuring affinity).  
Appendix A.3.4 Pelleting Assay – Basic Protocol 
Note: The basic protocol described in section 4 is used to determine if a protein of interest co-
sediments with F-actin. Once binding to F-actin is established, the affinity of this interaction can 
be measured following the protocol described in section 5. 
 
4.1) Prepare the reaction buffer the day of use by diluting the 10X stock to 1X and add DTT to a 
final concentration of 1 mM. 
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Note: (Optional) Add polidocanol to a final working concentration of 0.02% in the reaction buffer. 
Polidocanol is a surfactant that reduces non-specific background binding and helps prevent 
hydrophobic proteins from sticking to the ultracentrifuge tube. 
 
4.2) Dilute the protein of interest to the desired concentrations in 1X reaction buffer in 
ultracentrifuge tubes. Keep samples volumes low (40-60 µL) to avoid using large amounts of 
protein by using ultracentrifuge tubes with small minimum volumes (e.g., 7 x 20 mm tubes that 
hold 0.2 mL). 
Note: Since many actin-binding proteins have an affinity for F-actin in the micromolar range, 
testing a protein of interest at 2 and 10 µM is recommended. If binding is not observed at 10 µM, 
it is unlikely that binding will be observed at higher concentrations. If the added protein makes up 
more than 10-20% of the final reaction volume, it may be necessary to dialyze the protein into the 
reaction buffer before doing the experiment. 
 
4.3) Add F-actin to the desired final concentration. 
Note: 2 µM is a useful concentration for initial experiments because it is well above the critical 
concentration (thus maintaining actin in the filamentous state) and it will produce a visible pellet 
when analyzed by SDS-PAGE (4.10). 
 
4.4) Prepare the following controls in ultracentrifuge tubes to make the assay informative. 
 
4.4.1) Prepare sample(s) containing the protein of interest without F-actin. Ensure that the 
concentration of protein in these samples matches the concentration in the “plus F-actin” samples. 
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These samples will determine the amount of protein that is aggregated or stuck to the sides of the 
ultracentrifuge tube in the absence of F-actin. 
 
4.4.2) Prepare negative control samples containing a control protein that does not bind F-actin at 
the same or similar concentration(s) used for the protein of interest, with and without F-actin. This 
is an important control because proteins can become “trapped” in actin filaments and pellet with 
F-actin even though they do not bind F-actin.  
Note: The amount of trapping can vary depending on F-actin source, buffer conditions, etc., and 
thus this control should be included in all experiments. Ideally, the control protein should have 
molecular weight similar to the protein of interest (e.g., for E-catenin (~100 kDa), BSA (66 kDa) 
is an appropriate control). Commercially available gel filtration standards make excellent control 
proteins since they cover a range of sizes and tend not to contain aggregates. 
 
4.4.3) Optionally, prepare positive control samples containing a protein that binds F-actin, with 
and without F-actin. Ensure that the concentration(s) are similar to those of the protein of interest. 
This control is helpful in that it demonstrates that the experimental conditions (e.g., prepared F-
actin, reaction buffer, centrifugation) permit F-actin binding. 
Note: Since the pelleting assay can fail to detect weak F-actin interactions (see Discussion), it is 
recommended that the known F-actin binding protein have a moderate-to-weak affinity for F-actin 
(in the low micromolar range). Purified F-actin binding proteins are commercially available. 
 
4.5) Incubate all samples for 30 min at RT. 
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Note: Longer incubation times are okay, assuming the protein of interest is stable, though likely 
unnecessary. If the protein of interest is not stable at RT, then samples can be incubated at 4 °C. 
In this case, longer incubation times may be necessary. 
 
4.6) Load the samples into the centrifuge rotor. Position the tubes within the rotor to assist in 
resuspending the pellet after centrifugation. For this, mark all centrifuge tubes (e.g., with a sample 
number) and place all tubes in the rotor in the same position (e.g., number facing out). 
 
4.7) Centrifuge at 100,000 x g for 20 min at 4 °C in an ultracentrifuge. 
 
4.8) After centrifugation, remove 3/4 of the supernatant (e.g., 45 µL if the starting volume was 60 
µL) from each tube and mix with 1/3 volumes of 4X sample buffer (15 µL in this case) in a separate 
microcentrifuge tube. 
 
4.8.1) Remove the remaining supernatant with a gel-loading tip, taking care not to disturb the pellet 
(which may be visible as a glassy spot). 
Note: It is important to remove the supernatant from the tubes as soon as possible after completion 
of the centrifuge run to limit protein dissociation post-separation. Also, do not wash the pellet with 
reaction buffer for the same reason. 
 
4.9) Add 4/3 volumes of 1X sample buffer to each pellet (e.g., 80 µL if the starting volume was 
60 µL). 
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Note: This makes the dilution the same as for the supernatant (step 4.8, 1/3 volumes of 4X sample 
buffer added) permitting direct comparison between pellet and supernatant samples and 
determining the percentage of protein that pelleted. 
 
4.9.1) Add sample buffer to all tubes and incubate for at least 5 min at RT. Allow the pellet to sit 
in the sample buffer to improve sample recovery. 
 
4.9.2) Triturate the sample 8-10X with a p200 pipette tip to resuspended the pellet, by continuously 
washing the pellet area of the tube. Gently scrape the pipette tip over the pellet during the trituration 
to help with resuspension. 
Note: Take care to avoid introducing air into the sample during the trituration, as this will cause 
the sample buffer to bubble and reduce sample recovery. 
 
4.9.3) Transfer the resuspended samples to microfuge tubes after trituration. 
 
4.10) Analyze the supernatant and pellet samples by SDS-PAGE and Coomassie staining193 by 
loading 10-15 µL of sample per lane, this is sufficient to visualize proteins. Proteins that co-
sediment with F-actin will be enriched in the “plus F-actin” pellet samples over the “no F-actin” 
pellet samples (Fig. 1A). 
Note: Standard Coomassie blue staining is sufficient for detection if protein concentrations are in 
the 0.1 – 10 µM range. Colloidal Coomassie9 or western blotting can be used for increased 
sensitivity if lower protein concentrations are used to measure higher-affinity interactions. 
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4.11) Image Coomassie-stained gels using a scanner or imaging system (step 5.12). 
Appendix A.3.5 Pelleting Assay – Quantification 
Note: If specific binding to F-actin is observed, it can be useful to measure the affinity of the 
interaction. This is accomplished by making a few changes and additions to the protocol outlined 
in section 4. For an excellent guide to designing and interpreting binding assays, see Pollard194. A 
flow chart (Fig. 2) is provided for assistance with the analysis and quantification. 
 
5.1) Determine the concentration range to test. The concentration range will depend on the protein, 
and should span from a concentration below the apparent Kd (e.g., 1 µM) to concentrations high 
enough to saturate binding. 
Note: It is critical that binding reach saturation in multiple samples at the high end of the 
concentration range to generate an accurate binding curve (Fig. 1C). As noted above, many actin-
binding proteins have an affinity for F-actin in the low micromolar range (1-5 µM). For a protein 
with a Kd of 0.5-1 µM, a useful starting concentration range would be 0.1 µM – 10 µM. 
 
5.2) Hard spin (step 2.3) the protein of interest to remove aggregates. Serially dilute the protein to 
make a concentration series, containing 7-8 samples, at 2X the final concentration to be tested. For 
example, if the range to test is 0.1 µM – 8 µM, prepare the following dilutions in 1X Reaction 
Buffer: 16, 8, 4, 2, 1, 0.5 and 0.2 µM.  
Note: As mentioned in step 4.2, if the added protein makes up more than 10%-20% of the first 
dilution (the 16 µM sample in the example above), it may be necessary to either concentrate the 
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protein further or dialyze the protein into 1X Reaction Buffer. Be sure to prepare enough of each 
dilution for “plus F-actin” and “no F-actin” samples. 
 
5.3) Prepare samples in ultracentrifuge tubes as in section 4. Add F-actin to appropriate samples 
and bring up to volume with 1X Reaction Buffer. For example, for 50 µL reactions using 2 µM F-
actin, each sample would comprise 25 µL 2X protein, 10 µL 10 µM F-actin and 15 µL 1X reaction 
buffer. Include control samples (4.4.2 & 4.4.3). 
Note: For negative and positive controls, use one concentration within the range to be tested (step 
5.1), ideally near the middle to high end of the range (e.g., 4 µM if the concentration range is 0.1 
to 10 µM). 
 
5.4) Incubate all samples for 30 min at RT. 
 
5.5) After 30 min, remove 1/5 of each sample (e.g., 10 µL of 50 µL reaction) and mix with 20 µL 
of water and 10 µL of 4X sample buffer. These are the “Total” samples and will be used to generate 
a standard curve. 
 
5.6) Load the samples into the ultracentrifuge rotor. Centrifuge at 100,000 x g for 20 min at 4 °C. 
 
5.7) Optionally, after centrifugation, remove 3/4 of the supernatant (e.g., 30 µL if the centrifuged 
volume was 40 µL) from each tube and mix with 4X sample buffer (10 µL in this case) in a separate 
microfuge tube. Remove the remaining supernatant with a gel-loading tip, taking care not to 
disturb the pellet. 
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Note: When measuring the binding affinity, it is not necessary to run the supernatant. Nonetheless, 
it can be useful to save the supernatant, especially when testing a new protein. 
 
5.8) Remove the supernatant if not analyzing (5.7). 
 
5.9) Resuspend the pellet in 1 volume of 1X sample buffer (e.g., 40 µL if the centrifuged volume 
was 40 µL). 
 
5.9.1) Add sample buffer to all tubes and incubate for at least 5 min at RT. 
 
5.9.2) Triturate the sample 8-10X with a p200 pipette tip, continually washing the pellet area of 
the tube. Gently scrape the pipette tip over the pellet during the trituration to help with 
resuspension. 
 
5.10) Transfer the resuspended protein to a microcentrifuge tube. These are the “Pellet” samples. 
 
5.11) Analyze Total and Pellet samples by SDS-PAGE193. Run all samples on one gel if possible; 
if not, run the pellet samples on one gel and the total samples on a second gel.  
Note: Given the number of samples, a large gel system is recommended for analysis. If running 
samples on two or more gels, it is important that all gels be stained identically – same Coomassie 
solution and identical time in stain/destain. 
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5.12) Image Coomassie-stained gels using an imaging system that measures protein band 
intensities over a wide (two to three log) and linear range. Ensure that images are collected with 
no saturated pixels. 
Note: Laser-based imaging systems offer the best sensitivity and signal-to-noise ratios. 
 
5.13) Using ImageJ or similar analysis program, measure protein band intensities and calculate the 
amount of bound protein. 
Note: For all sample measurements, use the selection tool in ImageJ to draw a region of interest 
(ROI) around each band and measure (Analyze > Measure) the area and mean gray value. Calculate 
the background for each gel by measuring the mean gray value from an area without sample. 
Subtract the background mean gray value from each ROI mean gray value and then multiply by 
the area to obtain the integrated density value for each band. 
 
5.13.1) Measure protein of interest band intensities from the Total samples (Fig. 2A). 
 
5.13.2) Generate a standard curve by plotting band intensity (integrated density measurements) 
versus protein mass (Fig. 2B). 
 
5.13.3) Measure the amount of protein of interest that co-sedimented with F-actin (co-sedimented 
protein, Fig. 2C). 
 
5.13.4) Measure the amount of protein of interest that sedimented in the absence of F-actin 
(background sedimentation, Fig. 2D). 
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5.13.5) Subtract the background sedimentation from the co-sedimented protein (i.e., subtract the 
values from step 5.13.4 from step 5.13.3) to determine the amount of protein that bound to F-actin. 
 
5.13.6) Measure the amount of F-actin in each pellet (Fig. 2E). Determine the average amount of 
F-actin per sample and then divide each sample by the average to determine the ratio of F-actin in 
each sample relative to the average (numbers below bands). 
 
5.13.7) For each sample, divide the amount of bound protein (calculated in step 5.13.5) by the F-
actin actin pellet ratio (5.13.6) to adjust for differences in the pellet. This value is the normalized 
bound protein. 
 
5.13.8) Use the standard curve (step 5.13.2) to calculate the amount (mass) of normalized bound 
protein (step 5.13.7) in each sample. 
Note: The protein removed initially (the “Total” sample) as well as the amount loaded (which, 
unless entire pellet was loaded, will be some fraction of the pellet) must be accounted for when 
calculating the total amount of protein that pelleted. 
 
5.13.9) Determine the concentration of bound protein in each sample from the total mass of protein 
in the pellet (calculated in step 5.13.8) and volume of the sample. Subtract this value from the 
starting concentration to determine the amount of free protein. Divide the concentration of bound 
protein by the concentration of actin (µM/µM of actin) and plot versus the concentration of free 
protein to generate a binding curve (Fig. 1C). 
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Note: Since F-actin is not a single uniform species it is difficult to extrapolate the molar 
concentration of F-actin from the G-actin concentration. Use the starting G-actin concentration to 
determine the amount of bound protein (µM/µM of actin) and estimate the apparent concentration 
of binding sites in the reaction. The concentration of binding sites is usually less than the 
concentration of actin monomers in the reaction, because not all of the actin polymerizes and 
because a single actin binding protein molecule can make contact with multiple monomers on the 
actin filament. 
 
5.14) Determine the affinity (Kd) and Bmax by nonlinear least squares regression from the binding 
curve using a statistical program. 
Note: Scatchard plots are discouraged for analyzing binding data, partly because they can obscure 
whether binding is saturated and they can distort experimental error194. 
Appendix A.4 Representative Results 
We examined E-catenin homodimer binding to F-actin in the co-sedimentation assay. 
Since past experiments have shown that the affinity of E-catenin homodimer for F-actin is around 
1 µM and the Bmax near 1159, we performed the assay with a low concentration of F-actin (0.2 µM 
rather than 2 µM; see Discussion). Since 0.2 µM is below the critical concentration, phalloidin 
was added to stabilize F-actin polymerized from rabbit skeletal muscle G-actin (step 3.3). 
Increasing concentrations of E-catenin homodimer (0.125 – 12.0 µM) were incubated in the 
presence or absence of 0.2 µM F-actin, the samples centrifuged and resulting pellets analyzed (Fig. 
1A). As expected, E-catenin homodimer cosedimented with F-actin above background (Fig. 1A, 
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compare F-actin pellet samples to No F-actin pellet samples). BSA was run as a negative control 
(Fig. 1B). Bound protein was quantified and plotted over free protein to calculate the affinity of 
the interaction (Fig. 1C). The plotted data best fit a Hill equation, and the calculated Kd was 2.9 
µM, the Bmax was 0.2 and the Hill coefficient (h) was 4.8. Thus, E-catenin homodimer binds F-
actin cooperatively with a low micromolar affinity, consistent with previous work (Kd of 2.9 µM 





Appendix Figure 1 High-speed F-actin co-sedimentation assay. 
A. Increasing concentrations (0.125 – 12.0 µM) of αE-catenin homodimer were incubated with (left panels) or 
without (right panels) 0.2 µM F-actin stabilized with phalloidin, incubated for 30 min at RT and centrifuged. 
Total (7.5% of the starting material) and pelleted material (50% of the pelleted material) were separated by 
SDS-PAGE and stained with Coomassie dye. B. 4 µM BSA was run as a negative control. Total and pellet 
samples, with (+) or without (-) F-actin, were separated by SDS-PAGE and stained with Coomassie dye. C. 
Bound αE-catenin (µM/µM actin) from A was plotted against free αE-catenin (µM) and data fit to a Hill 




Appendix Figure 2 Actin pelleting quantification – flow chart. 
The schematic outlines key steps in section 5 with examples of Total and Pellet samples (A, C-E) and standard 
curve (B) used for quantification. 5.13 steps: 1) Measure the amount of protein of interest in the Total 
samples (A). 2) Generate a standard curve by plotting band intensity versus protein mass (B). 3) Measure the 
amount of protein of interest that co-sedimented with F-actin (C). 4) Measure the amount of protein of 
 118 
interest that pelleted in the absence of F-actin (D). 5) Subtract D from C to determine the amount of protein 
bound to F-actin. 6) Measure the amount of F-actin in each pellet (E), calculate the average amount of F-actin 
per sample and then divide each sample by the average (numbers below show ratio). 7) For each sample, 
divide the amount of bound protein (calculated in step 5) by the F-actin pellet ratio (calculated in step 6) to 
adjust for differences in the pellet. 8) Use the standard curve (B) to calculate the amount (mass) of normalized 
bound protein in each sample (step 7). 9) Determine concentration of free protein and bound protein to create 
a binding curve. 
Appendix A.5 Discussion 
The actin co-sedimentation assay is a straightforward technique that can quickly determine 
if a protein binds F-actin. With some modifications, the technique can also be used to measure the 
affinity of the interaction. In addition to points raised in the protocol above, the following issues 
should be considered when designing, conducting and interpreting the assay. 
Appendix A.5.1 Protein of interest 
Freshly prepared or frozen protein can be used in the assay. If frozen protein is used, it is 
highly recommended that results be compared with fresh (never frozen) protein to ensure that 
freezing is not affecting F-actin binding. 
Appendix A.5.2 G-actin source 
Many pelleting experiments use G-actin isolated from muscle because of its relative 
abundance. There are three main actin isotypes in mammals – alpha, beta and gamma – that are 
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remarkably similar (>90% sequence identity). Nonetheless, there are functional differences 
between the isotypes195,196. If possible, the G-actin isotype used in the binding assay should match 
the in vivo isotype. For example, if testing a protein expressed in skeletal muscle, alpha-actin is 
the best choice; if examining a protein expressed in fibroblast, beta-actin is recommended. 
Appendix A.5.3 Phalloidin use  
Since phalloidin binds F-actin it can interfere or even block the binding of some F-actin 
binding proteins (e.g., phalloidin blocks cofilin from binding to actin filaments197). Thus, 
phalloidin should be used with caution, and results compared to non-phalloidin-treated samples 
when possible. 
Appendix A.5.4 High background 
It is not uncommon for proteins to sediment in the absence of F-actin (Fig. 1A, no F-actin 
pellet samples). However, high levels of background sedimentation can mask true actin co-
sedimentation and make it difficult, if not impossible, to determine if a protein binds F-actin or 
measure the affinity of the interaction. Adding polidicanol to the reaction buffer (step 4.1) can 
reduce background significantly and is an easy solution. If that doesn’t reduce background, 
adjusting the reaction buffer, salt concentration and/or incubation temperature may help. 
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Appendix A.5.5 Binding curve 
To generate a binding curve, it is necessary to vary the concentration of either the protein 
of interest or F-actin over a series of reactions. In practice, it is easier and preferable to maintain 
F-actin at a fixed concentration and vary the concentration of the protein of interest. Maintaining 
F-actin at a fixed concentration (e.g., 2 µM) in the pelleting assay limits non-specific trapping at 
higher concentrations of F-actin and prevents depolymerization at lower (< 0.5 µM) concentrations 
of F-actin. Depolymerization can be prevented using phalloidin, though this introduces a potential 
complicating factor into the system (see step 3.3 and above). Maintaining F-actin at a fixed 
concentration also allows one to compare (and normalize) the F-actin pellet across samples and 
identify failed experiments (where the F-actin pellet is highly variable, preventing analysis across 
concentrations). Finally, maintaining F-actin at a fixed concentration allows one to determine if 
binding to the actin filament is cooperative (Fig. 1C). 
Appendix A.5.6 Saturated binding 
As in all binding experiments, it is critical that binding to F-actin is saturated and that the 
concentration of protein plus F-actin plateaus (Fig. 1C). Without a plateau, it is not possible to 
calculate an accurate dissociation equilibrium constant. Thus, it is important to plan carefully the 
dilution series to be tested and always include higher concentrations of protein (at least 5-10 fold 
higher than the expected Kd). 
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Appendix A.5.7 Binding analysis 
In order for the measured dissociation constants to be conclusive, the assay should be 
performed using an F-actin concentration such that the concentration of binding sites on F-actin 
for the protein of interest is much lower than the affinity. To check whether this criterion was met, 
estimate the concentration of binding sites from Bmax. For example, if [F-actin] was 2 µM and 
Bmax = 0.5, then [binding sites] ≈ 1 µM. The Kd should be greater than [binding sites] by at least 
5-10 fold. If the measured Kd is of the same order of magnitude as [binding sites], then it is possible 
that the observed binding curve represents a titration of high-affinity binding sites rather than a 
true binding isotherm. If this is observed, repeat the assay using a 10-fold lower F-actin 
concentration to measure an accurate affinity. For high-affinity interactions, phalloidin 
stabilization (step 3.3) may be necessary in order to achieve an F-actin concentration low enough 
to measure affinity accurately. 
Finally, there are fundamental limitations with the co-sedimentation assay that researchers 
should be aware of when performing and evaluating the assay. Most importantly, the co-
sedimentation assay does not produce a true equilibrium constant. The products of binding (protein 
plus F-actin) are separated from the reactants during centrifugation, whereupon the products can 
then dissociate to create a new equilibrium. As a result, the co-sedimentation assay can 
miscalculate or fail to detect low affinity interactions. Since many actin-binding proteins have a 
low (micromolar) affinity for F-actin, a negative result (i.e., no detectable binding) in the assay 
does not necessarily mean a protein does not bind F-actin. As an alternative, TIRF microscopy-
based single filament binding assays are more sensitive and more accurate for determining a 
dissociation constant (for reviews on this technique, see198,199). Nonetheless, despite these 
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limitations the pelleting assay is an effective tool within the means of most researchers to 
determine if a protein binds F-actin and to measure the affinity of the interaction. 
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Appendix B Protein Purification Protocol 
Appendix B.1 Protein Induction 
1.1) Grow an overnight culture of BL21 cells or other bacterial strain transformed with a pGEX 
(or similar) bacterial expression plasmid containing the protein of interest. Start 30mL of culture 
per liter of induction. 
 
1.2) Seed 1 liter of LB ampicillin with 30mL of starter culture. Incubate at 37C and 220 RPM 
until OD reaches 0.6-0.8. 
 
1.3) When OD is reached, add 0.5mM IPTG to induce protein production. Lower the temperature 
to 30C and incubate for 4 hours. For large or difficult to induce proteins the temperature can be 
lowered to 18C and incubated overnight. 
 
1.4) Pellet the cells by centrifuging at 5000g for 15 minutes. 
 
1.5) Resuspend the pellet in 10mL of resuspension buffer (see appendix B.5) and freeze in liquid 
nitrogen. Frozen cell suspensions can be kept at -80C for >5 years.  
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Appendix B.2 Protein Purification 
2.1) Thaw frozen cell suspension quickly by placing conical tubes in beaker filled with cold water. 
 
2.2) To suspension add: Protease Inhibitors (Kept at 100x=10ul per 1mL), DNAse, EDTA, and 
DTT. Example: Conical tube with 30mL of solution would need: 
(a) Protease Inhibitors 100X (Roche): 300 uL 
(b) DNAse (Sigma; 50ug/ul final conc): 300 uL 
(c) EDTA (Sigma; 2mM Final Conc): 120 uL of .5M EDTA 
(d) DTT (Sigma; 5mM Final Conc): 150 uL of 1M DTT 
 
2.3) Lyse cells in EmulsiFlex homogenizer. Cells should be run through system three times 
between 15,000 and 20,000 PSI. 
 
2.4) Centrifuge cell suspension at 20,000g for 30 minutes at 4°C. 
 
2.5) Incubate post-centrifuged suspension with 5 ml bed volume of glutathione agarose beads (for 
every 2L of culture) equilibrated with PBSTR Wash Buffer (appendix B.5). Do not exceed 5mL 
bed volume per 2L culture or 5mL bed volume per 50mL tube. Incubate at 4°C for 30 minutes 
with gentle mixing. 
 
2.6) Following binding incubation (Step 2.5), pellet beads by spinning gently in centrifuge (1 




2.7) Wash beads 1 time with ice cold cleavage buffer (appendix B.5) and combine tubes.  
 
2.8) Incubate beads with TEV Protease in 10mL Cleavage Buffer overnight at 4ºC with gentle 
agitation. 
Appendix B.3 FPLC Protocol 
Appendix B.3.1 Cation/Anion Column Preparation – AKTA Purifier FPLC 
3.1) Fill a 500mL flask with 400mL of MonoQ A buffer (appendix B.5). Fill a 250mL flask fill 
with 200mL of MonoQ B buffer. 
 
3.2) Perform a pump wash to equilibrate with buffer. 
 
3.3) Set pump to 4ml/min and alarm pressure to 4MPa. Equilibrate the ion exchange column with 
1 column volume MonoQ A buffer.  
 
3.4) Using the gradient setting, increase the concentration of monoQ B to 100% over 1 minute. 
Allow the concentration of MonoQ B to remain at 100% for 1 column volume to elute any proteins 
from the column. 
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3.5) Decrease the gradient to 0% MonoQ B over 1 minute and re-equilibrate with 1 column volume 
of MonoQ A. 
Appendix B.3.2 Sample Preparation and Loading 
3.6) Filter TEV Incubated protein through column into 50mL tube. There should be no more than 
15mL of flow through in the tube. 
 
3.7) Fill tube to 45mL with MonoQ A buffer and add EDTA to a final concentration of 2mM. 
 
3.8) Filter the sample into a new tube through a 0.22M filter to remove and aggregates. 
 
3.9) Transfer the filtered sample to the loop and place the caps on the end. Use a 5mL syringe and 
the MonoQ A buffer remove any bubbles present. 
 
3.10) Attach the loop to the FPLC loading port. 
Appendix B.4 Running the FPLC 
Appendix B.4.1 Ion Exchange Column 
4.1) Select the appropriate column and set the sample injection volume to the volume in the loop. 
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4.2) A typical program will inject the sample and wash the column with 2 column volumes of 
MonoQ A buffer to remove unbound protein. A gradient will then be applied increasing the 
concentration of monoQ B buffer to 40% over 5 column volumes while collecting 1.5 mL 
fractions. The majority of proteins will elute in this range. 
 
4.3) Stop fractionation and increase the concentration of MonoQ B buffer to 100% over 1 column 
volume to elute any other bound proteins. Rinse the column with 2 column volumes of MonoQ A 
buffer to re-equilibrate the column. 
Appendix B.4.2 Size Exclusion Column 
4.4) Prepare a 500mL flask with 400mL of S200 buffer (appendix B.5) and perform a pump wash 
to equilibrate. 
 
4.5) Attach the 5mL loop to the FPLC and flush with 10mL of S200 buffer. Load the sample from 
the ion exchange column using a 5mL syringe. 
 
4.6) A typical size exclusion program will equilibrate the column with 1 column volume of S200 
buffer then inject the sample and elute with 1 column volume of S200 buffer while collecting 1mL 
fractions. 
 
4.7) Purified proteins can then be concentrated and used in experiments or frozen in liquid nitrogen 
and stored at -80ºC for later use. 
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Appendix B.5 Buffers 
Resuspension Buffer: 20mM Tris pH 8.0, 200mM NaCl 
 
PBSTR Wash Buffer: 1x PBS, 300mM NaCl, 0.05% Tween20, 5mM DTT 
 
Cleavage Buffer: 20mM Tris pH 8.0, 150mM NaCl, 1mM EDTA, 10% Glycerol, 5mM DTT 
 
MonoQ A Buffer: 20mM Tris pH 8.0, 1mM DTT 
 
MonoQ B Buffer: 20mM Tris pH 8.0, 1M NaCl, 1mM DTT 
 
S200 Buffer: 20mM Tris pH 8.0, 150mM NaCl, 10% Glycerol, 1mM DTT 
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Appendix C Limited Proteolysis 
1.1) Aliquot sequence-grade trypsin (Roche) in molecular biology grade H2O to get 1 µg/µL.  
25 µg trypsin + 25 µL H2O = 1 µg/µl. Aliquot in 5 µL / vial and flash freeze aliquots in liquid 
nitrogen. 
 
1.2) Dilute protein of interest to 12 µM with proteolysis buffer (20mM Tris pH 8.0, 150mM NaCl, 
1mM DTT). 100L is required per protein tested. 
 
1.3) Dilute trypsin to 0.25g/mL in proteolysis buffer. 
 
1.4) Add 12L of protein and 3L of diluted trypsin. Incubate samples for 0’, 2.5’, 5’, 15’, 30’, 
60’, 120’ at room temperature. For the 0’ sample add water instead of trypsin. 
 
1.5) To stop reaction add 15L of 2X Laemmli Sample Buffer and Boil for 2 minutes. 
 
1.6) Load 15L onto 4-20% gradient SDS-PAGE gel and stain with Coomassie. 
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Appendix D PHEM Fix and Immunostaining 
Appendix D.1 PHEM Fix Preparation 
Final Stock Volume 
60 mM PIPES pH 7.0 0.5 M 60 ml 
25 mM HEPES pH 7.0 1 M 12.5 ml 
10 mM EGTA pH 8.0 0.1 M 50 ml 
2 mM MgCl2 1 M 1 ml 
0.12 M Sucrose 1.2 M 50 ml 
4% Paraformaldehyde  20 g 
  500 ml 
 
1.1) Dissolve paraformaldehyde in 300 ml water.  Add few drops of 10 N NaOH and stir while 
heating in fume hood.  When dissolved, let cool to room temperature. 
 
1.2) Add PIPES, HEPES, EGTA, MgCl2 and Sucrose. Adjust pH to 7.3-7.4, then adjust final 
volume of 500 ml with water. Aliquot and freeze at –20 C in non-defrosting freezer.  Aliquots 
are good for about 1 year. 
 
1.3) Thaw at 37 C and dispose of any unused portion (DO NOT refreeze). Note: after prolonged 
periods of freezing, it may be necessary to heat for 20-30 minutes and vortex to get 
paraformaldehyde into solution. If it does not go into solution, discard. 
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Appendix D.2 Fixation/Staining 
1.4) Replace media with warm fixative (37 °C) and fix for 10 minutes at room temperature. 
 
1.5) Wash 2X in PBS, 5 min/wash.  Fixed cells can be stored for weeks at 4 C in PBS + 0.02% 
azide.  However, if staining cells transfected with a fluorescent protein, it's best to stain soon after 
fixation (1-2 days). 
 
1.6) When ready to stain, permeabilize cells with PBS + 0.2% Triton X-100 for 2 min at RT. 
Timing is important and can vary between cells lines, but 2 min works for most cell types. 
 
1.7) Wash 2X in PBS, 5 min/wash. Block coverslips in PBS + 10% BSA 1 hour at RT, or overnight 
at 4 C. Rinse 1X in PBS. 
 
1.8) Primary antibody staining. Dilute antibodies in PBS + 1% BSA and stain for 1 hr at RT or 
ON at 4 C.  Hardier cells (e.g. MDCK epithelial cells, fibroblasts) can be stained upside down to 
conserve antibody; delicate cells types (e.g. neurons) should be stained right side up.  Coverslips 
should be stained on parafilm in a humidified chamber (moistened Kimwipes in a closed plastic 
container works well). 
 
1.9) Wash coverslips 2X in PBS, 5 min/wash. 
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1.10) Secondary antibody staining. Dilute antibodies in PBS + 1% BSA.  Stain for 45 min to 1 hr 
at RT.  Do not stain overnight.  If using phalloidin to stain for F-actin, add to secondary mix (use 
1:200 – 1:500). 
 
1.11) Wash 2X in PBS, 5 min/wash. If you want to DAPI stain, you can do a quick (5 min) stain 
here, followed by 2 more washes. 
 
1.12) Mount coverslips in favorite fixing media.  Seal/adhere coverslips with nail polish if 
necessary.  Allow sufficient time to dry, clean coverslips with diluted Windex and image. 
 133 
Bibliography 
1. Green KJ, Roth-Carter Q, Niessen CM, Nichols SA. Tracing the Evolutionary 
Origin of Desmosomes. Current Biology. 2020;30(10):R535-R543. 
doi:10.1016/j.cub.2020.03.047. 
2. Noorman M, van der Heyden MAG, van Veen TAB, et al. Cardiac cell–cell 
junctions in health and disease: Electrical versus mechanical coupling. Journal of 
Molecular and Cellular Cardiology. 2009;47(1):23-31. 
doi:10.1016/j.yjmcc.2009.03.016. 
3. Sheikh F, Ross RS, Chen J. Cell-Cell Connection to Cardiac Disease. Trends in 
Cardiovascular Medicine. 2009;19(6):182-190. doi:10.1016/j.tcm.2009.12.001. 
4. McCain ML, Lee H, Aratyn-Schaus Y, Kleber A, Parker KK. Cooperative coupling 
of cell-matrix and cell–cell adhesions in cardiac muscle. Proc Natl Acad Sci USA. 
June 2012:1-6. doi:10.1073/pnas.1203007109/-/DCSupplemental. 
5. Vite A, Radice GL. N-Cadherin/Catenin Complex as a Master Regulator of 
Intercalated Disc Function. Cell Communication & Adhesion. 2014;21(3):169-179. 
doi:10.3109/15419061.2014.908853. 
6. Horsley V, Pavlath GK. Forming a Multinucleated Cell: Molecules That Regulate 
Myoblast Fusion. Cells Tissues Organs. January 2004:1-12. 
doi:10.1159/000075028. 
7. Oren-Suissa M, Podbilewicz B. Cell fusion during development. Trends in Cell 
Biology. November 2007:1-10. doi:10.1016/j.tcb.2007.09.004. 
8. Ehler E. Cardiac cytoarchitecture-why the “hardware” is important for heart 
function! BBA - Molecular Cell Research. 2016;1863(Part B):1857-1863. 
doi:10.1016/j.bbamcr.2015.11.006. 
9. Rayns DG, Simpson FO, Ledingham JM. Ultrastructure of Desmosomes in 
Mammalian Intercalated Disc; Appearances After Lanthanum Treatment. Journal of 
Cell Biology. July 1969:1-5. 
10. Franke WW, Borrmann CM, Grund C, Pieperhoff S. The area composita of adhering 
junctions connecting heart muscle cells of vertebrates. I. Molecular definition in 
intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal 
proteins. European Journal of Cell Biology. 2006;85(2):69-82. 
doi:10.1016/j.ejcb.2005.11.003. 
 134 
11. Sheikh F, Chen Y, Chen Y, et al. alpha-E-catenin inactivation disrupts the 
cardiomyocyte adherens junction, resulting in cardiomyopathy and susceptibility to 
wall rupture. Circulation. 2006;114(10):1046-1055. 
doi:10.1161/CIRCULATIONAHA.106.634469. 
12. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. 
Cardiovasc Res. April 2004:1-14. doi:10.1016/j.cardiores.2003.11.035. 
13. Wickline ED, Dale IW, Merkel CD, Heier JA, Stolz DB, Kwiatkowski AV. αT-
Catenin Is a Constitutive Actin-binding α-Catenin That Directly Couples the 
Cadherin·Catenin Complex to Actin Filaments. J Biol Chem. 2016;291(30):15687-
15699. doi:10.1074/jbc.M116.735423. 
14. Maeda M, Holder E, Lowes B, Valent S, Bies RD. Dilated cardiomyopathy 
associated with deficiency of the cytoskeletal protein metavinculin. Circulation. 
1997;95(1):17-20. doi:10.1161/01.cir.95.1.17. 
15. Calore M, Lorenzon A, De Bortoli M, Poloni G, Rampazzo A. Arrhythmogenic 
cardiomyopathy: a disease of intercalated discs. Cell Tissue Res. May 2015:1-10. 
doi:10.1007/s00441-014-2015-5. 
16. van Hengel J, Calore M, Bauce B, et al. Mutations in the area composita protein αT-
catenin are associated with arrhythmogenic right ventricular cardiomyopathy. 
European Heart Journal. 2012;34(3):201-210. doi:10.1093/eurheartj/ehs373. 
17. Zhao Z-M, Reynolds AB, Gaucher EA. The evolutionary history of the catenin gene 
family during metazoan evolution. BMC Evolutionary Biology. 2011:1-13. 
18. Dickinson DJ, Nelson WJ, Weis WI. A Polarized Epithelium Organized by 𝛃- and 
𝛂-Catenin Predates Cadherin and Metazoan Origins. Science. March 2011:1-5. 
doi:10.1126/science.1198904. 
19. Hartsock A, Nelson WJ. Adherens and tight junctions: Structure, function and 
connections to the actin cytoskeleton. Biochimica et Biophysica Acta (BBA) - 
Molecular Cell Research. March 2008:1-10. doi:10.1016/j.bbamem.2007.07.012. 
20. Mège RM, Ishiyama N. Integration of Cadherin Adhesion and Cytoskeleton at 
Adherens Junctions. Cold Spring Harb Perspect Biol. 2017;9(5):a028738–19. 
doi:10.1101/cshperspect.a028738. 
21. Takeda H, Shimoyama Y, Nagafuchi A, Hirohashi S. E-cadherin functions as a cis-
dimer at the cell-cell adhesive interface in vivio. Nature Structural Biology. March 
1999:1-3. 
22. Zuppinger C, Eppenberger-Eberhardt M, Eppenberger HM. N-Cadherin: Structure, 
Function and Importance in the Formation of New Intercalated Disc-Like Cell 
Contacts in Cardiomyocytes. Heart Failure Reviews. October 2000:1-7. 
 135 
23. Perez TD, Nelson WJ. Cadherin Adhesion: Mechanisms and Molecular Interactions. 
Handbook of Experimental Pharmacology. 2004:1-19. doi:10.1007/978-3-540-
68170-0_1. 
24. Radice GL, Rayburn H, Matsunami H, Knudsen KA, Takeichi M, Hynes RO. 
Developmental Defects in Mouse Embryos Lacking N-Cadherin. Developmental 
Biology. December 1996:1-15. 
25. Kostetskii I, Li J, Xiong Y, et al. Induced Deletion of the N-Cadherin Gene in the 
Heart Leads to Dissolution of the Intercalated Disc Structure. Circulation Research. 
February 2005:1-9. doi:10.1161/01.RES.0000156274.72390.2c. 
26. Luo Y, Ferreira-Cornwell MC, Baldwin HS, et al. Rescuing the N-cadherin 
knockout by cardiac-specific expression of N- or E-cadherin. Development. January 
2001:1-11. 
27. Gul IS, Hulpiau P, Saeys Y, van Roy F. Evolution and diversity of cadherins and 
catenins. Experimental Cell Research. 2017;358(1):3-9. 
doi:10.1016/j.yexcr.2017.03.001. 
28. Peifer M, Berg S, Reynolds AB. A Repeating Amino Acid Motif Shared by Proteins 
with Diverse Cellular Roles. Cell. March 1994:1-3. doi:10.1016/0092-
8674(94)90353-0. 
29. Peifer M, Yap AS. Traffic control: p120-catenin acts as a gatekeeper to control the 
fate of classical cadherins in mammalian cells. Journal of Cell Biology. October 
2003:1-4. doi:10.1083/jcb.200310090. 
30. Nanes BA, Chiasson-MacKenzie C, Lowery AM, et al. p120-catenin binding masks 
an endocytic signal conserved in classical cadherins. Journal of Cell Biology. 
October 2012:1-16. doi:10.1083/jcb.201205029. 
31. Chen X, Kojima S-I, Borisy GG, Green KJ. p120 catenin associates with kinesin and 
facilitates the transport of cadherin–catenin complexes to intercellular junctions. 
Journal of Cell Biology. October 2003:1-11. doi:10.1083/jcb.200305137. 
32. Pieters T, van Roy F, van Hengel J. Functions of p120ctn isoforms in cell-cell 
adhesion and intracellular signaling. Frontiers in Bioscience. January 2012:1-26. 
33. Braga VMM, Yap AS. The challenges of abundance: epithelial junctions and small 
GTPase signalling. Current Opinion in Cell Biology. September 2005:1-9. 
doi:10.1016/j.ceb.2005.08.012. 
34. Anastasiadis PZ. p120-ctn: A nexus for contextual signaling via Rho GTPases. 
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. December 2006:1-
13. doi:10.1016/j.bbamcr.2006.08.040. 
 136 
35. Choi H-J, Gross JC, Pokutta S, Weis WI. Interactions of Plakoglobin and Beta-
Catenin with Desmosomal Cadherins. J Biol Chem. October 2009:1-13. 
36. Valenta T, Hausmann G, Basler K. The many faces and functions of 𝛃-catenin. 
EMBO J. 2012;31(12):2714-2736. doi:10.1038/emboj.2012.150. 
37. Zhou J, Qu J, Yi XP, et al. Upregulation of 𝛄-catenin compensates for the loss of 𝛃-
catenin in adult cardiomyocytes. American Journal of Physiology Heart and 
Circulatory Physiology. December 2007:1-7. doi:10.1152/ajpheart.00576.2006. 
38. Haegel H, Larue L, Ohsugi M, Fedorov L, Harrenknecht K, Kemler R. Lack of 𝛃-
catenin affects mouse development at gastrulation. Development. September 1995:1-
9. 
39. Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. June 
2008:1-8. 
40. Zhao Y, Wang C, Wang C, et al. An essential role for Wnt/β-catenin signaling in 
mediating hypertensive heart disease. Scientific Reports. June 2018:1-14. 
doi:10.1038/s41598-018-27064-2. 
41. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS. 𝛂(E)-Catenin is an actin-
binding and -bundling protein mediating the attachment of F-actin to the membrane 
adhesion complex. Proc Natl Acad Sci USA. September 1995:1-5. 
42. Buckley CD, Tan J, Anderson KL, et al. The minimal cadherin-catenin complex 
binds to actin filaments under force. Science. 2014;346(6209):1254211-1254211. 
doi:10.1126/science.1254211. 
43. Pokutta S, Choi H-J, Ahlsen G, Hansen SD, Weis WI. Structural and 
thermodynamic characterization of cadherin·β-catenin·α-catenin complex formation. 
J Biol Chem. 2014;289(19):13589-13601. doi:10.1074/jbc.M114.554709. 
44. Liang X, Gomez GA, Yap AS. Current perspectives on cadherin-cytoskeleton 
interactions and dynamics. Cell Health and Cytoskeleton. January 2015:1-14. 
doi:10.2147/CHC.S76107. 
45. Merkel CD, Li Y, Raza Q, Stolz DB, Kwiatkowski AV. Vinculin anchors contractile 
actin to the cardiomyocyte adherens junction. Molecular Biology of the Cell. 
September 2019:1-12. doi:10.1091/mbc.E19-04-0216). 
46. Herrenknecht K, Ozawa M, Lenter M, Kemler R. The Uvomorulin-Anchorage 
Protein a-Catenin Is a Vinculin Homologue. Proc Natl Acad Sci USA. July 1991:1-5. 
47. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, Takeichi M. Identification of a 
Neural a-Catenin as a Key Regulator of Cadherin Function and Multicellular 
Organization. Cell. July 1992:1-9. 
 137 
48. Janssens B, Goossens S, van Roy F. aT-Catenin: a novel tissue-specific b-catenin-
binding protein mediating strong cell-cell adhesion. Journal of Cell Science. August 
2001:1-12. 
49. Chiarella SE, Rabin EE, Ostilla LA, Flozak AS, Gottardi CJ. αT-catenin: A 
developmentally dispensable, disease-linked member of the α-catenin family. Tissue 
Barriers. 2018;0(0):1-12. doi:10.1080/21688370.2018.1463896. 
50. Torres M, Stoykova A, Huber O, et al. An 𝛂-E-catenin gene trap mutation defines 
its function in preimplantation development. Proc Natl Acad Sci USA. January 
1997:1-6. 
51. Park C, Falls W, Finger JH, Longo-Guess CM, Ackerman SL. Deletion in Catna2, 
encoding 𝛂N-catenin, causes cerebellar and hippocampal lamination defects and 
impaired startle modulation. Nature Genetics. June 2002:1-6. doi:10.1038/ng908. 
52. Uemura M, Takeichi M. 𝛂N-Catenin Deficiency Causes Defects in Axon Migration 
and Nuclear Organization in Restricted Regions of the Mouse Brain. Developmental 
Dynamics. August 2006:1-8. doi:10.1002/dvdy.20841. 
53. Li J, Goossens S, van Hengel J, et al. Loss of αT-catenin alters the hybrid adhering 
junctions in the heart and leads to dilated cardiomyopathy and ventricular 
arrhythmia following acute ischemia. Journal of Cell Science. 2012;125(4):1058-
1067. doi:10.1242/jcs.098640. 
54. Vite A, Li J, Radice GL. New functions for alpha-catenins in health and disease: 
from cancer to heart regeneration. Cell Tissue Res. 2015;360(3):773-783. 
doi:10.1007/s00441-015-2123-x. 
55. Christensen AH, Benn M, Tybjaerg-Hansen A, Haunso S, Svendsen JH. Screening 
of Three Novel Candidate Genes in Arrhythmogenic Right Ventricular 
Cardiomyopathy. Genetic Testing and Molecular Biomarkers. March 2011:1-6. 
doi:10.1089/gtmb.2010.0151. 
56. Elliott PM, Anastasakis A, Asimaki A, Green KJ, van Tintelen JP. Definition and 
treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. 
European Journal of Heart Failure. July 2019:1-10. doi:10.1002/ejhf.1534. 
57. Hatzfeld M, Keil R, Magin TM. Desmosomes and Intermediate Filaments: Their 
Consequences for Tissue Mechanics. Cold Spring Harb Perspect Biol. May 2017:1-
22. doi:10.1101/cshperspect.a029157. 
58. Herrmann H, Aebi U. Intermediate Filaments: Structure and Assembly. Cold Spring 
Harb Perspect Biol. October 2016:1-22. doi:10.1101/cshperspect.a018242. 
59. Paulin D, Li Z. Desmin: a major intermediate filament protein essential for the 
structural integrity and function of muscle. Experimental Cell Research. October 
2004:1-7. doi:10.1016/j.yexcr.2004.08.004. 
 138 
60. Green KJ, Jaiganesh A, Broussard JA. Desmosomes: Essential contributors to an 
integrated intercellular junction network. F Research. December 2019:1-16. 
doi:10.12688/f1000research.20942.1. 
61. Broussard JA, Getsios S, Green KJ. Desmosome regulation and signaling in disease. 
Cell Tissue Res. 2015;360(3):501-512. doi:10.1007/s00441-015-2136-5. 
62. Delmar M, McKenna WJ. The Cardiac Desmosome and Arrhythmogenic 
Cardiomyopathies. Circulation. September 2010:1-15. 
doi:10.1161/CIRCRESAHA.110.223412. 
63. Delva E, Tucker DK, Kowalczyk AP. The Desmosome. Cold Spring Harb Perspect 
Biol. July 2009:1-17. doi:10.1101/cshperspect.a002543. 
64. Kowalczyk AP, Green KJ. Structure, Function, and Regulation of Desmosomes. 
Progress in Molecular Biology and Translation Science. February 2015:1-20. 
doi:10.1016/B978-0-12-394311-8.00005-4. 
65. Schmidt A, Jager S. Plakophilins—hard work in the desmosome, recreation in the 
nucleus? European Journal of Cell Biology. February 2005:1-16. 
doi:10.1016/j.ejcb.2004.12.020. 
66. Al-Jassar C, Bikker H, Overduin M, Chidgey M. Mechanistic Basis of Desmosome-
Targeted Diseases. Journal of Molecular Biology. 2013;425(21):4006-4022. 
doi:10.1016/j.jmb.2013.07.035. 
67. Corrado D, Basso C, Judge D. Cardiomyopathy Compendium: Arrythmogenic 
Cardiomyopathy. Circulation. September 2017:1-19. 
doi:10.1161/CIRCRESAHA.117.309345.). 
68. Virani SS, Alonso A, Benjamin EJ, Tsao CW. Heart Disease and Stroke 
Statistics— 2020 Update. Circulation. February 2020:1-458. 
doi:10.1161/CIR.0000000000000757. 
69. Beffagna G, Occhi G, Nava A, Towbin JA, Danieli GA, Rampazzo A. Regulatory 
mutations in transforming growth factor-h3 gene cause arrhythmogenic right 
ventricular cardiomyopathy type 1. Cardiovasc Res. January 2005:1-8. 
doi:10.1016/j.cardiores.2004.10.005. 
70. van Tintelen JP, Entius MM, Bhuiyan ZA, et al. Plakophilin-2 Mutations Are the 
Major Determinant of Familial Arrhythmogenic Right Ventricular 
Dysplasia/Cardiomyopathy. Circulation. March 2006:1-9. 
doi:10.1161/CIRCULATIONAHA.105.609719. 
71. Patel DM, Dubash AD, Kreitzer G, Green KJ. Disease mutations in desmoplakin 
inhibit Cx43 membrane targeting mediated by desmoplakin–EB1 interactions. 
Journal of Cell Biology. September 2014:1-19. doi:10.1083/jcb.201312110. 
 139 
72. Kam CY, Dubash AD, Magistrati E, et al. Desmoplakin maintains gap junctions by 
inhibiting Ras/MAPK and lysosomal degradation of connexin-43. Journal of Cell 
Biology. August 2018:1-17. doi:10.1083/jcb.201710161&domain=pdf. 
73. Sato PY, Coombs W, Lin X, et al. Interactions Between Ankyrin-G, Plakophilin-2, 
and Connexin43 at the Cardiac Intercalated Disc. Circulation. June 2011:1-9. 
doi:10.1161/CIRCRESAHA.111.247023. 
74. Borrman C, Grund C, Kuhn C, Hofmann I, Pieperhoff S, Franke WW. The area 
composita of adhering junctions connecting heart muscle cells of vertebrates. II. 
Colocalizations of desmosomal and fascia adhaerens molecules in the intercalated 
disk. European Journal of Cell Biology. 2006;85(6):469-485. 
doi:10.1016/j.ejcb.2006.02.009. 
75. Goossens S, Janssens B, Bonne S, et al. A unique and specific interaction 
between  aT-catenin and plakophilin-2 in the area composita, the mixed-type 
junctional structure of cardiac intercalated discs. Journal of Cell Science. 
2007;120(12):2126-2136. doi:10.1242/jcs.004713. 
76. Pieperhoff S, Schumacher H, Franke WW. The area composita of adhering junctions 
connecting heart muscle cells of vertebrates. V. The importance of plakophilin-2 
demonstrated by small interference RNA-mediated knockdown in cultured rat 
cardiomyocytes. European Journal of Cell Biology. July 2008:1-13. 
doi:10.1016/j.ejcb.2007.12.002. 
77. Pieperhoff S, Franke WW. The area composita of adhering junctions connecting 
heart muscle cells of vertebrates – IV: Coalescence and amalgamation of 
desmosomal and adhaerens junction components – Late processes in mammalian 
heart development. European Journal of Cell Biology. June 2007:1-15. 
doi:10.1016/j.ejcb.2007.04.001. 
78. Goodenough DA, Paul DL. Gap Junctions. Cold Spring Harb Perspect Biol. June 
2009:1-19. doi:10.1101/cshperspect.a002576. 
79. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and 
connexin expression in diseased myocardium. Cardiovasc Res. September 2008:1-
11. doi:10.1093/cvr/cvn133. 
80. Goodenough DA, Goliger JA, Paul DL. Connexins, Connexons, and Intercellular 
Communication. Annual Reviews. January 1996:1-30. 
81. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc 
Res. April 2004:1-5. doi:10.1016/j.cardiores.2003.11.013. 
82. Lambiase PD, Tinker A. Connexins in the heart. Cell Tissue Research. May 2015:1-
10. doi:10.1007/s00441-014-2020-8. 
 140 
83. Verheule S, Kaese S. Connexin diversity in the heart: insights from transgenic 
mouse models. Frontiers in Pharmacology. June 2013:1-14. 
doi:10.3389/fphar.2013.00081/abstract. 
84. Ideker RE, Kong W, Pogwizd S. Purkinje Fibers and Arrhythmias. Pacing Clinical 
Electrophysiology. March 2010:1-4. doi:10.1111/j.1540-8159.2008.02232.x. 
85. Reaume AG, de Sousa PA, Kulkarni S, et al. Cardiac Malformation in Neonatal 
Mice Lacking Connexin43. Science. March 1995:1-7. doi:10.1126/science.7892609. 
86. Gutstein DE, Morley GE, Tamaddon H, et al. Conduction Slowing and Sudden 
Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43. 
Integrative Physiology. February 2001:1-7. 
87. Kaplan SR, Gard JJ, Protonotarios N, Brousse N, Fontaine G, Saffitz JE. 
Remodeling of myocyte gap junctions in arrhythmogenic right ventricular 
cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 
May 2004:1-9. doi:10.1016/j.hrthm.2004.01.001. 
88. Miller PW, Clarke DN, Weis WI, Lowe CJ, Nelson WJ. The Evolutionary Origin of 
Epithelial Cell–Cell Adhesion Mechanisms. In: Functional Organization of 
Vertebrate Plasma Membrane. Vol 72. Current Topics in Membranes. Elsevier; 
2013:267-311. doi:10.1016/B978-0-12-417027-8.00008-8. 
89. Pokutta S, Weis WI. Structure of the Dimerization and b-catenin-binding region of 
a-catenin. Molecular Cell. March 2000:1-11. 
90. Koslov ER, Maupin P, Pradhan D, Morrow JS, Rimm DL. 𝛂-Catenin Can Form 
Asymmetric Homodimeric Complexes and/or Heterodimeric Complexes with b-
Catenin. J Biol Chem. October 1997:1-7. 
91. Nieset JE, Redfield AR, Jin F, Knudsen KA, Johnson KR, Wheelock MJ. 
Characterization of the interactions of a-catenin with a-actinin and b-
catenin/plakoglobin. Journal of Cell Science. March 1997:1-10. 
92. Yang J, Barford D, Tonks NK, Dokurno P. Crystal structure of the M-fragment of a-
catenin: implications for modulation of cell adhesion. European Molecular Biology 
Organization. 2001:1-12. 
93. Pokutta S, Drees F, Takai Y, Nelson WJ, Weis WI. Biochemical and Structural 
Definition of the l-Afadin- and Actin-binding Sites of α-Catenin. J Biol Chem. 
2002;277(21):18868-18874. doi:10.1074/jbc.M201463200. 
94. Hirano Y, Amano Y, Yonemura S, Hakoshima T. The force-sensing device region 
of α-catenin is an intrinsically disordered segment in the absence of intramolecular 
stabilization of the autoinhibitory form. Genes Cells. 2018;7:357–16. 
doi:10.1111/gtc.12578. 
 141 
95. Choi H-J, Pokutta S, Weis WI. αE-catenin is an autoinhibited molecule that 
coactivates vinculin. Proc Natl Acad Sci USA. May 2012:1-6. 
doi:10.1073/pnas.1203906109/-/DCSupplemental. 
96. Thomas WA, Boscher CC, Chu Y-S, et al. 𝛂-Catenin and Vinculin Cooperate to 
Promote High E-cadherin-based Adhesion Strength. J Biol Chem. 
2013;288(7):4957-4969. doi:10.1074/jbc.M112.403774. 
97. Ishiyama N, Tanaka N, Abe K, Takeichi M, Ikura M. An Autoinhibited Structure of 
a-Catenin and Its Implications for Vinculin Recruitment to Adherens Junctions. J 
Biol Chem. May 2013:1-14. 
98. Ishiyama N, Sarpal R, Wood MN, et al. Force-dependent allostery of the a-catenin 
actin-binding domain controls adherens junction dynamics and functions. Nature 
Communications. November 2018:1-17. doi:10.1038/s41467-018-07481-7. 
99. Mei L, de los Reyes SE, Reynolds MJ, Leicher R, Liu S, Alushin GM. Molecular 
mechanism for direct actin force-sensing by 𝛂-catenin. eLife. October 2020:1-32. 
doi:10.7554/eLife.62514. 
100. Xu X-P, Pokutta S, Torres M, et al. Structural basis of 𝛂E-catenin-F-actin catch 
bond behavior. eLife. October 2020:1-21. doi:10.7554/eLife.60878. 
101. Shibahara T, Hirano Y, Hakoshima T. Structure of the free form of the N‐terminal 
VH1 domain of monomeric α‐catenin. FEBS. June 2015:1-7. 
doi:10.1016/j.febslet.2015.05.053. 
102. Yao M, Qiu W, Liu R, et al. Force-dependent conformational switch of alpha-
catenin controls vinculin binding. Nature Communications. 2014;5:1-11. 
doi:10.1038/ncomms5525. 
103. Li J, Newhall J, Ishiyama N, et al. Structural Determinants of the Mechanical 
Stability of 𝛂-Catenin. J Biol Chem. July 2015:1-14. 
104. Barrick SK, Li J, Kong X, Ray A, Tajkhorshid E, Leckband DE. Salt bridges gate 𝛂-
catenin activation at intercellular junctions. Molecular Biology of the Cell. January 
2018:1-12. doi:10.1091/mbc.E17-03-0168). 
105. Terekhova K, Pokutta S, Kee YS, et al. Binding partner- and force- promoted 
changes in αE-catenin conformation probed by native cysteine labeling. Scientific 
Reports. October 2019:1-13. doi:10.1038/s41598-019-51816-3. 
106. Rangarajan ES, Izard T. Dimer asymmetry defines α-catenin interactions. Nature 
Structural & Molecular Biology. 2013;20(2):188-193. doi:10.1038/nsmb.2479. 
107. Mayerhofer A. Human testicular peritubular cells: more than meets the eye. 
Reproduction. April 2013:1-10. doi:10.1530/REP-12-0497. 
 142 
108. Maiden SL, Hardin J. The secret life of 𝛂-catenin: Moonlighting in morphogenesis. 
Journal of Cell Biology. November 2011:1-10. doi:10.1083/jcb.201103106. 
109. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. Hyperproliferation and 
Defects in Epithelial Polarity upon Conditional Ablation of a-Catenin in Skin. Cell. 
February 2001:1-13. 
110. Lien W-H, Klezovitch O, Fernandez TE, Delrow J, Vasioukhin V. aE-Catenin 
Controls Cerebral Cortical Size by Regulating the Hedgehog Signaling Pathway. 
Science. 2006;311(5767):1606-1609. doi:10.1126/science.1123513. 
111. Qiao J, Rellinger EJ, Kim KW, et al. Identification of α-N-catenin as a novel tumor 
suppressor in neuroblastoma. Oncotarget. August 2019:1-13. 
112. Austin KM, Trembley MA, Chandler SF, et al. Molecular mechanisms of 
arrhythmogenic cardiomyopathy. Nature Reviews Cardiology. August 2019:1-19. 
doi:10.1038/s41569-019-0200-7. 
113. Fanjul-Fernandez M, Quesada V, Cabanillas R, et al. Cell-cell adhesion genes 
CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal 
carcinomas. Nature Communications. October 2013:1-9. doi:10.1038/ncomms3531. 
114. Stahn V, Nagel I, Fischer-Huchzermeyer S, et al. Molecular Analysis of Hybrid 
Neurofibroma/Schwannoma Identifies Common Monosomy 22 and &alpha;-T-
Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor. The American Journal 
of Pathology. 2016;186(12):3285-3296. doi:10.1016/j.ajpath.2016.08.019. 
115. Miyashita A, Arai H, Asada T, et al. Genetic association of CTNNA3 with late-
onset Alzheimer’s disease in females. Human Molecular Genetics. November 
2007:1-16. doi:10.1093/hmg/ddm244. 
116. Smith JD, Meehan MH, Crean J, McCann A. Alpha T-catenin (CTNNA3): a gene in 
the hand is worth two in the nest. Cell and Molecular Life Sciences. July 2011:1-6. 
doi:10.1007/s00018-011-0728-0. 
117. O’Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly 
interconnected protein network of de novo mutations. Nature. April 2012:1-7. 
doi:10.1038/nature10989. 
118. Bacchelli E, Ceroni F, Pinto D, et al. A CTNNA3 compound heterozygous deletion 
implicates a role for aT-catenin in susceptibility to autism spectrum disorder. 
2014;6(1):1-11. doi:10.1186/1866-1955-6-17. 
119. Folmsbee SS, Wilcox DR, Tyberghein K, et al. αT-catenin in restricted brain cell 
types and its potential connection to autism. Journal of Molecular Psychiatry. April 
2016:1-13. doi:10.1186/s40303-016-0017-9. 
 143 
120. Zhang Y, Chen K, Sloan S, et al. An RNA-Sequencing Transcriptome and Splicing 
Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. Journal of 
Neuroscience. December 2014:1-19. doi:10.1523/JNEUROSCI.1860-14.2014. 
121. Busby V, Goossens S, Nowotny P, Janssens B, van Roy F, Lovestone S. aT-Catenin 
Is Expressed in Human Brain and Interacts With the Wnt Signaling Pathway But Is 
Not Responsible for Linkage to Chromosome 10 in Alzheimer’s Disease. 
NeuroMolecular Medicine. April 2004:1-14. 
122. Aberle H, Butz S, Stappert J, Weissig H, Kemler R, Hoschuetzky H. Assembly of 
the cadherin-catenin complex in vitro with recombinant proteins. Journal of Cell 
Science. August 1994:1-9. 
123. Heier JA, Pokutta S, Dale IW, et al. Distinct intramolecular interactions regulate 
autoinhibition of vinculin binding in 𝛂T-catenin and 𝛂E-catenin. J Biol Chem. 
2021;296:100582. doi:10.1016/j.jbc.2021.100582. 
124. Daugherty RL, Serebryannyy L, Yemelyanov A, et al. α-Catenin is an inhibitor of 
transcription. Proc Natl Acad Sci USA. April 2014:1-6. 
doi:10.1073/pnas.1308663111. 
125. Sun Y, Zhang J, Ma L. 𝛂-Catenin: A tumor supressor beyond adherens junctions. 
Cell Cycle. July 2014:1-6. doi:10.4161/cc.29765. 
126. Dominguez R, Holmes KC. Actin Structure and Function. Annual Reviews. June 
2011:1-20. doi:10.1146/annurev-biophys-042910-155359. 
127. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. α-Catenin Is a Molecular 
Switch that Binds E-Cadherin-β-Catenin and Regulates Actin-Filament Assembly. 
Cell. 2005;123(5):903-915. doi:10.1016/j.cell.2005.09.021. 
128. Benjamin JM, Kwiatkowski AV, Yang C, et al. αE-catenin regulates actin dynamics 
independently of cadherin-mediated cell–cell adhesion. J Cell Biol. 
2010;189(2):339-352. doi:10.1083/jcb.200910041. 
129. Lee SE, Chunsrivirot S, Kamm RD, Mofrad MRK. Molecular Dynamics Study of 
Talin-Vinculin Binding. Biophysical Journal. July 2008:1-10. 
doi:10.1529/biophysj.107.124487. 
130. Burridge K, Chrzanowska-Wodnicka M. Focal Adhesions, Contractility, and 
Signaling. Annual Reviews. June 1996:1-58. 
131. Watabe-Uchida M, Uchida N, van Roy F, Takeichi M. a-Catenin-Vinculin 
Interaction Functions to Organize the Apical Junctional Complex in Epithelial Cells. 
Journal of Cell Biology. July 1998:1-11. 
 144 
132. Weiss EE, Kroemker M, Rudiger A-H, Jockusch BM. Vinculin Is Part of the 
Cadherin–Catenin Junctional Complex: Complex Formation between 𝛂-Catenin and 
Vinculin. J Biol Chem. April 1998:1-10. 
133. Xu W, Baribault H, Adamson ED. Vinculin knockout results in heart and brain 
defects during embryonic development. Development. December 1997:1-11. 
134. Zemljic-Harpf AE, Ponrartana S, Avalos RT, et al. Heterozygous Inactivation of the 
Vinculin Gene Predisposes to Stress-Induced Cardiomyopathy. The American 
Journal of Pathology. 2004;165(3):1033-1044. doi:10.1016/S0002-9440(10)63364-
0. 
135. Zemljic-Harpf AE, Miller JC, Henderson SA, et al. Cardiac-Myocyte-Specific 
Excision of the Vinculin Gene Disrupts Cellular Junctions, Causing Sudden Death 
or Dilated Cardiomyopathy. Molecular and Cellular Biology. 2007;27(21):7522-
7537. doi:10.1128/MCB.00728-07. 
136. Shiraishi I, Simpson DG, Carver W, et al. Vinculin is an Essential Component for 
Normal Myofibrillar Arrangement in Fetal Mouse Cardiac Myocytes. Journal of 
Molecular and Cellular Cardiology. August 1997:1-12. 
137. Vasile VC, Ommen SR, Edwards WD, Ackerman MJ. A missense mutation in a 
ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic 
cardiomyopathy. Biochemical and Biophysical Research Communications. May 
2006:1-6. doi:10.1016/j.bbrc.2006.04.151. 
138. Rangarajan ES, Izard T. The Cytoskeletal Protein 𝛂-Catenin Unfurls upon Binding 
to Vinculin. J Biol Chem. 2012;287(22):18492-18499. 
doi:10.1074/jbc.M112.351023. 
139. Peng X, Nelson ES, Maiers JL, DeMali KA. New Insights into Vinculin Function 
and Regulation. Internal Review of Cell and Molecular Biology. May 2011:1-39. 
doi:10.1016/B978-0-12-386043-9.00005-0. 
140. Bakolitsa C, Cohen DM, Bankston LA, et al. Structural basis for vinculin activation 
at sites of cell adhesion. Nature. July 2004:1-4. 
141. Carisey A, Tsang R, Greiner AM, et al. Vinculin Regulates the Recruitment and 
Release of Core Focal Adhesion Proteins in a Force-Dependent Manner. Current 
Biology. 2013;23(4):271-281. doi:10.1016/j.cub.2013.01.009. 
142. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat 
Rev Mol Cell Biol. 2005;6(8):622-634. doi:10.1038/nrm1699. 
143. Collinet C, Lecuit T. Stability and Dynamics of Cell-Cell Junctions. Progress in 
Molecular Biology and Translation Science. June 2013. 
 145 
144. Nelson WJ. Rugulation of cell-cell adhesion by the cadherin-catenin complex. 
Biochemical Society Transactions. June 2008:1-12. doi:10.1042/BST0360149. 
145. Ratheesh A, Yap AS. A bigger picture: classical cadherins and the dynamic actin 
cytoskeleton. Nat Rev Mol Cell Biol. September 2012:1-7. doi:10.1038/nrm3431. 
146. Brasch J, Harrison OJ, Honig B, Shapiro L. Thinking outside the cell: how cadherins 
drive adhesion. Trends in Cell Biology. June 2012:1-23. 
doi:10.1016/j.tcb.2012.03.004. 
147. Shapiro L, Weis WI. Structure and Biochemistry of Cadherins and Catenins. Cold 
Spring Harb Perspect Biol. August 2009:1-23. doi:10.1101/cshperspect.a003053. 
148. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the Cadherin-
Catenin-Actin Complex. Cell. 2005;123(5):889-901. doi:10.1016/j.cell.2005.09.020. 
149. Yonemura S, Wada Y, Watanabe T, Nagafuchi A, Shibata M. α-Catenin as a tension 
transducer that induces adherens junction development. Nature Publishing Group. 
2010;12(6):533-542. doi:10.1038/ncb2055. 
150. Kim T-J, Zheng S, Sun J, et al. Dynamic Visualization of α-Catenin Reveals Rapid, 
Reversible Conformation Switching between Tension States. Current Biology. 
2015;25(2):218-224. doi:10.1016/j.cub.2014.11.017. 
151. Lyon RC, Zanella F, Omens JH, Sheikh F. Mechanotransduction in Cardiac 
Hypertrophy and Failure. Circulation Research. April 2015:1-15. 
doi:10.1161/CIRCRESAHA.116.304937.). 
152. Li J, Gao E, Goossens S, van Roy F, Radice GL. Alpha-Catenins Control 
Cardiomyocyte Proliferation by Regulating Yap Activity. Integrative Physiology. 
December 2014:1-25. doi:10.1161/CIRCRESAHA.116.304472/-/DC1. 
153. Folmsbee SS, Morales-Nebreda L, van Hengel J, et al. The cardiac protein 𝛂T-
catenin contributes to chemical induced asthma. American Journal of Physiology. 
December 2014:1-6. doi:10.1152/ajplung.00331.2014. 
154. Barry AK, Tabdili H, Muhamed I, et al. α-Catenin cytomechanics – role in cadherin-
dependent adhesion and mechanotransduction. Journal of Cell Science. April 
2014:1-31. doi:10.1242/jcs.139014. 
155. Kwiatkowski AV, Pokutta S, Choi H-J, Nelson WJ, Weis WI. In vitro and in vivo 
reconstitution of the cadherin– catenin–actin complex from Caenorhabditis elegans. 
Proc Natl Acad Sci USA. January 2016:1-10. doi:10.1073/pnas.1007349107/-
/DCSupplemental/pnas.1007349107_SI.pdf. 
156. Miller PW, Pokutta S, Ghosh A, et al. Danio rerio αE-catenin Is a Monomeric F-
actin Binding Protein with Distinct Properties from Mus musculus αE-catenin. J 
Biol Chem. 2013;288(31):22324-22332. doi:10.1074/jbc.M113.458406. 
 146 
157. Siegel LM, Monty KJ. Determination of Molecular Weights and Frictional Ratios of 
Proteins in Impure Systems by use of Gel Filtration and Density Gradient 
Centrifugation. Application to Crude Preparations of Sulfite and Hydroxylamine 
Reductases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 
March 2003:1-17. 
158. Choi SH, Estaras C, Moresco JJ, Yates JR, Jones KA. a-Catenin interacts with APC 
to regulate b-catenin proteolysis and transcriptional repression of Wnt target genes. 
Genes and Development. November 2013:1-17. doi:10.1101/gad.229062.113. 
159. Hansen SD, Kwiatkowski AV, Ouyang C-Y, et al. 𝛂E-catenin actin-binding domain 
alters actin filament conformation and regulates binding of nucleation and 
disassembly factors. Molecular Biology of the Cell. November 2013:1-11. 
doi:10.1091/mbc.E13-07-0388). 
160. Janssen MEW, Kim E, Liu H, et al. Three-Dimensional Structure of Vinculin Bound 
to Actin Filaments. Molecular Cell. January 2006:1-11. 
doi:10.1016/j.molcel.2005.11.020. 
161. Bianchini JM, Kitt KN, Gloerich M, Pokutta S, Weis WI, Nelson WJ. Reevaluating 
αE-catenin monomer and homodimer functions by characterizing E-cadherin/αE-
catenin chimeras. J Cell Biol. 2015;210(7):1065-1074. doi:10.1083/jcb.201411080. 
162. Frank D, Frey N. Cardiac Z-disc Signaling Network. J Biol Chem. 
2011;286(12):9897-9904. doi:10.1074/jbc.R110.174268. 
163. Knudsen KA, Soler AP, Wheelock MJ. Interaction of a-Actinin with the 
Cadherin/Catenin Cell-Cell Adhesion Complex via a-Catenin. J Cell Biol. 1995:1-
11. 
164. Maki K, Han S-W, Hirano Y, Yonemura S, Hakoshima T, Adachi T. Mechano-
adaptive sensory mechanism of α-catenin under tension. Nature Publishing Group. 
April 2016:1-9. doi:10.1038/srep24878. 
165. Needham PG, Trumbly RJ. In vitro characterization of the Mig1 repressor from 
Saccharomyces cerevisiae reveals evidence for monomeric and higher molecular 
weight forms. Yeast. June 2006:1-16. doi:10.1002/yea.1429. 
166. Fowler VM. Identification and purification of a novel Mr 43,000 tropomyosin-
binding protein from human erythrocyte membranes. J Biol Chem. 
1987;262(26):12792-12800. doi:10.1016/S0021-9258(18)45276-3. 
167. Ehler E, Moore-Morris T, Lange S. Isolation and Culture of Neonatal Mouse 
Cardiomyocytes. JoVE. 2013;(79):1-10. doi:10.3791/50154. 
168. Rubsam M, Broussard JA, Wickstrom SA, Nekrasova O, Green KJ, Niessen CM. 
Adherens Junctions and Desmosomes Coordinate Mechanics and Signaling to 
 147 
Orchestrate Tissue Morphogenesis and Function: An Evolutionary Perspective. Cold 
Spring Harb Perspect Biol. October 2018:1-23. doi:10.1101/cshperspect.a029207. 
169. Priest AV, Shafraz O, Sivasankar S. Biophysical basis of cadherin mediated cell-cell 
adhesion. Experimental Cell Research. 2017;358(1):10-13. 
doi:10.1016/j.yexcr.2017.03.015. 
170. Meng W, Takeichi M. Adherens Junction: Molecular Architecture and Regulation. 
Cold Spring Harb Perspect Biol. November 2009:1-15. 
doi:10.1101/cshperspect.a002899. 
171. Imamura Y, Nagafuchi A, Itoh M. Functional Domains of a-Catenin Required for 
the Strong State of Cadherin-based Cell Adhesion. Journal of Cell Biology. March 
1999:1-12. 
172. le Duc Q, Shi Q, Blonk I, et al. Vinculin potentiates E-cadherin mechanosensing and 
is recruited to actin-anchored sites within adherens junctions in a myosin II–
dependent manner. J Cell Biol. 2010;189(7):1107-1115. doi:10.1083/jcb.201001149. 
173. Maki K, Han S-W, Hirano Y, Yonemura S, Hakoshima T, Adachi T. Real-time 
TIRF observation of vinculin recruitment to stretched α-catenin by AFM. Scientific 
Reports. January 2018:1-8. doi:10.1038/s41598-018-20115-8. 
174. Twiss F, le Duc Q, van der Horst S, et al. Vinculin-dependent Cadherin 
mechanosensing regulates efficient epithelial barrier formation. Biology Open. 
November 2012:1-15. doi:10.1242/bio.20122428. 
175. Hulpiau P, Gul IS, van Roy F. New Insights into the Evolution of Metazoan 
Cadherins and Catenins. Progress in Molecular Biology and Translation Science. 
June 2013:1-1. 
176. Pang SM, Le S, Kwiatkowski AV, Yan J. Mechanical stability of ⍺T-catenin and its 
activation by force for vinculin binding. Molecular Biology of the Cell. July 2019:1-
8. doi:10.1091/mbc.E19-02-0102). 
177. Li Y, Merkel CD, Zeng X, et al. The N-Cadherin Interactome in Primary 
Cardiomyocytes as Defined Using Quantitative Proximity Proteomics. Journal of 
Cell Science. 2019;132(3):jcs229757–16. doi:10.1242/jcs.229757. 
178. Wood MN, Ishiyama N, Singaram I, et al. α-Catenin homodimers are recruited to 
phosphoinositide-activated membranes to promote adhesion. J Cell Biol. 
2017;54:jcb.201612006-jcb.201612017. doi:10.1083/jcb.201612006. 
179. Huveneers S, Oldenburg J, Spanjaard E, et al. Vinculin associates with endothelial 
VE-cadherin junctions to control force-dependent remodeling. Journal of Cell 
Biology. March 2012:1-12. doi:10.1083/jcb.201108120. 
 148 
180. Guo Z, Neilson LJ, Zhong H, et al. E-cadherin interactome complexity and 
robustness resolved by quantitative proteomics. Science Signaling. November 
2014:1-28. doi:10.1126/scisignal.2005473. 
181. Sakakibara S, Mizutani K, Sugiura A, et al. Afadin regulates actomyosin 
organization through αE-catenin at adherens junctions. J Cell Biol. 
2020;219(5):549–16. doi:10.1083/jcb.201907079. 
182. Oldenburg J, van der Krogt G, Twiss F, et al. VASP, zyxin and TES are tension- 
dependent members of Focal Adherens Junctions independent of the α-catenin-
vinculin module. Scientific Reports. November 2015:1-14. doi:10.1038/srep17225. 
183. Kobielak A, Fuchs E. α-Catenin: At the Junction of Intercellular Adhesion and Actin 
Dynamics. Nat Rev Mol Cell Biol. August 2004:1-28. 
184. Abe K, Takeichi M. EPLIN mediates linkage of the cadherin–catenin complex to F-
actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci USA. January 
2008:1-7. 
185. Giannini AL, Vivanco MDM, Kypta RM. α-Catenin Inhibits β-Catenin Signaling by 
Preventing Formation of a β-Catenin·T-cell Factor·DNA Complex. J Biol Chem. 
2000;275(29):21883-21888. doi:10.1074/jbc.M001929200. 
186. Neuber S, Muhmer M, Wratten D, Koch PJ, Moll R, Schmidt A. The Desmosomal 
Plaque Proteins of the Plakophilin Family. Dermatology Research and Practice. 
April 2010:1-11. doi:10.1155/2010/101452. 
187. Cerrone M, Montnach J, Lin X, et al. Plakophilin-2 is required for transcription of 
genes that control calcium cycling and cardiac rhythm. Nature Communications. 
July 2017:1-16. doi:10.1038/s41467-017-00127-0. 
188. Pollard TD. Actin and Actin-Binding Proteins. Cold Spring Harb Perspect Biol. July 
2016:1-19. doi:10.1101/cshperspect.a018226. 
189. Hansen MDH, Kwiatkowski AV. Control of Actin Dynamics by Allosteric 
Regulation of Actin Binding Proteins. Internal Review of Cell and Molecular 
Biology. June 2013. 
190. Lappalainan P. Actin-binding proteins: the long road to understanding the dynamic 
landscape of cellular actin networks. Molecular Biology of the Cell. August 2016:1-
4. doi:10.1091/mbc.E15-10-0728. 
191. Mullins RD, Hansen SD. In vitro studies of actin filament and network dynamics. 
Current Opinion in Cell Biology. 2013;25(1):6-13. doi:10.1016/j.ceb.2012.11.007. 
192. Simpson RJ, Adams PD, Golemis E. Basic Methods in Protein Purification and 
Analysis. 2009. 
 149 
193. Laemmli UK. Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature. 1970;227(5259):680-685. doi:10.1038/227680a0. 
194. Pollard TD. A Guide to Simple and Informative Binding Assays. Molecular Biology 
of the Cell. 2010;21(23):4061-4067. doi:10.1091/mbc.E10-08-0683. 
195. Perrin BJ, Ervasti JM. The Actin Gene Family: Function Follows Isoform. 
Cytoskeleton. September 2010:1-5. doi:10.1002/cm.20475). 
196. Tondeleir D, Vandamme D, Vandekerckhove J, Ampe C, Lambrechts A. Actin 
isoform expression patterns during mammalian development and in pathology: 
insights from mouse models. Cell Motil Cytoskeleton. 2009;66(10):798-815. 
doi:10.1002/cm.20350. 
197. Prochniewicz E, Janson N, Thomas DD, La Cruz De EM. Cofilin Increases the 
Torsional Flexibility and Dynamics of Actin Filaments. Journal of Molecular 
Biology. October 2005:1-11. doi:10.1016/j.jmb.2005.09.021. 
198. Kuhn JR, Pollard TD. Real-Time Measurements of Actin Filament Polymerization 
by Total Internal Reflection Fluorescence Microscopy. Biophysj. 2005;88(2):1387-
1402. doi:10.1529/biophysj.104.047399. 
199. Hansen SD, Zuchero JB, Mullins RD. Cytoplasmic Actin: Purification and Single 
Molecule Assembly Assays. In: Coutts AS, ed. Adhesion Protein Protocols: 
Purification and Single Molecule. Adhesion Protein Protocols. Totowa, NJ: Humana 
Press; 2013:145-170. 
